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ABSTRACT

Autism is a severe developmental disorder that was first described by Kanner
in 1943. It is characterised by four major criteria: marked social deficits, delay in
language development, a restricted range of stereotyped repetitive behaviours and
onset of the disease within the first three years of life.
The last decade of research has provided support for a strong genetic basis in
the aetiology of autism. Firstly, a number of genetic conditions, such as fragile X
syndrome, chromosome 15 anomalies and tuberous sclerosis, have been associated
with autism. Secondly, family studies have demonstrated that the recurrence risk for
autism among siblings of autistic children is 50-200 times higher compared to the
risk of autism in the general population (4-5 in 10 OOO births). Thirdly, twin studies
show a significantly higher concordance rate among monozygotic twins compared to
dizygotic twins.
To explore the theory of a biological basis of autism, molecular genetic
strategies were employed in this study. Two collaborative groups (Stanford
University in the U.S.A. and Edith Cowan University/Graylands Hospital in Perth,
Australia) scanned the entire human genome for autism susceptibility genes in 90
American multiplex families, making this the largest genome screen in autism to
date. Candidate regions were also run in an additional group of 41 Australian
multiplex families. One hundred of the total of 519 markers were analysed as part of
this PhD project. Since autism is most likely a complex disorder involving
interacting genes with unknown modes of inheritance, non-parametric linkage
analysis utilising the multipoint sib-pair approach is the best method presently
available for identifying these susceptibility genes.
ii

Using this method and given the power of the study to reliably detect genes
of moderate effect, findings from this PhD project and the overall genome scan
provide substantial evidence for the absence of such genes in autism. Regions that
may, however, contain these disease-predisposing loci were identified. These
include regions on chromosomes l p and 22q. Results from other smaller genome
scanning studies also indicate these two candidate regions as possibly containing loci
involved in the aetiology of autism. Our results could also not exclude chromosomes
7q, 9q, l Oq, 1 l p and 17, regions that have previously been suggested by other studies
to contain susceptibility loci. Overall, our data were most consistent with a model of
2:::15

susceptibility loci, each with a small effect on autism.
These results are important for future studies. In particular, they have shown

the requirement for a large sample size to detect genes of small effect contributing to
a disorder. Whilst it may be difficult for individual research groups to recruit an
adequate sample size, collaboration with other groups may provide sufficient power
to detect these susceptibility loci. By combining our results with those from other
linkage studies on autism, we may also be able to eliminate some genetic models for
this disease and provide an insight into the boundaries of the autistic phenotype.
With advances in the Human Genome Project and the development of
rigorous statistical approaches to the analysis of multifactorial diseases, the
molecular characterisation of genes that have a small effect on the overall aetiology
of complex polygenic disorders, such as autism, could soon be feasible.

iii
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CHAPTER 1
INTRODUCTION AND LITERATURE REVIEW

1.1

Introduction

Autism is a severe, lifelong neuropsychiatric disorder with a profound impact
on the affected individuals, their families and society at large. The causes of autism
remain unknown, however a large number of observations suggest that genetic factors
may play a role in its aetiology. This PhD project explores this hypothesis via the
search for susceptibility genes for autism throughout the human genome.
The introduction and literature review begin by giving a historical perspective
on the study of autism and the changes in diagnostic criteria throughout the last 40
years, resulting in what is thought to be a more valid method of diagnosis (ICD-10 &
DSM-IV). The findings from epidemiological research in autism are then described,
followed by an account of the aetiological models of autism. Specific reference is
made to the genetic model and diseases thought to co-occur with autism that could
point to candidate regions in the genome. A brief review on the brain mechanisms
that are thought to be involved in autism follows. Although there is extensive
literature on this subject, only areas relevant to the genetics of autism are reviewed.
The introduction concludes by suggesting the modes of inheritance which are most
pertinent to this disorder. Using these models, the methods ·of linkage analysis that
could be applied to locate susceptibility loci are described.
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1.2

Historical Overview of Autism

Children exhibiting symptoms similar to autism have been recognised for a
long time, with the earliest reports made at the beginning of the 19th century (Vaillant,
1962). Clear descriptions have been given by Haslam (1809), Itard (translation into
English by Lane 1976), and Critchley and Earl (1932). However, it was Leo Kanner
(1943) and Hans Asperger (1944), independent of each other, who first described the
syndrome and assigned to it a particular name including reference to autism. Kanner
was the first to outline the common characteristics and special qualities of the
behaviour of children with autism. His original paper outlined 11 children carefully
observed over 5 years. These individuals all shared "fascinating peculiarities";
including delayed echolalia, pronoun reversal, failure to use speech to communicate,
an anxious desire to preserve sameness, repetitive behaviours, failure to anticipate
being lifted, a general lack of awareness of other people's existence or feelings and a
lack of ability to play imaginatively with other children. He also described these
children as having a normal intellectual potential (based mainly on their "intelligent
physiognomies") and good physical health. Although his assumptions about normal
intelligence were refuted in future studies due to the occurrence of mentally retarded
individuals with autism, Kanner's description of autism continues to be one of the
most vivid representations of the behaviour of autistic children.
Asperger' s ( 1944) definition of the syndrome (autistic psychopathy) was very
similar to the disease Kanner described at the symptom level, however, there were
some notable differences. Asperger's definition did not specify an age of onset,
whereas to be diagnosed with Kanner' s definition of autism the onset of the disease
had to be within the first 3 years of life. Also, the children described by Asperger all
2

developed speech before school age, they typically had large vocabularies and
reasonable grammar, and, although socially isolated, they were not unaware of the
existence of others. Asperger described the children he studied as odd in appearance
in contrast to the alert, attractive look often mentioned as typical of the children
Kanner studied. According to the International Classification of Diseases (ICD-10)
the syndromes described by Kanner and Asperger are two separate disorders, namely
autism and Asperger syndrome respectively. The main criteria that distinguish these
two disorders are the lack of mental retardation as well as the absence of a language
delay in individuals with Asperger syndrome. It has also been noted that Asperger
syndrome is at least five times more common than the autistic disorder (Gillberg,
1989; Ehlers and Gillberg, 1993). Whether Asperger disorder and autism represent
aetiologically separate entities, rather than different degrees of severity of the same
condition, is not yet known (Volkmar et al., 1994; Frith, 1991). With the identity of
the genes involved in the "core" syndrome of autism, it is hoped that the boundary of
the autistic phenotype can be determined.

1.3

Clinical Diagnosis of Autism

The classification and diagnosis of autism have changed over time as the key
features and associated characteristics of the disorder have been revised. Until
recently, there were two predominant models for the diagnosis of psychiatric
disorders, rnµnely "the great professor" principle and "the consensus of experts". In
the beginning of this century, many great men in psychiatry, including Kraepelin and
Bleuler, developed and published their own diagnostic systems of the major psychoses
3

(Kraepelin and Diefendorf, 1 923 ; Bleuler and Brill, 1924 ). Whether these diagnostic
criteria were accepted or rejected relied on many factors (e. g. clarity of thought and
clinical applicability). Ultimately, however, the validity of these systems rested on the
personal authority of their originators which was generally only feasible within the
region of the country in which they lived (Kendler, 1990). This led to the use of
different diagnostic systems in different countries or even different regions within the
same country. With the development of national and international psychiatric
organisations, committees were formed to resolve specific diagnostic issues. This was
generally achieved by the "consensus of experts" approach, although sometimes the
issue would be put to a vote. Examples of diagnostic criteria formulated using this
approach are the Diagnostic and Statistical Manual of Mental Disorders I and II
(DSM-I and DSM-II; American Psychiatric Association (APA), 1952 and 1968)
Kanner and Eisenberg ( 1956) were the first to define a set of diagnostic
criteria for autism. These became known as "Kanner' s criteria" and included the
following:
(I)

profound lack of affective contact with other people,

(II)

an anxiously obsessive desire for the preservation of sameness in the child's
routines and environment,

(III)

a fascination for objects, which are handled with skill in fine motor
movements,

(IV)

mutism or a kind oflanguage that does not seem intended for inter-personal
communication,

(V)

good cognitive potential shown in feats of memory or skills on performance
tests.
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They also emphasised that onset of autism should be from birth or before 30 months
of age, and that the first two criteria were essential for the diagnosis. They stated in
this paper that, if a child was diagnosed with the first two features, the rest of the
typical clinical picture would also be found.
Rutter (1978) developed the second set of diagnostic criteria. He suggested
four criteria for defining childhood autism. These were:
(I)

impaired social development which has a number of special characteristics out
of keeping with the child's intellectual level,

(II)

delayed and deviant language development that also has certain defined
features and is out of keeping with the child's intellectual level,

(III)

"insistence on sameness" as shown by stereotyped play patterns, abnormal
preoccupations or resistance to change,

(IV)

Onset before 30 months
The American Psychiatric Association and the World Health Organisation

(WHO) have also published their definitions of autism in the Diagnostic and Statistical
Manual of Mental Disorders (DSM) and the International Classification of Diseases
(ICD), respectively. The development of DSM-III (American Psychiatric
Association, 1980) saw a change in the way autism was defined, mainly due to the
increased knowledge obtained through research. These organisations used available
scientific information in the development and evaluation of proposed changes and
used diagnostic criteria that would greatly facilitate the reliability and validity of future
studies (Kendler, 1990).
DSM-III and DSM-III-R (American Psychiatric Association, 1987) contained
criteria for autism which were quite different from each other and from those of the
International Classification of Diseases (ICD). The DSM-III-R diagnostic criteria of
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autism tended to overdiagnose this disorder compared with the ICD-1 0 (World
Health Organisation, 1990) and the DSM-III. DSM-III-R also elaborated the
symptoms of autistic disorder, discarded the age criterion and did not contain the
childhood-onset pervasive developmental disorder subgroup. The criteria used in
ICD-1 0 and, recently, DSM-IV (American Psychiatric Association, 1 994 ) are
different again from their previous versions, however, they are essentially similar to
each other and will allow future studies conducted in different countries to be more
comparable.
Regardless of the diagnostic manual used, the diagnosis of autism rests on a
set of behavioural criteria, invariably comprising communication, social interaction
and behavioural deficits. Each manual emphasises slightly different sub-criteria for
each class of these symptoms. However, they all agree that there must be severe
problems: (I ) in the ability to develop relationships with people; (2) in the
development of speech, with abnormal language patterns and communicative use of
speech after it develops; and (3) in coping with any forced change in routine. These
three categories of problems are now often referred to as "the triad of social, language
and behavioural impairment" (Wing, 1981 ). Some manuals (Kanner and Eisenberg,
1956; Rutter, 1 978; APA, 1 980; WHO, 1 990; WHO, 1992 ; APA, 1994) require that
the age of onset be before 3 0-36 months, whereas others specify only that signs of the
triad be present from infancy or childhood (APA, 1987). The set of diagnostic criteria
of the DSM-IV and the ICD-1 0 are the ones currently most often used. The criteria
in the ICD-1 0 manual were used to diagnose the subjects for this study (Table 1 ).
The precision of these definitions will continue to evolve as new research
clarifies the phenotype (visible characteristics of autism). At present, DSM-IV
International Field Trials have indicated that the clinical diagnosis of autism remains
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one of the most reliable diagnoses in psychiatric or developmental research (Volkmar

et al., 1994).
Table 1 : Diagnostic Criteria for Autistic Disorder

A. Qualitative impairments in reciprocal social interaction, as manifested by at least two of
the following four:

( 1 ) Failure adequately to use eye-to-eye gaze, facial expression, body posture and gesture
to regulate social interaction

(2) Failure to develop peer relationships that involve a mutual sharing of interests,
activities, and emotions

(3) Lack of socio-emotional reciprocity
(4 ) Lack of spontaneous seeking to share enjoyment, interests, or achievements with other
people (eg. a lack of showing, bringing, or pointing out to other people objects of
interest to the individual)
B . Qualitative impainnents in communication as manifested by at least one of the following
four
( 1 ) a delay in, or total lack of, development of spoken language that is not accompanied
by an attempt to compensate through alternative modes of communication
(2) relative failure to initiate or sustain conversational interchange
(3 ) stereotyped and repetitive use of words or phrases
(4) lack of varied spontaneous make-believe or social imitative play
C. Restricted, repetitive, and stereotyped patterns of behaviour, interests, and activities, as
manifested by at least one of the following four:
( 1 ) Encompassing preoccupation with stereotyped and restricted patterns of interest
(2) Apparently compulsive adherence to specific, non-functional, routines/rituals
(3) Stereotyped and repetitive motor mannerisms
(4) Preoccupations with part-objects or non-functional elements of play material
D. At least six of the above twelve symptoms must be present.
E. Developmental abnormalities (in at least one of language, social interaction, or play) must
have been present in the first 3 years for the diagnosis to be made.
Table from ICD-10, WHO (World Health Organization) 1992.
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1.4

Epidemiology

Epidemiology is the branch of medical science that deals with the incidence,
distribution, and control of disease in a population (Webster's). Prevalence refers to
the rate of the disorder present in the population at a given point of time and

Incidence refers to the number of new cases occurring in the population during a
given period (Bristol et al. , 1996). Epidemiological surveys of autism are important
to identify the prevalence and/or incidence of this developmental disorder, and the
requirements for specialised educational and medical services for this group of
children. These surveys are also important to genetic studies, in order to show the
increase in the prevalence rate within families affected by the disease compared to the
general population. This allows the genetic component involved in aetiology of the
disorder to be evaluated.

1.4.1

Prevalence

A number of population-based studies on the prevalence of autism have been
completed, with the rates varying enormously across studies. Recent reviews of the
epidemiological surveys of autism (Wing, 1993; Gillberg, 1995; Honda et al., 1996;
Fombonne et al. , 1 997; Fombonne, 1 999) show that rates vary from 0. 7/ 1 0 OOO
(Treffert, 1 970) to 2 1 . 1/ 1 0 OOO (Honda et al. , 1996). Much of the variation across
studies can be explained by the use of relatively small samples, and differences in
ascertainment schemes and diagnostic criteria. A review by Honda et al. ( 1996)
divided published prevalence studies of autism by population size (Table 2). Those
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studies with populations ofless than 50,000 showed an average prevalence of 13.4
per 10,000, whereas studies with populations of more than 50,000 had an average
prevalence of approximately 5.8 per 10,000. Honda et al. (1996) suggested that the
reason for the discrepancies between the two population sizes could be due to the
higher number of overlooked cases in the larger populations. It is still not proven
what population size is optimal for epidemiological studies of autism, and sizes less
than 50,000 may be too small for this rare disorder.
Studies in the last few years have estimated the prevalence of autism to be
typically around 0.1 in 10,000 children (Landgren et al. , 1996; Webb et al. , 1997;
Arvidsson et al. , 1997). This is 2-5 times greater than the figure commonly reported
in the past (2 to 5 in 10 OOO children). The high rate reported in these more recent
studies could be attributed to the researchers' increased awareness of the autism
spectrum disorders and the inclusion of these disorders in their epidemiology studies.
Autism spectrum disorders is a term used to describe all conditions involving severe
autistic symptomatology, or those conditions with severe autistic symptomatology
that do not meet operationalised criteria for autistic disorder/childhood autism
(Gillberg, 1995).
In Gillberg' s (1995) review of epidemiological studies of autism, he provided
an estimate of the overall prevalence of autism in the population. In this report he
reviewed all papers published in books or journals that included reference to the
words "autism" and "prevalence", and were written in English or with comprehensive
English summaries included. Only papers that met the follo�ing criteria were
included in the review:
•

The study used defined diagnostic criteria for autism;
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•

The population studied referred to a specific age-cohort from a
geographically defined population;

•

The initial screening for autistic individuals was made within a large
population of children, including not only those who had already been
clinically diagnosed as "autistic" or "psychotic"; and

•

The final diagnosis had been made after clinical examination of possible
cases by a research team or by primary care clinical staff who provided the
information requested by the research team as part of the study.

Table 2 lists those 1 6 studies which met the criteria for inclusion and which had been
published by 1 st of June 1 993. Publications in italics were those noted in the Honda et

al. ( 1 996) and the Fombonne ( 1 999) reviews but were not included in Gillberg
( 1 995). The mean prevalence across all 1 6 studies was 6.5 per 1 0 OOO children. This
mean was computed by adding all cases diagnosed with autism and dividing that
figure by the total sum of all those individuals who participated in the original
screening. If the prevalence figures were added and divided by 1 6 the figure would be
8.4 (±4.4 (S.D.)). It is interesting to note that if the two US.A. studies were
removed (the U.S.A.'s mobile population and the unevenly distributed health-care
system around the country causes problems in population-based studies), the mean
rate of reported autism in the studies published after 1985 would be 1 1 . 8 per 1 0 OOO
children. This figure is very close to the recent prevalence estimates of around 0. 1 in
1 0,000 (Landgren et al. , 1996; Webb et al. , 1 997; Arvidsson et al. , 1997). As
previously mentioned, these studies also included individuals diagnosed with autism
spectrum disorders. In this study, only children with the "core" synqrome of autism
were included in the analysis and, in turn, a prevalence rate of 4 -5 per 1 0 000 children
born was used throughout.
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Table 2: Prevalence Studies of Autism by Population (prevalence is given as n
per 1 0 OOO children born)

Study

Region

Population
Size

Prevalence

Male:Female

Population size <50,000
Honda et al. (1996)

Japan

8, 53 7

21. 1

2. 6: 1

Sugiyama and Abe ( 1 989)

Japan

1 2,263

13.0

?

Canada

20,800

10. 1

2.5: 1

Matsuishi et al. ( 1 987)

Japan

32,834

1 5 .5

4.7: 1

Ishii and Takahashi ( 1 982)

Japan

34,987

1 6.0

6.0: 1

England

35,000

4.9

1 6 .0: 1

Fombonne (1999)

Review

> 4, 000, 000

5. 2

3. 8: 1

Fombonne et al. (1997)

French

325, 347

5. 4

1.8:l

Fombonne & du Mazaubrun (1992)

French

274, 81 6

4. 9

2. 1 : 1

Gillberg e t al. ( 1 99 1 a)

Sweden

78, 1 06

1 1 .5

2. 8 : 1

USA

1 84,822

4.0

3 . 7: l

France

1 3 5, 1 80

10.8

2.0:1

Japan

95,394

13.8

4. 1 : 1

USA

1 80,986

3 .3

2.7: 1

Germany

279, 61 6

1.9

2. 2: 1

Steffenburg and Gillberg ( 1 986)

Sweden

78,4 1 3

7.5

3 .0: l

Gillberg ( 1 984)

Sweden

1 25,584

4.0

1 .8 : l

McCarthy et al. (1 984)

Ireland

65, 000

4. 3

1 . 3:l

Bohman et al. ( 1 983)

Sweden

>50,000

6.1

1 .6: l

Hoshino et al. ( 1 9 82)

Japan

2 1 7,626

5 .0

9.0: l

Denmark

>50,000

4.3

1 .4: l

USA

899, 750

3. 1

3. 4 : 1

England

78,000

4.5

2 .6 : 1

Bryson et al. ( 1 988)

Wing and Gould ( 1 979)
Population size >50,000

Ritvo et al. ( 1 989)
Cialdella and Mamelle ( 1 989)
Tanoue et al. ( 1 9 8 8)
Burd et al. ( 1 987)
Steinhausen et al. (1986)

Brask ( 1 972)
Treffert (19 70)
Lotter ( 1 966)

(Gillberg, 1995; Honda et al. , 1 996)
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1.4.2 Incidence

Only one paper to date (Honda et al. , 1996) has reported the cumulative
incidence of childhood autism. A measure of incidence can often be more useful than
prevalence, but can be difficult to calculate in childhood disorders (Stein and Susser,
1 98 1 ) . In autism, problems generally arise due to the difficulty in identifying the exact
age in which the first symptoms of the disease arise. Honda et al. ( 1996) overcame
this problem by using cumulative incidence up to five years of age within a specified
birth cohort. They reported a cumulative incidence of 1 6.2 per 1 0 OOO in the birth
cohort. This value was lower than the reported prevalence for this population, which
according to the authors was a consequence of parents staying in areas where special
facilities were available for their autistic children.

1.4.3

Sex Ratios

Autism is known to affect males more frequently than females. Papers on
autism constantly report the male:female ratio to be 3-4: 1. Population studies,
however, show a variety of values ranging from 1.3: 1 (McCarthy et al. , 1984 ) to 1 6: 1
(Wing and Gould, 1 979). In the reviews of sixteen population studies of autism,
Wing ( 1 993) and Gillberg ( 1 995) found that the ratio was closer to 2-3: 1 (Table 2).
Wing ( 1 993) pointed out, that "the exceptionally high ratio in the Wing and Gould
( 1 979) study ( 1 6 : 1 ) was most probably a chance finding due to the small number of
autistic children identified". There have also been several studies suggesting that the
ratio is associated with IQ levels, with an equal proportion of males to females seen
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among autistic children with severe and profound mental retardation (Wing, 1 98 1 ;
Gillberg, 1 984).
The reason for the higher vulnerability of males to autism is unknown. Many
speculations have been put forth to explain the skewed sex ratios, and one rationale
could be due to a genetic involvement. Skuse et al. ( 1997) recently presented
evidence for one or more loci on the human X chromosome influencing social
cognition. Males do not express these imprinted loci as they are only expressed from
a paternally inherited X chromosome. Skuse et al. ( 1997) suggested that such a locus
might offer some explanation of why boys are more vulnerable than girls to
developmental disorders of speech and language. The X-chromosome was examined
in detail within this study to determine whether any susceptibility loci were present on
this chromosome. Alternatively, because girls have better developed superficial social
and language skills early in life, the basic disabilities associated with autism could go
unrecognised for longer periods of time. This would lead to an underestimate of the
prevalence of autism in girls and elevate the difference in the sex ratio (Gillberg,
1995).

1.4.4

Mental Retardation and Epilepsy in Autism

Intellectual handicap ( defined as IQ under 70) has been shown to be present in
75-90% of cases of autism (Gillberg, 1 990) (Figure 1 ). It has also been shown to be
the single most powerful predictor of outcome in autism (Venter et al. , 1 992), since
the severity of autistic symptoms is related to verbal IQ (Bolton et al. , 1 994).
Although autism and mental retardation are strongly associated, the accompanying
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risks and neurological findings are different. Mental retardation is associated with an
increased rate of major pre- and perinatal abnormalities, while autism is associated
with mainly minor abnormalities (Finnegan and Quarrington, 1979). In addition,
although autism and mental retardation are associated with the same disorders (eg.
infantile spasm and congenital rubella), other conditions that are usually associated
with intellectual handicap rarely give rise to autism (eg. cerebral palsy). These
different associations suggest that while there is some overlap in the specific disorders
known to cause the two conditions, that overlap is small (Folstein and Rutter, 1988).
Also, since it is difficult to distinguish between mental retardation and autism in
children with low IQs (< 30), such individuals were removed from the study to
prevent misdiagnosis (see section 2. 1.3).

Mental
Retardation

Epilepsy

Autism

Figure 1 : The co- morbidity of mental retardation, epilepsy and autistic disorder.

Epilepsy is also common in people with autism, particularly between early
childhood and adolescence (Figure 1). About 20% of autistic individuals develop
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non-febrile seizures before the age of about 3 years. Another 1 5-20% develop
seizures around the time of puberty or later (Olsson et al. , 1 988; Volkmar & Nelson,
1 990; Gillberg and Coleman, 1992). The increased incidence of epilepsy and
abnormal electroencephalograms (EEG) in autistic children, compared with other
psychiatric patients, was the first piece of evidence that autism is a biological disorder
of the brain rather than a psychogenic disorder (Ornitz, 1978). Although epilepsy is
not strongly associated with IQ, it does seem to have a higher prevalence in autistic
individuals who are mentally retarded (Bailey et al. , 1 996). The prevalence of
epilepsy among the individuals used in this study is not discussed as it is beyond the
scope of this project.

1.5

Aetiological Models of Autism

The causes of autism still remain uncertain, and opinions about the aetiology
have varied over the years. It was first put forth by Kanner ( 1 943) that autism was
due to an inborn defect, since the onset of the disorder occurs very early in life. Other
views suggested that the condition is the outcome of parental neglect, rejection, or
indifference (Bene, 1958; Bettelheim, 1 967; Despert, 1956). Numerous clinical and
epidemiological studies, however, have failed to show a positive association between
autism and qualities of upbringing or frequency of stress experiences (Cantwell et al. ,
1 978; Bailey et al. , 1 996). Accordingly, it seems unlikely that psychosocial
environmental risk factors are involved in the aetiology of autism. Current research
findings support Kanner' s initial interpretations, and it is now generally accepted that
autism has a biological cause.
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Like other behavioural syndromes, autism is an aetiologically heterogeneous
disorder. A number of neurological conditions, some traumatic, some infectious, and
some genetic in aetiology, have been reported to be associated with autism. These
conditions are presumably the cause of the syndrome in a small number of cases and
so they will be reviewed below. Fragile X syndrome, chromosome 1 5 deletions and
several other disorders are discussed in more detail; since these conditions are
frequently reported to co-occur with autism, the chromosomal regions involved have
been included in this study as candidate regions for susceptibility loci to autism.
Although the exact figures are unknown, cases with a known or presumed aetiology
constitute a small proportion ( 1 0-25%; see section 1.5. 1. 2) of all autistic children.
The majority of cases are of unknown aetiology and several observations suggest that
genetic factors may play a role. This theory, supported by family and twin studies as
well as the presence of other related conditions within the family, is also reviewed in
the following section.

1.5.1

Neurological Conditions Associated with Autism

1.5.1.1 Prenatal, Perinatal and Neonatal Factors
Pre-, peri- and neonatal complications have been reported to be more
prevalent in individuals with autism than in control groups (Deykin and MacMahon,
1 980; Finnegan and Quarrington, 1 979; Torrey et al., 1975). These factors include
abnormal obstetrical presentation (Finnegan and Quarrington, 1979; Levy et al. ,
1988), advanced maternal age (Gillberg and Gillberg, 1 983 ; Tsai and Stewart, 1 983 ) ,
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low birth weight (Knobloch and Pasamanick, 1975), prematurity (Gilberg and
Gilberg, 1983), use of medication during pregnancy (Deykin and MacMahon, 1980),
viral illness (Deykin and MacMahon, 1979), low Apgar score (Finnegan and
Quarrington, 1979), vaginal bleeding (Gilberg and Gillberg, 1983; Knobloch and
Pasamanick, 1975; Torrey et al. , 1975) and hyperbilirubinemia (Finnegan and
Quarrington, 1979). In studies controlling for birth order, no differences in the rates
of pre-, peri- and neonatal problems between autistic subjects and control subjects
were detected (Lord et al. , 1991; Piven et al. , 1993). The association of pre-, peri
and neonatal factors with autism has an uncertain significance (Rutter et al. , 1990),
and it has been suggested that these factors could be consequences of underlying
genetic problems in the fetus (Bailey et al. , 1995; Bolton et al. , 1994).

1.5.1.2 Associated Disorders

A number of pathological conditions have been reported to be associated with
autism. These range from infectious diseases to chromosomal abnormalities, and
neurocutaneous and metabolic disorders. Gillberg and Coleman ( 1996) recently
reviewed all population studies on autism published in the English language with
particular reference to co-morbidity. Seven studies met the criteria for inclusion in the
survey. These criteria were similar to those used in Gillberg's (1995) paper for
estimating the overall prevalence of autism in the population (see above). They found
that approximately one in four people (24.4%) with autism have an associated
disorder. There was also a trend for higher rates of associated disorders among
individuals with severe mental retardation. It still remains unclear whether the
associated disorders are aetiologically linked to the symptoms of autism or whether
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the individuals have two separate and unrelated disorders (Gillberg and Coleman,
1996). Other studies regard additional disorders as rather rare (up to 10%) among
autistic children (Ritvo et al. , 1990; Smalley, 1991; Rutter et al. , 1994). The reasons
for the discrepancy could be due to differences in the stringency of diagnostic criteria
for the associated conditions as well as ethnic differences in the aetiology of the
disorders (Gillberg, 1992a).

Infectious Diseases
Pre- and postnatal infections associated with autism include encephalitis
(Deykin and MacMahon, 1979; Markowitz, 1983), syphilis (Stubbs, 1978; Stubbs and
Crawford, 1977), toxoplasmosis (Todd, 1986), CMV-infection (Stubbs et al. , 1984),
herpes simplex (Ghaziuddin et al. , 1992a) and congenital rubella (Chess, 1971). The
evidence for these associations is not convincing in the majority of cases.
The association between congenital rubella and autism was first shown by
Chess (1971). However in a follow-up study, Chess (1977) noted that the autistic
symptoms in these children with congenital rubella improved over time. A review of
epidemiological studies in autism (Fombonne, 1998) reported a 0.9% median rate of
congenital rubella, a value not significantly different from the rates in control groups.
A recent Japanese survey of autism conducted in the aftermath of a rubella epidemic
also failed to document any single case of autism associated with congenital rubella
(Honda et al., 1996).
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Chromosomal Abnormalities
Autism has been linked to different chromosomal abnormalities. While most
of these abnormalities involve sex chromosomes, structural autosomal defects have
also been reported. Recent reviews of the literature (Gillberg, 1 998; Lauritsen et al. ,
1 999) have reported abnormalities in each of the autosomes and of the gonosomes
among individuals with autism / autism-like behaviour. These include a partial
trisomy 8q (Ritvo et al., 1990), a partial trisomy 6p2 l -6p25-ter (Burd et al. , 1988), a
partial trisomy 1 5 (Gillberg et al. , 199 1 b; Schinzel, 1990), a 1 q deletion (Murayama et

al. , 1 99 1 ) and several other defects such as a translocation t(3 ; 12)(p26.3;q23.3)
(Fahsold et al. , 199 1 ) or a complex chromosome rearrangement involving
chromosomes 1 ,7 and 2 1 (Lopreiato and Wulfsberg, 1992). Most of these
abnormalities have only been reported in isolated cases of autism and it is not known
whether they are associated with autistic behaviour by chance alone (Gillberg and
Coleman, 1992). In a review of the literature on autosomal chromosome
abnormalities from January 1987 to June 1998, Lauritsen et al. ( 1 999) detected three
interesting regions with multiple reports of cases with abnormalities in the same area.
These include l 5q 1 1 - 13 , I 6q23 and l 7p 1 1.2, with chromosome 1 5 being the most
frequently reported aberrant site. These regions are good candidates for containing
susceptibility loci involved in the aetiology of autism, and were studied within the
course of this study. Chromosome 1 5 abnormalities (Gillberg et al. , 1 99 1 b) together
with Down syndrome (trisomy 2 1 ) (Wakabayashi, 1 979), and fragile X (Hagerman,
1 989), have also all been reported to co-occur with autism in a number of studies and
are reviewed in detail below.
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Chromosome 15 Aberrations
Aberrations, including duplications and to a lesser extent deletions, on the
proximal long arm of chromosome 15, have been reported to be the single most
common identifiable cause of autism (Schroer et al. , 1998). Kerbeshian et al. ( 1990)
first reported an individual with autism who had a supernumerary inversion on
chromosome 1 5 . Since then, there have been a number of reports that associate
deletions, uniparental disomy (UPDs), or supernumerary inverted duplications on
chromosome 1 5 with autism. Autistic patients with these aberrations commonly have
mental retardation and epilepsy as well (Baker et al. , 1994 ; Bundey et al. , 1994 ,
Schroer et al. , 1998).
The most common abnormality involves duplications within the 1 5q 1 1-q 13
region (Gillberg et al. , 1 99 1 b, Martinsson et al. , 1994 ; Bundey et al. , 1994 ; Baker et
al. , 1994; Flejter et al. , 1996; Cook et al. , 1 997a). This is the critical region for
Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Both of these
syndromes involve developmental abnormalities and mental retardation, and show
abnormalities in the 4 Mb-region spanning 15q 1 1 -q 1 3 . In the case of PWS, both .
alleles at this specific location on chromosome 1 5 have been inherited from the
mother or the paternal allele has been deleted. AS, on the other hand, is the
deficiency of normal maternal DNA at 1 5ql 1-ql3 (Chan et al. , 1993 ) . Although
PWS and AS have not been shown to be directly associated with autism, duplications
in this region have. All duplications of the PWS/AS critical region in autistic patients
have been maternal in origin (Robinson et al. , 1993 ; Leana-Cox et al. , 1 994 ; Schinzel
et al. , 1 994 ; Flejter et al. , 1 996; Cook et al. , 1997a). These studies found that
paternally inherited duplications of 1 5 q 1 1-q 1 3 lead to a non-autistic phenotype,
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whereas maternally inherited duplications usually lead to autism or atypical autism.
This suggests that an imprinted gene at chromosome 15 may contribute to
susceptibility to autism in some cases.

Down Syndrome
Wakabayashi (1979) first described the association of Down syndrome (DS)
with autism. Since then, a number of studies have reported the occurrence of autism
in individuals with Down syndrome (Wing and Gould, 1979; Gath and Gumley, 1986;
Bregman and Volkmar, 1988; Myers and Pueschel, 1991; Gillberg et al. , 1986;
Ghaziuddin et al. , 1992b; Howlin et al., 1995; Ghaziuddin, 1997). The association
reported in these studies could be explained by ( 1) a family history and genetic
predisposition to autism (Ghaziuddin, 1997), (2) complicating physical conditions that
occur in DS (such as brain damage) and may increase the risk of autism symptoms
(Gillberg et al. , 1986), (3) the wide range of deficits caused by trisomy 21 that could
contribute to the emergence of autistic features (Howlin et al., 1995), and ( 4)
neuropathological aberrations present in both disorders might reflect altered patterns
of functional organisation that are common to both (Ghaziuddin et al. , 1992b).
Overall the occurrence of Down syndrome in people with autism is relatively rare.
Presently, it does not seem that Down syndrome, as such, predisposes to the
development of autistic behaviour (Gillberg, 1993).
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Fragile X
The association of fragile X syndrome and autism is well established, however
the prevalence of this association differs significantly between studies. The fragile X
syndrome is the most common cause of hereditary mental retardation. It is a recessive
X-linked disease with incomplete penetrance and affects boys and girls at a ratio of
3: 1 (Davies, 199 1 ). Originally it was detected cytogenetically by the presence of the
fragile site (FraX) Xq27.3. In 199 1 , Verkerk et al. identified the FMR- 1 gene (fragile
X mental retardation) that is responsible for this disorder, and the syndrome can be
detected with molecular genetic methods.
Studies before the identification of the FMR- 1 gene reported the rate of fragile
X in individuals with autism to range from O to 25%, with an average of 7% (Bolton
and Rutter, 1990). The wide variation between studies could be due to the
ascertainment procedures utilised, to the use of small sample sizes, as well as different
diagnostic methods (Folstein and Piven, 199 1 ). In addition, the common fragile site
at Xq27.2 could have produced frequent false-positive results in individuals with low
levels of FraX (Xq27.3) expression (ie. 1 % to 3%) (Ramos et al. , 1989; Sutherland
and Baker, 1990).
More recent investigations, which use standard techniques and the same valid
and reliable clinical diagnostic criteria (ADI, see section 2. 1.2), have tended to report
lower rates of co-occurrence between the two syndromes (Bailey et al. , 1993a; Piven

et al. , 1 99 1 a). Bailey et al. ( 1 993a) replicated the Piven et al. ( 1 99 1 a) study, and
detected the fragile X anomaly in 1.6% of autistic individuals from a combined sample
of autistic twins, hospital patients, and individuals from families with several members

22

affected by autism or related cognitive phenotypes. Bailey et al. (1993a) surmised
that the similarity of the two findings supports the conclusion that the fragile X
anomaly accounts for only a small proportion of the genetic influences in autism. It
should also be noted that most medical centres currently test patients with autistic
behaviour for fragile X. If positive, these individuals are usually diagnosed with
fragile X or fragile X with autistic features instead of autism itself.

Neurocutaneous Disorders

Three neurocutaneous disorders have been described in association with
autism or autistic symptomatology. These include tuberous sclerosis (mapped to
chromosomes 9 and 16), neurofibromatosis (NF 1 maps to chromosome 17 and NF2
to chromosome 22), and hypomelanosis of lto (believed to reside on chromosome
l 5q) (Gillberg and Coleman, 1992). The association between hypomelanosis of lto
and autism has only been reported in case studies (Akefeldt and Gillberg, 1991;
Zappella, 1993). Tuberous sclerosis and neurofibromatosis have been reported in
epidemiological studies of autistic populations at rates greater than would be expected
by chance.

Tuberous Sclerosis

Tuberous sclerosis (TSC) is an autosomal dominant disorder involving benign
tumour growth in various organs, including skin, brain, eye, kidney, and heart
(Gomez, 1988). It has a variable expression and exhibits genetic heterogeneity. This
disorder, like fragile X, has been investigated in detail with respect to its association
with autism. Smalley et al. (1992) reviewed the literature regarding the frequency of
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autism in TSC and found rates ranging from 17-58% in studies using various
diagnostic instruments. This related to a frequency of TSC among autistic individuals
in the order of 0.4-3%. They also noted an increase in the estimated frequency (814%) in a subgroup of autistic subjects with seizures (Gillberg, 1 99 1 ; Riikonen and
Simell, 1 990). Since then, three population-based studies of TSC have examined
autism rates. Hunt and Shepherd ( 1 993 ) found that 24% (5 of2 1 ) of children with
TSC in Western Scotland met the criteria for autism. These individuals were
diagnosed using a 1 3-item scale, with a score of 7 or greater indicating autism.
Gillberg et al. ( 1 994), in their study in Western Sweden, found a rate of 6 1 % ( 17 of
2 8) of individuals with TSC meeting the DSM-III-R (APA, 1 987) criteria for autistic
disorders. In a Californian study, Gutierriz et al. ( 1 998) found the frequency of
autism in their sample of2 8 TSC probands to be 29%. These probands were all
diagnosed using the revised Autism Diagnostic Interview, based on ICD- 1 0 and
DSM-IV criteria (see section 2. 1.2 ; WHO, 1 992; APA, 1 994 ). In an overview of all
of these epidemiological studies, Gutierrez et al. ( 1 998) surmised that autism occurs
in approximately 25% of individuals with TSC, with the majority of these people
showing evidence of mental retardation as well. He also noted that infantile seizures
and mental retardation are significant risk factors for the development of autism in
TSC, for example in the Gillberg et al. ( 1 994 ) sample, 13 of the 1 7 children with
autism and TSC had a history of infantile spasms. Overall, if the population
prevalence of TSC is taken to be 1 /6,800 (Ahlsen et al. , 1 994), it could be suggested
that TSC accounts for up to 4 % of all cases of autism.
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Neurofibromatosis
Neurofibromatosis is also an autosomal dominant disorder with a variable
severity of symptoms that primarily affect the nervous system. So far, two types of
neurofibromatoses have been identified. Neurofibromatosis type 1 (NFl) has been
mapped to chromosome 17 and occurs with an incidence of 1 /3 OOO (Barker et al. ,
1987). NF 1 predisposes individuals to the development of skin spots ( cafe au lait
macules) and tumours within the peripheral nervous system (Rouleau et al. , 1993 ).
Neurofibromatosis type 2 (NF2), which occurs with an incidence of 1 /33000-50000
(Kanter et al. , 1980; Evans et al. , 1992), is characterised by a predisposition to the
development of tumours of the central nervous system, including acoustic neuromas,
meningiomas, neurofibromas and ependymomas (Martuza and Eldridge, 1988). The
chromosomal region containing mutation(s) responsible for NF2 was narrowed,
through a combination of family studies and deletion mapping in tumours, to
chromosome 22 q 1 2 (Seizinger et al. , 1986; Rouleau et al. , 1987; Seizinger et al. ,
1987; Couturier et al. , 1990; Rouleau et al. , 1 989). Recently, two groups of
investigators independently isolated a candidate gene for this disease (Rouleau et al. ,
1993 ; Trofatter et al. , 1993). They showed that this gene, designated Schwannomin
(SCH), is the site of the mutations causing NF2 by demonstrating germline and
somatic SCH mutations in NF2 patients and in NF2-related tumours. Most of the
variants were nonsense, frameshift, or splice mutations predicted to lead to the
synthesis of a truncated SCH protein.
Gillb�rg and Forsell ( 1 984) were the first to report an association between
autism and neurofibromatosis. A systematic community study was carried out in
individuals born in the Goteborg region of Sweden between the years of 1 962-1976.
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From this total population screening, 2 children out of the 26 diagnosed with infantile
autism were reported to have NF I . This corresponds to a rate of 7.7%. Future
studies, however, have failed to replicate these results. Fombonne et al. ( 1997) in the
French epidemiological survey of autism noted that the rate of neurofibromatosis was
very low. Their rate of 0.3% was similar to the median rate of four other surveys
(reviewed in Fombonne, 1998) and identical with the rate found in a large sample of
34 1 referred autistic children in Denmark (Mouridsen et al., 1992). This rate is not
significantly different from what would be found by chance alone. Fombonne et al.
( 1997) concluded that, when these results are amalgamated, they strongly go against
the claim of an association between autism and neurofibromatosis (Gillberg and
Forsell, 1984 ).

Recent studies, therefore, show no specific association with neurocutaneous
disorders and autism, however, they may be useful in the investigation of the
neuropathology or pathophysiology of autism. Since both tuberous sclerosis and
neurofibromatosis present with brain lesions that are variable in location,
neuropathological studies comparing cases with and without associated autism may
suggest brain areas that are focal points of the pathophysiology of autism (Folstein
and Rutter, 1988; Hunt, 1995).

Metabolic Disorders
Disorders caused by a metabolic deficit have also been associated with autism
at a level that is possibly greater than suggested by chance alone. These include
phenylketonuria (PKU) (Friedmann, 1969), lactic acidosis (Coleman and Blass, 1985)
and hypothyroidism (Gillberg et al. , 1 992a). PKU was the first genetic condition to
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be reported in association with autism. It is an inborn error of metabolism that is
inherited in an autosomal recessive fashion, and is usually, but not always, associated
with mental retardation (Felling, 1934). Since the initiation of programmes for the
screening of newborns for PKU and the institution of a phenylalanine-restricted diet
within the first weeks oflife, the frequency of this disorder rapidly decreased.
However, there have been reported cases of autistic children with classic untreated
PKU (Miladi et al. , 1992; Chen and Hsiao, 1989; Pueschel et al. , 1985; Friedman,
1969; and others). After the initiation of a phenylalanine-restricted diet, the autistic
symptoms improved (Friedman, 1969). From the above observation and after noting
that autistic symptoms were present in children with PKU and normal intelligence,
Friedman (1969) concluded that autism and mental retardation were separate
disorders. This supports the hypothesis that, on a pathophysiological level, autism
and mental retardation have different mechanisms (Folstein and Rutter, 1988). At
present, PKU is the metabolic disorder most frequently reported to co-occur with
autism, however this association is rare, as shown by a review of six recent
epidemiological studies (Fombonne, 1998) which failed to report any single case.

1 .5.2 Autism as a Genetic Disorder

It is generally considered that some cases of autism have a genetic basis
(Bolton and Rutter, 1990) as shown by the data above and the publications reviewed
below. The proportion of cases of autism with a genetic aetiology, however, is
unknown. As mentioned above, the percentage of cases of autism associated with
other disorders range from 10 to 25%, including 5 to 14% with a known genetic
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disorder or chromosomal anomaly (Smalley, 1997). However, there is uncertainty as
to the proportion of autism cases that have a genetic basis without demonstrable
associated disorders.
Nevertheless, there is a general consensus as to the importance of genetic
factors in the development of autism. Evidence that supports this view has been
derived by family and twin studies, as well as the family aggregation of other
conditions.

1.5.2.1 Family Studies

Publications by Smalley et al. (1988) and Bolton and Rutter (1990) reviewed a
number of epidemiological and family studies of autism and estimated the prevalence
of autism in siblings of autistic children to be about 2 - 3%. A more recent family
study by Bolton et al. (1994) that examined 153 siblings of 99 autistic individuals
found the sib recurrence risk to be 2.9%. Also, a study by Jorde et al. (1991), based
on a large scale epidemiologic survey in Utah, reported a recurrence risk of 3.7% if
the first autistic child was male and 7. 0% for female pro bands. Studies have shown
that parents with an autistic child may limit further childbearing since the disease is so
severe. However, if families that have stopped further child-bearing after having a
child with autism are removed from the family studies, the recurrence risk in siblings
may be greater than the average noted by Smalley et al. (1988) and Bolton and Rutter
(1990). Indeed, a family study by Ritvo et al. (1989) took into account the "stoppage
rules" evident in families with autism and reported a risk of autism for siblings born
after the pro.band of 8.6%. In summary, the recurrence risk in siblings is in the region
of 2 - 9%. This represents a 45 - 200-fold increase in risk relative to the population
prevalence (4. 5 in 10,000, see section 1.4.1).
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1.5.2.2 Twin Studies
Since family studies cannot separate genetic and non-genetic (environmental)
influences, twin studies are also used for establishing a genetic aetiology. In twin
studies, a disease that is at least partially determined genetically is expected to show a
higher concordance rate among monozygotic (MZ) twins compared to dizygotic (DZ)
twins. MZ twins normally have 1 00% of their genes in common, while DZ twins
have, on average, 5 0% of their genes in common. This genetic relationship results in
the phenotypic differences between MZ twins being attributed to environmental
influences, while phenotypic differences between DZ twins are attributed to both
genetic dissimilarity and environment. There have been three major twin studies of
autism (Table 3). Ritvo et al. ( 1 985a) found a MZ concordance of 95% (22/23) and
DZ concordance of 24% (4/17), whilst Steffenburg et al. ( 1989) found a MZ
concordance of9 1 % ( 1 0/ 1 1 ) and a 0% (0/ 1 0) concordance in same sex DZ twins. In
a recent study that uses some of the same twins described in an earlier study by
Folstein and Rutter ( 1 977), Bailey et al. ( 1 995) found a MZ concordance of 73%
(27/37) and a DZ concordance of O (0/20). The first study by Ritvo et al. ( 1 985a)
was not systematic (the subjects were collected by advertisement) and there were also
problems in the re-diagnosis of affected individuals (including failing to take into
account the possibility of a broader phenotype). This may have inflated the
concordance rates reported. Combining the data from the last two studies, the
average MZ concordance rate is 77% and the average DZ concordance rate is zero.
The DZ concordance rates were calculated from a small sample size and are not
significantly different from the approximate sib recurrence rate of 3 %. It may be
concluded from these studies that the MZ concordance is much higher than the DZ
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concordance rate, providing further support that genetic influences predominate in the
aetiology of many cases of autism.

Table 3: Systematic Twin Studies on Autism
Study

MZ Twins

DZ Twins

Ritvo et al. ( 1 985a)

95% (22/23)

24% (4/ 1 7)

Steffenburg et al. ( 1 989)

9 1% ( 1 0/1 1 )

0% (0/ 1 0)

Bailey et al. ( 1 995)

7 3 % (27/37)

0% (0/20)

(update of Folstein and Rutter ( 1 977) twin study)

Twin studies can also be utilised to estimate the heritability of liability to
autism. Bailey et al. (1995) used their calculated MZ concordance rate of 73% and,
since no DZ twins were ascertained during the course of the study, the 2. 9% rate of
autism among siblings of autistic individuals was applied (Bolton et al. , 1994). They
also utilised two different prevalence estimates, 1.75 in 10,000 (Wing et al. , 1976)
and 10 in 10,000 (Gillberg et al. , 1991a) in their calculations. Using structural
equation modelling (Bentler, 1989), they estimated the broad heritability of liability to
autism to be 93% and 91% for the base rates of 1.75 and I O in 10,000 respectively.
This again supports the role of genetic factors in the aetiology of autism.

1.5.2.3 Family Aggregation of Other Conditions

Clinical observations have noted the social peculiarities present in some
parents of autistic children, as well as a history of developmental disorders of reading
and spelling in parents as well as siblings of autistic probands (Folstein and Piven,
1991). Recent studies using standardised assessment procedures have reported that
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cognition, language and personality deficits, and psychiatric disorders are present in
families with autistic probands. These are discussed below.

Cognitive Deficits
A high rate of cognitive deficits (ie. reading, spelling and articulation
disorders; language delay and mental retardation) has been noted in families of autistic
children. A study by Bartak et al. ( 1 975) found that reading or language disabilities
were present in first-degree relatives in 26% of families. Folstein and Rutter ( 1 977)
reported similar results in their twin study. They found that the concordance rate for
cognitive deficits was 82% for MZ twins and 1 0% for DZ pairs. A twin study by Le
Couteur et al. ( 1989a) replicated Folstein and Rutter's results and suggested that
cognitive abnormalities might be a milder expression of a common underlying genetic
abnormality in autism.
Piven et al. ( 1989a) interviewed mothers of autistic children (N=37) about
their other children (N=67). Fifte�n percent of non-autistic siblings were reported to
have had cognitive disorders as children. It was also noted that most of these
cognitive problems were in reading and spelling, and none of these non-autistic
siblings were mentally retarded.

Specific Language Abnormalities
Landa et al. ( 1989) assessed social communication in parents of autistic
individuals and control subjects matched for IQ scores and educational level. They
reported a significantly higher rate of deficits in both social use of language
(pragmatic language) and in story telling (narrative discourse) in the parents compared
to the controls.
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Personality Characteristics
Particular personality characteristics have been reported in parents and siblings
of autistic probands, at a rate greater than expected by chance alone. Kanner and
Eisenberg ( 1 956) noted that the parents in their study were perfectionists with
interests in abstract ideas and lacked interest in developing relationships with others.
Although they interpreted these findings as being evidence that "faulty" child rearing
was the cause of autism, this has later been disproved (Cantwell et al. , 1 978). Recent
studies using the family history method (Macdonald et al. , 1989; DeLong and Dwyer,
1988; Wolff et al. , 1 988) and a standardised interview (Piven et al. , 1989b), have
shown an increase of incidence of social deficits in these families.

Psychiatric Disorders
Several studies have also reported an increased rate of psychiatric disorders in
first-degree relatives of autistic probands (Piven et al. , 199 1 b). Major affective
disorder (Piven et al. , 1989a; DeLong and Dwyer, 1988) and anxiety disorders (Piven

et al. , 1989a) were found to have significantly higher rates compared with control
groups. Since these disorders occurred, in most cases, prior to the birth of the
proband, they could not be attributed to the stress of having an autistic child.
Schizoaffective disorders have been diagnosed in a number of families in which the
probands have autism and fragile X syndrome (Hagerman, 1989; Gillberg, 1992b).
Finally, there have been several reports on the co-existence of autism and elective
mutism within first-degree relatives (Gillberg et al. , 1992b).

A variety of different abnormalities aggregate in families of autistic individuals
as shown by the above studies examining cognitive deficits, personality
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characteristics, language, and psychiatric disorders in relatives of autistic individuals.
It has been suggested (Folstein and Piven, 1991) that these deficits may be
manifestations of an underlying genetic liability to autism or part of the broader
phenotype, since they are often mild and share similar characteristic features of autism
(eg. aloofness and pragmatic language deficits). These deficits were not explored
further in this project, due to the small number of studies published on this topic and
the diagnostic problems, at present, in separating individuals with these deficits from
normal controls.

1.5.2.4 Summary of Genetic Involvement in Autism

In summary, there are a few specific genetic conditions that can be associated
with autism. Among cases of unknown aetiology, the evidence shown above
proposes a 50-200-fold increase in genetic liability to autism in siblings of autistic
probands, relative to the population prevalence. Family studies have also indicated
that both parents and siblings have a higher liability for social and cognitive deficits
that are milder but conceptually similar to those found in autism. Whilst other factors
may alter this underlying genetic liability such as sex, IQ, and prenatal and perinatal
injury, the overall evidence suggests that the liability to autism is largely genetically
determined. This hypothesis was examined in this study by searching for susceptibility
loci involved in the aetiology of autism.
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1.6

Neurobiological Factors

There is substantial evidence that autism is associated with abnormalities in the
brain. However, the link between neurobiological findings and symptomatology in
this genetically influenced developmental disorder has yet to be identified. The
neurobiology of autism has been studied in great detail and there is an extensive
literature on the subject, which is often complex and inconsistent. The poor
replicability of neurobiological investigations arises for at least two reasons. First,
there is lack of methodological consistency between studies. Results seem to be
dependent upon the comparison group used and the variable on which the groups are
matched (Dawson, 1996). Second, immense heterogeneity exists in the behavioural
expression of autism, and studies differ in the subject populations they examine.
Variability in clinical diagnosis and differences in the specificity of individual
diagnostic instruments used in each study can also lead to heterogeneity of the sample
and contribute to the differences observed (Bailey et al. , 1996).
Current views about the localisation of abnormalities in the brain associated
with autism are the product of neuropsychological, neuroanatomical (including
neuroimaging and postmortem studies), and neurochemical studies. As previously
mentioned, there exists a vast amount of literature on the neurobiology of autism.
The majority of this is not within the scope of this project and only areas relevant to
the overall understanding of this study will be reviewed.
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1.6.1

Neuropsychological

Indirect evidence of abnormal brain function has been derived from
neuropsychological studies (Happe, 1994a). These investigations have been uniform
in finding deficits in certain aspects of higher order cognitive functions, including
abstract and pragmatic language, encoding of complex information, and executive
(frontal) functions (Bristol et al. , 1996). Deficits in executive functioning in autism
include impairments in thinking about consequences and the context of the activity,
and in planning for and appropriately solving problems in a flexible, efficient manner.
It has been proposed that these impairments result in the repetitive behaviours and
inflexible style of thinking characteristic of autism (Ozonoff et al. , 1991). The
universal impairment in social cognition found in neuropsychological studies of autism
suggests the involvement of certain brain regions known to mediate social and
emotional behaviour, namely, regions of the limbic system, such as the amygdala and
orbital frontal cortex. Other studies have found an association between "theory-of
mind" impairments and autistic symptoms (McEvoy et al. , 1993; Ozonoff et al. ,
1991). "Theory of mind" abnormalities refer to the inability to take notice of, and
think about, the mental states of others (Frith, 1989), and may be related to the
deficits in social interaction and social use of language found in autism (Lainhart and
Piven, 1995). This theory has resulted in a great deal of research over the past 5-10
years to determine how it relates to autism, and has been revised recently to
accommodate the large amount of neurobiological research. These studies have
shown autistic children to be impaired on a variety of experimental tasks requiring
theory of mind for successful solutions (Baron-Cohen et al. , 1985; Happe, 1994b).
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1.6.2

Neuroanatomical

Mental retardation is present in approximately three-quarters of autism cases
(Rutter, 1 979). Mental handicap syndromes have often been associated with gross
abnormalities in brain development, with a reduction in brain size frequently observed,
as well as abnormalities in the cerebral hemispheres and overlying cortex (Bailey et

al. , 1 996). In turn, it has been proposed that autism may be associated with gross
abnormalities in brain development and that one such abnormality may be responsible
for the distinctive symptomatology present in autism. A number of structural imaging
and postmortem studies have been conducted to test this theory.

1.6.2.1 Neuroimaging Studies

In viva structural and functional imaging studies in autism have shown that the
most consistent neuroanatomical lesions involve the cerebellar vermis (Courchesne et

al. , 1994). Magnetic resonance imaging (MRI) studies, in particular, have shown a
reduction in the cross-sectional area of the cerebellar vermis (hypoplasia) (Courchesne

et al. , 1987; Gaffney et al. , 1987; Courchesne et al., 1988; Hashimoto et al. , 1995).
The largest of these studies was by Hashimoto et al. ( 1 995), who found hypoplasia of
lobules VI and VII when a group of 1 02 people with autism were compared to 1 12
control subjects. This difference was also found in children less than 2 years old who
were later diagnosed with autism. Studies by other groups using similar anatomical
methods have failed to replicate these findings (Garber and Ritvo, 1 992; Holttum et

al. , 1 992; Kleiman et al. , 1992; Piven et al. , 1992). Reasons given for the
discrepancy in the "failed" replication studies include small sample size and the use of
patient controls versus healthy volunteer controls.
36

Another MRI study has suggested that minor malformations of the cerebral
cortex may be important in a subgroup of autistic individuals (Piven et al. , 1990).
Also, a positron emission tomography study showed that the functional relationship
between the frontal and parietal cortex and subcortical structures in autistic subjects
appear to differ from normal (Horwitz and Rumsey, 1994). These findings correlate
with the severity of autism and specific clinical deficits and may be related to less
efficient information processing (Minshew, 1994).
Abnormalities in the medial temporal lobe and related structures have also
been associated with autism. Hetzler and Griffin (1981) and DeLong (1992),
recognised the similarities between autistic behaviour and Kluver-Bucy syndrome, and
characterised autism as the effect of developmental dysfunction in structures of the
medial temporal lobe, especially the hippocampus and amygdala. This was supported
by Bachevalier' s (1994) finding that lesions of medial temporal lobe structures
induced in newborn monkeys result in behaviour resembling autism, whereas no such
changes were noted to result from similar lesions induced in adult monkeys.
A number of neuroimaging studies have also reported both indirect and direct
evidence of enlarged brain size in autism. These studies have shown: (1) head
circumference greater than the 97th percentile in approximately 20-40% of autistic
people (Bailey et al. , 1996; Davidovitch et al. , 1996; Woodhouse et al. , 1996;
Lainhart, 1997); (2) increased brain weight at autopsy (Bailey et al. , 1993b) and; (3)
increased brain volume (Piven et al. , 1995; Filipek, 1996). It is surprising to note that
a number of disorders reported to be associated with autism (eg. tuberous sclerosis,
neurofibromatosis and hypomelanosis of lto; see above), are also occasionally
associated with increased brain size or head circumference (Bailey et al. , 1996).
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1.6.2.2 Post-Mortem Studies
To date, fewer than 3 5 brains from autistic individuals have been examined,
and none of these with current immunocytochemical techniques for synaptic,
cytoskeletal, or glial markers. The early studies suggest abnormal neuronal
development, evidenced by reduced neuronal cell size and increased cell packing
density of limbic system structures, with decreased dendritic branching in the
hippocampus, and reduced numbers of Purkinje cells in the cerebellar hemispheres
(Bauman, 1 996; Raymond et al. , 1996). An investigation of a single autistic brain by
Rodier et al. ( 1 996) also suggested a decrease in the number of neurons in the motor
cranial nerve nuclei. These findings have not been associated with seizures, use of
medication, nor the severity of clinical symptoms. Since Purkinje cell loss is a
recognised complication of epilepsy (Meldrum and Bruton, 1992), and autopsy
studies have lacked mental retardation controls, the degree to which any finding is
specific to autism remains unknown (Bailey, 1993).

1.6.3

Neurochemistry

Neurochemical studies of neurotransmitters and immunological abnormalities
can provide much information for most neurobiological studies. Interpretation of the
results, however, is problematic since the biological variable being assayed is usually
rather remote from either brain function or structure. Also, in the case of autism, it is
difficult to know whether the difference between subjects and controls is due to
aetiological factors or consequences of some aspect of autistic behaviour or cognition
(Bailey et al. , 1 996). Many changes in neurochemicals have been associated with
38

autism (eg. serotonin (Gillberg and Coleman, 1992), dopamine (Cook, 1990),
norepinephrine (Gillberg and Svennerholm, 1987), endogenous opioids (Sahley and
Panksepp, 1987) and glial proteins and gangliosides (Ahlsen et al. , 1993)), however,
most of these findings have been inconclusive.
The most commonly replicated biological abnormality in autism is
hyperserotoninaemia. The interest in serotonin is due to its effects on central nervous
system (CNS) development, social behaviour, sleep, aggression, anxiety, and affective
regulation (Cook and Leventhal, 1996). There is a significant amount of evidence
that serotonin in the blood is raised (hyperserotoninaemia) in approximately one-third
of patients with autism, and that this increase is due to increased platelet serotonin
(Gillberg and Coleman, 1992). However, since increased blood levels of serotonin
have been found in about one-half of non-autistic severely retarded children, it is still
not clear whether this finding is only obtained in mentally retarded autistic individuals
(Gillberg, 1993). Recent studies from behavioural neuroscience, pharmacological,
and genetic studies have indicated that serotonin is involved in many of the symptoms
of autistic disorder, such as aggression, anxiety and inflexible rituals and routines
(Cook and Leventhal, 1996). These results led Cook et al. ( 1997b) to examine a
possible linkage between the serotonin gene and autism (see below). Advances in the
molecular biology of serotonin-related pathways are likely to provide an increased
understanding about the underlying neurobiological mechanisms in autism and help in
developing appropriate treatment of the social and cognitive dysfunction associated
with autism (Piven, 1997).
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1.6.4

Summary of the Brain Mechanisms Involved in Autism

The available evidence suggests that autism involves widespread brain
dysfunction at both the cortical and subcortical levels, however the primary site of the
brain injury has not as yet been identified. Investigators have been recently debating
whether there is only one pathway in the brain that is not functioning normally due to
one or multiple mutations and this is what is causing autism, or whether there are
multiple deficits that, in combination, cause what is known as autism. Bristol et al.
( 1996), in a report to the National Institutes of Health on the state of the science in
autism, stated that "the pathophysiology of autism, or the structural and functional
abnormalities of the brain and how precisely they result in the abnormal behaviour of
autism is far more complex than what brain structures or neurochemicals are involved.
Each level of analysis is highly complex and, at present, only pieces of this puzzle in
autism have been identified."

1.7

Mode of Inheritance

Given the evidence of a genetic predisposition to autism, studies on the
familial segregation of the disorder have been undertaken in order to identify a
specific mode of genetic transmission. Segregation analysis can be used to estimate
key parameters such as the allele frequency, penetrance, and proportion of cases
explained by. the proposed model of inheritance. However, problems with segregation
analysis exist, especially for genetically complex disorders. A complex disorder is one
that does not exhibit classical Mendelian recessive or dominant inheritance attributable
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to a single gene locus. First of all, segregation analysis can be extremely sensitive to
ascertainment biases (eg. the preferential inclusion of affected individuals may cause
the penetrance to be greatly overestimated). Secondly, it may not be able to
distinguish between the many possible modes of inheritance for complex traits. Some
examples of these include: (a) a single gene disorder with reduced penetrance, (b)
heterogeneity ( caused by two or more independent genes), ( c) oligogenic inheritance
(interaction of a small number of different genes with at least one of moderate effect
on the disorder), and (d) polygenic inheritance (interaction of a large number of
different genes, each with a small effect on the disease). Thirdly, the number of genes
influencing the trait is especially difficult to estimate (Lander and Schork, 1994).
Many genetic models have been postulated for autism. These include autosomal
recessive (Ritvo et al. , 1 985b), polygenic (Jorde et al. , 199 1 ; Tsai et al. 198 1 ), and X
linked (Gurling, 1 986; Szatmari and Jones, 199 1 ).
Ritvo et al. ( 1985b) applied simple segregation analysis to a sample of 4 6
multiplex families (with two or more autistic children). Multiplex families were
selected in preference to sporadic cases, to minimise the probability of detecting single
events due to environmental incidents, phenocopies, or new mutations (Smalley et al. ,
1 988). The authors found a segregation ratio of 0. 1 9 ± 0.07, which is consistent with
that expected under autosomal recessive transmission (ie. 0.25). While one would
expect the frequency of affected sib-pairs for an autosomal recessive inheritance to be
around 2 5%, the "stoppage rules" prevalent in autistic families could account for the
low sibling recurrence observed (-3%). Indeed, when Jones and Szatmari ( 1 988)
reanalysed these data, adjusting for truncated family size due to "stoppage", the
results were also consistent with an autosomal recessive model of inheritance (0.2 7).
The results obtained by Ritvo et al. ( 1985b) are inconclusive, however, due to the
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biased nature of the sample (which was ascertained in part by advertising for multiple
incidence families) and uncertainties about diagnosis (Bailey et al. , 1 996).
A further study by the same research group (Jorde et al. , 199 1 ), calculated a
different result. This investigation carried out a complex segregation analysis using
data collected in the UCLA-Utah Epidemiological Survey. The uniform collection of
data helped to circumvent difficulties caused by selective ascertainment and thus
produced a sample more appropriate for segregation analysis. In this segregation
analysis they used a mixed model, compared to the simple segregation analysis
employed in the previous study. The authors concluded that a single major locus
model of inheritance is unlikely, but could not rule out a multifactorial threshold
model (ie. a large number of genes or environmental effects contributing to an
underlying liability). However, they also noted that a major gene could be segregating
in a small proportion of families that could not be detected by the mixed-model
segregation analysis, even with the large data set used. The revised analysis was
repeated assuming that eleven parents initially considered unaffected were affected
(these individuals showed clinical deficits in the three major areas characteristic for
autism). This analysis resulted in a shift in the model to a dominant major single
locus. It could be concluded that, to predict the exact mode of inheritance of autism,
accurate diagnostic information is required on the parents. Since autistic individuals
generally do not marry and there are no clear-cut diagnostic criteria for milder forms
of autism, this could prove very difficult.
X-linked recessive inheritance has also been proposed (Szatmari and Jones,
1 99 1 ), which could explain the increase in risk in males compared to females (3 : 1 ).
Again, since it is difficult to diagnose parents, it is hard to assess directly the lack of
male-to-male transmission.
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The excess proportion of males affected with autism could also be accounted
for by the following models (Szatmari and Jones, 199 1 ) :
1 . Autosomal inheritance, with a lower penetrance for females compared t o males;
2. Polygenic inheritance, with a higher genetic load required for females to express
the phenotype;
3. X-linked recessive inheritance for some individuals and an environmental cause for
others (mixed aetiology);
4 . X-linked recessive or autosomal inheritance (genetically complex aetiology).
The results from these segregation studies on autism have been inconclusive.
Even though modifying factors, such as sex-influenced inheritance, reduced
penetrance, and variable expression, could account for some of the deviations present,
overall a multifactorial model (with the interaction of multiple genes) is more likely
than a monogenic model (Bailey et al. , 1996). This conclusion was drawn from two
observations (Bailey et al. , 1996). First of all there is a significant difference between
the concordance rate of MZ and DZ twins (Bailey et al. , 1995; Steffenburg et al. ,
1989; Folstein and Rutter, 1977). If it is assumed that the MZ concordance rate is
77% and the DZ concordance rate is 3% (see section 1.5.2), this gives a MZ to DZ
concordance ratio of 77/3 = 25. This high ratio cannot be explained by one or two
loci predisposing to the disorder: if a single recessive gene was responsible, a ratio of
only 4 ( 1 00/25 = 4 ) would be calculated; and a dominant gene would contribute even
less (ie. 1 00/50 = 2 or 1 00/75 = 1 .3 ). There is also a larger drop in cases of autism
when looking at second-degree and third-degree relatives compared to first-degree
relatives (DeLong and Dwyer, 1988; Jorde et al. , 1 99 1 ; Szatmari et al. , 1995). For
any disorder caused by a single major gene, the risk to relatives should fall by roughly
a half as genetic distance increases (Risch, 1 990b). Combined data from the four
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studies gives a O. 18% risk of autism for second degree relatives with a O.12% risk for
third-degree relatives. However, these data were collected from family histories
which may underestimate the risk of disorder in extended relatives (Weissman et al. ,
1986).
Secondly, Pickles et al. (1995) estimated that the number of genes responsible
for autism, using latent class analysis, ranged between two and ten, however a three
gene model was the most likely. Similar results were also obtained in simulations
performed by our group, using the same approach but with individuals diagnosed with
a "core", less broad definition of autism (Risch, unpublished). The population
prevalence was assumed to be 1/2500, the MZ concordance rate was 77% and the sib
risk value was presumed to be 3%. These figures lead to a MZ twin concordance to
population prevalence ratio AM = 1925, and a sib risk ratio As = 75 (see section
1.8.3.1). Assuming a multiplicative model and fixing the value of As, the value of AM
was predicted under a number of epistatic genetic models (Table 4). As can be seen
from the table, models specifying only 1 or 2 contributing loci or infinite contributing
loci give a poor fit to AM. Models with three or more loci begin to provide an
adequate fit to AM, depending on the degree of recessivity. In turn, these simulations
showed that numerous plausible genetic models fit the data used, however, there must
be at least 3 contributing susceptibility loci and the number depends on the degree of
recessivity.
In conclusion, it is clear that autism is not a single major gene disorder and the
data at present point to a multifactorial complex disorder with many genes implicated.
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Table 4: Predicted Values of the Population Prevalence Ratio (AM) (Observed = 1925),
Fixing As = 75 for Several Multiplicative Multilocus Models (Note: loci are referred to as
additive, recessive or intermediate, depending on the effect of that particular locus/loci).
Genetic Model

Predicted A M

1 locus, additive (As(i) = 75)

1 49

1 locus, recessive (As(i) = 75)

299

Infinite loci, additive

5 625

2 loci, additive (11,s(i) = 8.66 each)

266

2 loci, recessive (As(i) = 8.66 each)

I 132

3 loci, additive (11,s(i) = 4.22 each)

411

3 loci, recessive (As(i) = 4.22 each)

3 996

3 loci, intermediate (11,s(i) = 4.22 each)

1 5 82
900

6 loci, additive (11,s(i) = 2.05 each)
6 loci, intermediate (As(i) = 2.05 each)

2222

l locus, additive (As(i) = 4), infinite others

246 1

l locus, additive (As(i) = 6), infinite others

1719

2 loci, additive (11,s(i) = 4), infinite others

1 846

1.8

Linkage Analysis

The convincing evidence of a genetic component in the liability to autism
makes the disease an obvious candidate for molecular genetic strategies (Rutter et al. ,
1994). These strategies search for susceptibility genes to a disorder, which could be
particularly helpful in elucidating the biological basis of autism since biochemical and
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neuroanatomical studies have been inconclusive. Presently, there are two major
approaches that use markers to identify genes underlying human diseases. The first is
"genetic linkage analysis". This method is most commonly used for determining the
chromosomal location of genes for inherited disorders, where the causative genes are
unknown. The second is the "candidate gene" method, which presupposes that there
is prior information on pathogenesis pointing to specific genes where variation is
likely to occur. The frequency of different alleles in the candidate gene is in turn
compared between affecteds and controls using statistical tests for association. There
are some diseases, mutations and specific alleles that have been shown to co-occur
with autism (eg. Fragile X, chromosome 1 5 deletions, HLA alleles). Although the
traditional candidate gene approach was not used in this study, these "candidate
regions" were investigated in greater detail in this project, using genetic linkage
analysis to identify susceptibility loci.

1.8.1

Principles of Genetic Linkage Analysis in Mendelian Inheritance

In principle, genetic mapping of disease loci involves locating the relative
position of a gene or genetic marker within the genome, by measuring its tendency to
segregate together with some other measurable trait through several generations. The
method of mapping genes by virtue of their co-segregation with other loci on a
chromosome through meiosis is termed genetic linkage analysis. Thus, genetic
mapping is a. description of a gene's meiotic behaviour rather than its physical location
(Thompson et al. , 1 99 1 ). Genetic linkage analysis is a tremendously important and
powerful approach in medical genetics because it allows mapping of genes, such as
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some disease genes, in which neither their biochemical nor their molecular basis has
yet been detected (Thompson et al. , 1991).
The production of accurate and high-resolution genetic linkage maps is
necessary for positional, as opposed to functional, cloning of genes. "Functional
cloning" refers to the identification of a disease gene based on fundamental
information about the basic biochemical defect, without reference to its chromosomal
map position. Pure "positional cloning" assumes no functional information, and the
responsible gene is located solely on the basis of genetic map position with the use of
linkage analysis (Collins, 1995). Even before the identification of a disease gene, its
placement on a genetic map is useful for identifying susceptible individuals and for
genetic counselling (Cox Matise et al. , 1994). The unit of measurement for genetic
linkage is the genetic length of a chromosome over which, on average, one
recombination event is observed ("recombination" referring to the process of crossing
over between homologous chromosomes during meiosis). This unit is called a
Morgan (in honour of Thomas Mor�an who discovered the process of crossing over
in 1910). A centiMorgan (cM) is the genetic length over which one observes
recombination in one percent of recombination events or meioses. In the human
genome, one cM translates roughly into one million base pairs (bp), when taking into
account the physical length of the genome (3 x 109 bp) (Thompson et al. , 1991).
In principle, the smaller the genetic distance between two loci, the greater the
probability that they will be linked and transmitted together to the next generation.
This goes against Mendel's law of independent assortment which states that an
individual's genes will be transmitted to the next generation independently of one
another. Mendel's law holds true for most pairs ofloci, except those that occupy the
same region of a chromosome. Under the process of independent assortment,
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recombinations in a particular chromosome occur 50% of the time. A recombination
frequency less than 50% or a genetic distance less than 50cM between two loci on the
same chromosome, infers that these two loci are linked.
Linkage studies look at the transmission of alleles in a family to estimate the
recombination frequency between known loci and the disease gene. The direct
method of linkage analysis involves observing and counting recombinants and
nonrecombinants. The recombination fraction is then calculated by dividing the
number of observed recombinants (k) by the number of opportunities for
recombination (n):

e = kin
To do this, it is important to know the linkage phase, ie. the chromosome on which
each allele is located. Generally, this can only be known in three or greater generation
families. For example, Figure 2 shows a three generation family with individuals
affected with the dominant disorder NFl (shaded symbol). The genotypes for a two
allele marker locus ( lF l O) are shown below each individual in the pedigree. Since the
genotypes of the grandparents are known, the linkage phase of the grandchildren is
known. Allele 1 seems to co-segregate with the disease phenotype (ie. this marker is
linked to the disease), therefore children in this family who are affected with N F 1
usually have allele 1 at lFlO. In seven out of eight children in generation three this
seems to be correct, however in one child a recombination has occurred (individual
III.6). The recombination frequency for this family is, therefore, 1 /8 = 1 2.5%, ie. the
marker and the disease locus are approximately 1 2.5cM apart.
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Figure 2 : An NF I pedigree in which each member has been typed for the I F I O polymorphism

(A). A recombination has occurred at individual Ill-6. (from Jorde, Carey and White, 1 995)

When the parental phase is unknown the recombination fraction is estimated
using the method of maximum likelihood (Fisher, 1921). In this method, the
likelihood (ie. the probability of occurrence of the data) is calculated for a variety of
assumed values of 8, and the e value associated with the highest likelihood is selected
as the best estimate (8max). A lod score (Z; Bernard, 1949) is the logarithm (log10) of
the likelihood that two loci are linked at a given recombination frequency (8), versus
the likelihood that the two loci are not linked (8 = 0.5). The likelihood principle is
defined as:
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Z(8) = log 1 o (L (8) / L (8=0. 5))

The lod scores are then graphed against the 8 values, as shown in Figure 3. The
estimate of the recombination fraction is, in turn, that value of 8 at which Z(8) is
highest (Zmax).
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LOO score
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1 .5
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Figure 3: The lod score is plotted against the recombination frequency to determine the most

likely recombination frequency for a pair of loci (from Jorde, Carey and White, 1995).
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Positive lod scores indicate evidence for linkage, and negative lods indicate
absence of linkage. If linkage exists between the two loci, the lod score is expected to
become larger with the addition of more families. Conventionally, a lod score of3.0
is the threshold used to declare linkage, since a score of 3.0 indicates that the
likelihood in favour of linkage is 1 OOO times greater than the likelihood against
linkage. Conversely, a lod score less than -2 (odds of 1 00 to 1 against linkage) is
considered to be evidence that two loci are not linked. Morton ( 1 955) originally
proposed these particular values. In calculating these values, Morton used a power
(to detect linkage if present) of 0.99 at the chosen recombination fraction (8< 1/2) and
a significance level (probability of a false-positive result) of O.00 1. His choice of
power and significance level was determined to ensure that the rate of false positive
results stay below 5 percent. The significance level of the test for linkage (0.00 1 ) is
much smaller than the significance levels of 0.05 or 0.0 1 customarily used in statistical
tests. The reason for this is that a large proportion of statistically significant false
positives are calculated using these values. When using a significance level of O.001 ,
all but a few percent of results are real. Whilst this holds true in a sequential test ( the
sampling of a number of small families in a sequential manner), in large-sample theory
(use of a large amount of informative data in the analysis) the rate of false positive
results increases and the lod score drops from 3 to 2.07. To obtain a lod score of 3 in
large sample theory, a significance level of a = 0.000 1 is required (Morton, 1 998).
This relates to a reliability of 0.996. Overall, in genetic linkage analysis a lod score of
3 is commonly used to declare a significant result of linkage between two loci.
A linkage map consisting of polymorphic DNA markers is the most
appropriate map, as it allows the inheritance of different alleles of each marker to be
traced in the families (informative genetic markers are ones that are highly
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polymorphic and are heterozygous in a large proportion of individuals). The closer
the genetic distance between the marker and the trait, the lower the probability that a
meiotic crossover between the two loci will occur to prevent co-inheritance of the
genetic marker (Thompson et al. , 1991). Linkage maps at 5-10 cM resolution are
sufficient to identify the map location of diseases with Mendelian patterns of
segregation, but for polygenic disorders which are characterised by multiple loci,
higher resolution maps may be necessary (Cox Matise et al. , 1994). When linkage
analysis is carried out as a sequence of pairwise comparisons between a trait locus and
each of a number of marker loci, this is referred to as "two-point" analysis. For this
type of analysis, lod scores are computed for each comparison (ie. trait vs. ith marker
or marker vs. marker) and combined with the results of the same comparison from
other families and/or investigators. With the production of dense genetic maps, it has
become possible to analyse several linked loci simultaneously. This is referred to as
"multipoint" linkage analysis (Lathrop et al. , 1984) and it is shown to be at least 5
times as efficient as two-point analysis in estimating the recombination value (Lathrop
et al. , 1985) (see section 1.8.3.2). Once the allele(s) of genetic markers are shown to

co-segregate with the disease phenotype, these markers provide information on the
position of the gene in the genome. With refined experimentation, the disease gene
can be located more precisely.
The prerequisites for linkage analysis in mapping disease genes responsible for
Mendelian disorders are that the locus linking to the disease must be present in
different forms in the population (ie. polymorphic genetic markers), and the
availability of a sufficient number of informative meioses where the same disorder
segregates. The following sections explore these prerequisites of linkage analysis for
a Mendelian trait.
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1.8.1.1 DNA Polymorphism
The term genetic polymorphism is used to describe variation in DNA
sequence. Polymorphic loci are characterised by a number of different alleles, which
allows members of a population to be categorised into distinct genotypes.
Polymorphic loci occur mainly throughout regions of the genome that do not contain
genes. Genetic polymorphism is, in turn, defined as the occurrence of multiple alleles
at a locus, where at least two alleles appear with frequencies greater than one percent.
By convention, then, polymorphic loci are those at which at least two percent of the
population are heterozygous (Ott, 1992). Polymorphic markers with a high
heterozygosity index (ie. the percentage of individuals that are expected to be
heterozygous at that locus) are desirable, as the presence of multiple alleles increases
the chance that the segregation of normal and disease-carrying chromosomes can be
traced within the pedigree.

1.8.1.2 Polymorphic DNA Markers
Several types of DNA polymorphism have been utilised as genetic markers.
These include (i) single nucleotide substitutions and (ii) repetitive DNA sequences.
Single nucleotide polymorphisms (SNPs) have recently been systematically identified
within the mapped sequence tagged sites (STS) distributed over the whole genome.
One type of SNP are restriction fragment length polymorphisms (RFLPs) and these
are detectable by restriction enzyme analysis (Kan and Dozy, 1 978). The variations
within these single nucleotides are usually biallelic (2 common alleles) and they have
the potential,for a +/- assay. These polymorphisms are also particularly suitable for
genomic analysis using microarrays, due to their simple structure. Microarrays, or
DNA chips, can contain as many as 3 000 SNPs (Sapolsky et al., 1 999) and would
53

therefore potentially allow whole genome analysis of many DNA samples in a
relatively fast and economic way. SNPs, however, are only about a third as
informative as microsatellites (see below) and a complete map will probably not be
available until the entire genome is sequenced (Tynan, 1998).
Tandem repeat sequences are sites where the same short DNA sequence is
repeated a number of times. These repeats are thought to arise by slippage during
replication and unequal crossing over (Efstratiadis et al. , 1980; Jeffreys et al. , 1986;
Levinson and Gutman, 1987). Replication errors during cell division can cause the
number of repeats to change. The frequency of this kind of replication error is high
enough to make alternative repeat lengths at the site common, but the rate of change
in the length of repeats is low enough that the size of the repeat sequence at the site
serves as a stable polymorphic trait in family studies (Housman, 1995).
Tandem repeat DNA elements include satellite DNA, minisatellite DNA and
microsatellite DNA. The polymorphism present in satellite DNA (which is present in
heterochromatin) is in the length of the clusters of tandem arrays, which can be up to
several megabases in length (Cooper and Krawczak, 1993). A number of different
families of satellite DNA tandem arrays have been identified, including a simple
sequence of 5-25 bp repeats, alphoid (171 bp repeat) and Sau3A (-68 bp repeat)
(reviewed by Vogt, 1990). Minisatellite sequences, which are also known as variable
number of tandem repeat (VNTR) polymorphisms, are variations in the length of
stretches of DNA containing a variable number of units of the same short sequence.
This core consensus sequence is GGTGGGCAGARG, where R is equal to a purine,
and there is t_hought to be approximately l04 copies of VNTRs in the human genome.
Finally, microsatellites are short (less than 500bp) tandem repeats, interspersed
throughout the genome with sequence motifs of one to five nucleotides (Hearne et al.,
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1992). The most abundant of these are the (CA/GT)n dinucleotide repeats, with
approximately 50,000 copies per haploid genome (Weber and May, 1989).
Microsatellites are the most useful of these DNA polymorphisms as they are
easily isolated and characterised, and they display considerable polymorphism due to
the large variation in the number of repeat units. Microsatellites are therefore the
most ideal markers, at present, for the construction of high-resolution genetic maps,
which can then be used to identify susceptibility loci involved in common genetic
diseases. RFLPs, on the other hand, exhibit a low degree of polymorphism, and
VNTRs are not evenly distributed throughout the genome, with clustering in the
telomeric and centromeric regions (Royle et al. , 1988), making them less useful in the
construction of genetic maps.
The first genetic linkage map in man was constructed using RFLPs (Donis
Keller et al. , 1986). Botstein et al. ( 1980) were the first to propose that differences in
the DNA sequence should be treated like allelic variants of a gene, allowing their use
as genetic markers for gene mapping. With the rapid rate of increase in the number of
polymorphic markers identified (Figure 4), many laboratories have used these markers
to construct genetic maps of whole chromosomes or particular portions of a
chromosome (NIH/CEPH, 1 992 ; Weissenbach et al. , 1 992). Due to the number of
CA repeats dispersed throughout the genome (-50,000; see above), these new genetic
maps consist mainly of these types of microsatellites. The Human Genome Project
(HGP) has completed mapping the entire human genome with polymorphic markers at
1 -cM intervals. This project, which officially began in 1990, also aims at locating all
the 60,000 to 70,000 genes of the haploid genome and sequencing the entire 3 billion
or more nucleotides within it.
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Figure 4: The number of lmown polymorphic markers from 1 9 8 1 till 1 993 (from Jorde, Carey
and White, 1 995).

1.8.1.3 Family Material

As mentioned previously, the possibility of obtaining a significant result in
genetic linkage studies relies on the availability of enough polymorphic markers and
the number of informative meioses. With recent progress in recombinant DNA
technologies and the completion of stage I of the Human Genome Project, which
aimed at constructing the genetic map, the availability of polymorphic markers poses
no significant problem. Genome-wide scans of the entire human genome with
microsatellite markers in informative families have been widely performed. Indeed, a
large number of important disease genes have been localised using this approach and
many have been cloned (eg. Early Onset Breast Cancer [Hall et al., 1990],
neurofibromatosis type II [Rouleau et al., 1993]). The availability of sufficient family
material is, however, a crucial point, and it is important to know how many
informative meioses are required before attempting a genome search by linkage
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analysis. This can be calculated by means of computer simulations, in which
segregation of a potentially informative marker is simulated in the available family
material. The simulation also estimates the expected and maximum lod-score which
could be attained in the selected number of families if the marker was linked to the
disease gene at a certain recombination fraction (estimate of the power of the
proposed study), and if the marker was unlinked to the disease gene (estimate of the
false positive rate). Traditionally, simulation analysis also requires the genetic model
(ie. the mode of inheritance) to be specified, and the results obtained are only valid
within the context of this model. It is important to specify an accurate genetic model,
since mis-specifying genetic parameters may cause a loss of power in localising
disease genes using the traditional lod-score method of genetic linkage analysis. The
sib-pair method of genetic linkage analysis was used in this study (see below in 1.8.3)
and does not rely on the specification of a genetic model, so the results are not reliant
on this parameter. However, once a reasonable genetic model can be postulated for
the transmission of the disease in the affected families, and there is enough family
material available, genetic linkage analysis using the traditional lod-score method is
known to work effectively to localise susceptibility loci.
Our group, assuming multilocus inheritance, completed computer simulations
on the first 100 families collected, to determine the expected maximum lod score
(EMLS) that could be obtained from this number of informative meioses. From these
simulations it is plausible to expect that we can identify any loci (EMLS > 3.0) with
As = 3 or more with a 1OcM marker map, if all markers have an average
heterozygosity of 0.67 (Table 5). With the addition of 100 more families we can
expect to detect any susceptibility loci with As � 2 using a 1OcM genetic map (het. =
0.67) (Table 5). As described in section 1. 5.2.1, our estimate of As for autism is
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between 50-200, thus our sample size should give enough power to discover at least
several gene effects.

Table 5 : EMLS for Multipoint Analysis, 10cM map, Het. = 0.67.

As

1.8.2

�

2.0

3.0

4.0

1 00

1 .9 1

3 .43

4.36

200

3 . 82

6.85

8.76

Complex Disorders

The use of linkage analysis in mapping complex traits is problematic since it is
difficult to find a precise model that adequately explains the inheritance pattern. As
previously defined, the term "complex trait" refers to any disorder that does not
exhibit classic Mendelian recessive or dominant inheritance attributable to a single
gene locus. Cystic fibrosis and Huntington's disease are classic examples of
Mendelian disorders. In both cases, genetic linkage analysis was used to localise the
disease gene. Finding a genetic marker that co-segregates with a complex trait,
however, may be complicated by many factors including reduced penetrance, presence
of phenocopies (non-genetic cases), genetic heterogeneity, polygenic inheritance and
high frequency of disease-causing alleles in the population (Lander and Schork,
1 994). Reduced penetrance, phenocopies and heterogeneity can be problems relevant
to some Mendelian disorders as well.
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(I)

Incomplete Penetrance and Phenocopy: Incomplete penetrance can be seen
when individuals carry the predisposing allele but do not show phenotypic
signs of the disease. Phenocopy, on the other hand, is seen when affected
individuals do not carry the predisposing allele but develop the disease due to
other causes (eg. environmental agents). These factors may affect genetic
mapping studies, since the predisposing allele may either be present in some
unaffected individuals or absent in some affected individuals.

(II)

Genetic Heterogeneity: Genetic heterogeneity is present in those disorders that
are caused by multiple mutations at several genes. This can result in identical
phenotypes, especially when the products of the affected genes are part of a
common biochemical pathway. An example is retinitis pigmentosa, which
involves retinal degeneration, and can result from mutations in any of at least
14 different loci (Bleeker-Wagemakers et al. , 1992; Kumar-Singh et al. ,
1993). Genetic heterogeneity affects genetic mapping because a certain
chromosome region will co-segregate with the disease in some families but not
others. Allelic heterogeneity (the presence of multiple disease-causing
mutations in a single gene), however, does not affect genetic mapping since
the disease locus co-segregates with the same chromosomal region in all
affected families.
The effect of genetic heterogeneity and incomplete penetrance was
examined in our sample of families using computer simulations. Assuming all
markers had an average heterozygosity of 0.67, we concluded that 200
families would detect linkage under the lowest penetrance model at a
recombination fraction of 0.05, if at least 50% of the families are linked to this
gene. Approximately 33% oflinked families would be sufficient in models
59

with higher penetrance or at lower recombination fractions. In the case that
only 25% of the families are linked, a sample size of 290 would be needed.
(III)

Polygenic Inheritance: Some complex traits require the simultaneous presence
of mutations in multiple genes and this is known as polygenic inheritance.
These multiple interacting genes may consist of either oligogenes
(incompletely penetrant genes with a relatively large and therefore potentially
recognisable effect on the trait) and/or polygenes (genes with a minor
individual effect on the trait that may make their isolation by linkage analysis
difficult) (Morton, 1998). Polygenic (complex) traits may be classified as
distinct traits, measured by a specific outcome, or quantitative traits, measured
by a continuous variable (eg. diastolic blood pressure) whose level may be
determined by the combined action of individual quantitative trait loci.

(IV)

High Frequency of Disease-Causing Alleles: If the disease-causing allele
occurs at a high frequency in the population, it could be difficult to localise.
An example of this is late-onset Alzheimer's disease. Linkage studies showed
weak evidence of linkage to chromosome l 9q. However, due to the low lod
scores, these results were dismissed. It was not until the discovery that the
apolipoprotein E type 4 allele on chromosome 19 was a predisposing factor
that it was realised that these linkage results were correct. The reason behind
the calculation of a low lod score was found when the frequency of this allele
was shown to be -16% in most populations, thus interfering with the
traditional linkage analysis (Corder et al. , 1993).
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1.8.2. 1 Defining the Disease Phenotype
Narrowing the definition of a disease, or restricting the patient population so
that only individuals with the "core" form of the disease are diagnosed, can assist in
overcoming some of the difficulties mentioned above in mapping complex diseases.
The selection of families is based on the presence of one or more of the following
characteristics:
(I)

Unusual phenotypic features: Identifying a subset of families with an unusual
phenotypic feature may reduce the number of genes involved in the disorder.
For example, it was found that colon cancer with extreme polyposis was
caused by a single dominant gene, and that other forms of colon cancer can be
distinguished by the phenotype of replication errors in tumours (Aaltonen et
al. , 1 993).

(II)

Age of Onset: Strictly genetic forms of disease often exhibit an earlier onset
compared to complex or sporadic forms. For example, genetic homogeneity
was found in breast cancer when only families with disease onset below 4 7
years were included in the analysis (Hall et al., 1990).

(III)

Extreme Severity: Particularly in the case of quantitative traits, it is often
shown that inclusion of individuals with phenotypic values in the tails of the
distribution increases the power to detect linkage (Risch and Zhang, 1995).
In this study, only individuals diagnosed with the "core" syndrome of autism

were included (ie. individuals diagnosed with Asperger syndrome and/or autistic
spectrum disorders were excluded). All individuals with an IQ below 3 0 and/or
associated with another disorder were also excluded from the analysis. By creating a
homogeneous set of families with a diagnosis that is replicable between clinicians, our
chance of detecting susceptibility loci should be increased.
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Age of onset was also examined as a basis of discriminating distinct subgroups
of families in our study. Results from the analysis of the first 37 families showed that
there was great variability in the ages of onset, ranging from briefly after birth to 78
months and that the ages of onset between siblings were not significantly different.
However, when both parents' reports of age of onset were examined separately, there
was high variability between the ages specified. From these data, it was concluded
that the use of retrospective parent reports of age of onset may be too unreliable and
we could find no evidence to support the value of dividing autistic families on the
basis of age of onset.

1.8.2.2 Linkage Analysis Methods Used for the Study of Complex Disorders

Genetic linkage analysis relies on the specification of an accurate genetic
model. However, it is difficult to use classical segregation analysis to accurately
model a complex trait since it requires a significant amount of pedigree data to
estimate the large number of unknown parameters required. In light of this problem,
many linkage analysis methods that differ from the traditional lod score method have
been proposed for complex traits. One involves using parametric linkage analysis
under several simple modes of inheritance (Risch et al. , 1989). This type of analysis is
called parametric because parameters such as penetrances and allele frequencies must
be specified for the disease gene. However, analysing data under a clearly "wrong"
model is expected to result in a loss of power and in biased estimation (overestimation
of the recombination fraction). For some two-locus models, the degree of
information loss has been shown to vary depending on the mode of inheritance
(Schork et al. , 1990). Other methods involve non-parametric linkage analysis. These
methods do not assume that a single major disease locus (with a specific mode of
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inheritance) accounts for the majority of the genetic variance, and are best suited for
searching for susceptibility loci involved in genetically complex disease. One non
parametric method is the affected sib pair approach, and this is the method of choice
in this study.

1.8.3 Sib-Pair Methodology

Affected sib-pair analysis examines siblings (both with the disease) for the
sharing of marker alleles at multiple sites in the genome. The more often the affected
siblings share the same allele at a particular site, the more likely it is that the site is
close to the disease gene (Penrose, 1935). Although allele-sharing methods are often
less powerful (in terms of the chance to detect linkage) than parametric analysis with a
correctly specified model, they tend to be more robust. Affected siblings show an
excess of allele sharing even in the presence of incomplete penetrance, phenocopy,
genetic heterogeneity and high-frequency disease alleles (Lander and Schork, 1994 ).
This method is very useful in studying autism, since the unknown parameters such as
affection status of the parents and the mode of inheritance do not need to be specified.
Sib-pair analysis involves testing whether affected siblings inherit a region that
is identical-by-descent (IBD) more often than expected under random Mendelian
segregation. Under random segregation the probabilities of sharing zero, one or two
alleles IBD are 25%, 50% and 25% respectively. If both parents are available, the
data can be partitioned into separate IBD sharing for the maternal and paternal
chromosomes. In this case, each affected sibling could share zero or one allele with
the other sibling, with a 50%-50% distribution expected under random segregation.
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A deviation from the expected 50% IBD allele sharing suggests the presence of a
trait-causing gene (Lander and Schork, 1994).

1.8.3.1 Power to Detect Linkage

The power of sib-pair methods to detect linkage to a disease-susceptibility
locus for a given sample size, depends only on the risk ratio As (ie. increase in risk to
siblings compared with the population prevalence) and on no other genetic model
parameters (such as number of alleles at a given locus, gene frequencies and
penetrance; Risch, 1990b). In autism, the increase in risk to siblings is equal to an
overall lambda (As) value of 50-200. This lambda value (As) is an overall risk ratio
that summarises the collective effect of all the disease loci. The higher the As value,
the stronger the genetic effect. A locus with a small genetic influence on the disease
corresponds to a As < 2 (ie. it determines <2-10% of the total genetic variance),
whereas a moderate to large gene effect coincides with a As > 4 (ie. it determines >420% of the total genetic variance). There is a high observed As value for autism,
suggesting that affected sib-pair analysis may be a powerful approach for mapping
susceptibility genes in this disorder. However, this still depends on the number of
genes involved and on their interaction with each other.
Genes for a specific disease can interact in either a multiplicative or additive
manner depending on the penetrances of the individual loci (ie. the probability of
being affected given a certain genotype). The genes responsible for autism are
generally thought to interact in a multiplicative manner. This means that if there are N
loci involved, the overall As is the product of the locus-specific risk ratios, ie. As =
A 1 A2 A3 . . . AN-IAN (Risch, 1990b). Since the locus-specific risk ratios are not known at
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the beginning of a study, exclusion mapping is generally conducted over a range of
lambda values. The range used in this study was between 1.5 and 1 0, representing
weak to strong gene effects.
The maximum likelihood statistic (MLS) T, is used to detect evidence for
linkage of a specific marker in a set of affected sib pairs. MLS is analogous to the lod
score statistic (Z) in that its value is the log 10 of the odds in favour of linkage
(Morton, 1955). A T value of3.0 corresponds to odds of 1 000: 1 in favour of linkage
and is considered to provide evidence of linkage. The MLS statistic T can be shown
mathematically as follows:

Where N is the number of affected sib-pairs, n0 is the number of sib-pairs that share 0
marker alleles IBD, N-no is the number that share 1 or 2 marker alleles IBD, and Naso
denotes the probability that a sib-pair share O alleles at a random locus IBD.
As evident from the above formula, the power to detect linkage at a given
value of As is directly proportional to the number of sib-pairs studied. Figure 5 shows
this relationship diagrammatically.
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Figure 5: Power to detect linkage at differing lambda values (As), using N affected sib pairs

and assuming zero recombination and a completely informative marker (From Risch, 1 990b)

Figure 5 shows that if the relative risk for a locus is 2, a sample size greater than 200
will be required to detect linkage with 80% power. However if As = 5, a sample size
of 60 will be sufficient to detect linkage with 80% power. This value represents the
minimal sample size required, since recombination (8) is assumed to be zero, and the
marker is assumed to be completely informative (100% polymorphic). .With
increasing 8, the power to detect linkage decreases drastically. A study by Risch
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( 1 990b), found that the power to detect linkage using the MLS approach on a sample
of 3 00 sib-pairs dropped by approximately 50% at a recombination fraction of about
0. 1 0. However, the effects of recombination can be reduced by using multi-marker
analysis (Goldgar, 1990; Fulker et al. , 1995; Olson, 1995; Kruglyak and Lander,
1 995).

1.8.3.2 Multipoint Sib-Pair Analysis
Multipoint linkage analysis examines several linked loci simultaneously to
locate disease susceptibility loci. Not only is this method able to detect linkage when
recombination between the marker and the disease locus is not equal to zero, but it
can increase the power to detect linkage (Risch, 1990b) and also can be used to
exclude regions of the genome from linkage to a disease gene (Risch, 1993).
Multipoint sib-pair analysis also allows for maximal use of marker information when
assessing linkage, and determines a confidence region likely to contain a susceptibility
gene. In this method of analysis, a lad score is calculated for each sib-pair at each
marker locus and at a number of intervals between these markers, under the
assumption of a specific lambda value. The lod scores at each interval are then added
up over all sib-pairs, which gives the total lod score. As in the lad score method, a
lod score of < -2 suggests lack of linkage and a lad score >3 is suggestive oflinkage.

1.8.3.3 Genes Localised in Complex Disorders Using Multipoint Sib-Pair
Analysis
Multipoint sib-pair analysis has been used to localise susceptibility loci for
some complex disorders. Three examples are insulin-dependent diabetes mellitus
(IDDM), multiple sclerosis (MS) and ankylosing spondylitis (AS).
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Insulin-Dependent Diabetes
Insulin-dependent or type 1 diabetes mellitus (IDDM) is an autoimmune
disease associated with loss of tolerance to several pancreatic islet cell molecules
(Krause et al., 1 979). It is a complex disorder determined both genetically and
environmentally, and frequently occurs in childhood. Mouse model studies have
shown that this severe form of diabetes is caused by a combination of a major effect at
the major histocompatability complex (MHC) and at least ten other susceptibility loci
elsewhere in the genome (Risch et al. , 1993 ; Podolin et al. , 1998). A genome-wide
scan of 3 56 affected sib-pair families from the United Kingdom indicated a similar
genetic basic for human IDDM. A major gene component was located at the MHC
locus (IDDMl) and can explain 34% of the familial clustering of the disease (MLS =
34, As = 2.5) (Davies et al. , 1994 ; Cucca et al. , 1998). Two other loci showed
evidence of linkage including chromosome 1 0pl3-p l 1 (MLS = 4.7, As = 1.56) and
chromosome l6q22- 1 6q24 (MLS = 3 .4, As = 1.6) (Mein et al. , 1998). The
programme used to calculate the multipoint MLS values and the information content
and exclusion maps was MAPMAKER/SIBS.

Multiple Sclerosis
Multiple sclerosis (MS) is a chronic neurological disorder which presents with
progressive sensory or motor dysfunction that can ultimately lead to disability and
death (Cumings et al., 1 965). Strong evidence indicates that MS is a complex
autoimmune disorder, with its definition based solely on clinical criteria and its mode
of inheritance non-Mendelian. Genetic influence in the disorder has been shown
through population and twin studies, with a 20-fold increase in risk for first degree
relatives over the general population (Sadovnick et al. , 1 988), and MZ concordance
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rates of 25-30% compared to 4% for DZ twins and siblings (Ebers et al. , 1986;
Mumford et al. , 1994). A genome-wide search using 257 microsatellite markers in
100 Canadian sib-pairs showed evidence oflinkage at chromosome 5p (D5S406) with
a maximum multipoint lod score of 3.1 (maximum pointwise lod score = 4. 24). This
value increased to 3.6 with the addition of 44 extra sib-pairs, but diminished to 1.6
when an extra 78 sib-pairs were analysed. It was suggested that there was significant
heterogeneity in the third data set compared to the first two, and evidence for a
susceptibility locus in that region of chromosome 5p could not be considered
confirmed (Ebers et al. , 1996).

Ankylosing Spondylitis
Ankylosing spondylitis (AS) or spondylarthritis is a common inflammatory
condition that is strongly associated with the filA region (Brown et al. , 1998). The
reduction in recurrence risk among increasingly distant relatives of AS patients
suggested that the genetic component of AS involved multiple interacting genes
(Lawrence, 1977). A genome-wide linkage screen was undertaken using 254
microsatellite markers in 121 affected sibling pairs with AS from Britain. Multipoint
analysis using the programme GeneHunter showed significant linkage to the MHC
region (MLS (D6S273) = 3. 8; MLS (82-2) = 8.1) , and suggested that 31% of the
susceptibility to AS is coded by genes linked to this region. A MLS of 2.6 was also
obtained on chromosome 16 at the locus D l6S422, suggesting that non-MHC genes
may also influence susceptibility to the disease (Brown et al. , 1998).
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1.8.4

Association Analysis

Association studies can be used in conjunction with linkage analysis to assist in
the detection of disease-susceptibility genes. This is particularly the case for genetic
effects too weak to be identified by current methods of linkage analysis (Risch and
Merikangas, 1996). Association studies examine the difference in frequencies of a
marker allele between patients and controls. An association will be detected if the
marker investigated is a susceptibility gene, or if it is in linkage disequilibrium (LD)
with the susceptibility gene locus.
Linkage disequilibrium is a term used to describe a situation in which an
arrangement of alleles at different loci on the same chromosome (the haplotype)
occurs at a frequency greater than would be expected by chance. This can be caused
by a variety of factors including: (I ) recent admixture of populations with different
allele frequencies, (2) selection in favour of a specific allele (which increases the
frequency of haplotypes containing this allele), and (3) genetic drift or population
bottlenecks and new mutation ( creates disequilibrium with closely linked markers)
(Weeks and Lathrop, 1995). Since LD decreases with time in proportion to the
recombination fraction between the loci, disequilibrium between closely linked loci
will decay less rapidly. If these linked loci in LD are in the vicinity of a gene, this may
lead to the identification of a disease-susceptibility gene in the affected individuals.
Using LD to map disease loci is more efficient in genetically isolated
populations. This is because there is a greater chance that there is only one ancestral
haplotype 01' which the disease mutation arose and, if the population is relatively
young, LD could extend over substantial distances increasing the probability of
detection. An example of an isolated population is the Finnish population which is
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believed to have settled in the region over I , OOO years ago, with little immigration
until at least the middle of the 14 th century (Virtaranta-Knowles et al. , 199 1 ).
A significant problem with association studies, however, is that the results are
highly sensitive to mis-specification of allele frequencies in the study population. This
can be due to recent admixture of different populations (with each sub-population
contributing different allele frequencies) (Knowler et al. , 1988), or to inappropriate
matching of patients and controls. The haplotype-relative-risk (HRR) approach
overcomes this problem by constructing an "artificial" control population from the set
of alleles that were not transmitted to affected offspring from their parents (Falk and
Rubinstein, 1987). The estimation of allele frequencies in this case is only conditional
on the transmitted versus non-transmitted alleles. A similar analysis is termed the
transmission-disequilibrium-test (TDT) (Spielman et al. , 1993). This method
compares the observed transmission of an allele of interest from heterozygous parents
with the expected rate of transmission (ie. 50%). The additional cost of typing more
individuals in these methods compared to traditional association analysis is well
justified, since population stratification problems leading to false positive results are
overcome. These family-based association methods have been used to detect disease
genes (Thomson, 1 995), and since they do not require any additional genotyping to
sib-pair linkage analysis, the two methods can be used in parallel to assist in the
detection of disease susceptibility loci. To ensure, however, that LD is independent of
any linkage present when multiple sibs from the same family are tested, a Monte Carlo
simulation is used (see Risch et al., 1 999; Appendix 6.3).
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1.8.5 Linkage and Association Studies in Autism

Due to the sufficiently large familial relative risks and the data mentioned
above supporting autism as a genetic disorder, mapping studies can be undertaken to
identify the genetic loci that contribute to the disorder (Bristol et al. , 1996). To date
there have been only three systematic genome scans in autism research and the
number of association studies in this disorder has been relatively limited. The results
from these molecular genetic studies are outlined below, in order of the area of the
genome they covered and the year in which they were completed.

1.8.5.1 HLA and 19 Autosomal Markers (Spence et al. , 1985)
The first linkage study in autism was accomplished by Spence et al. ( 1985).
They studied 34 multiplex families (two or more autistic children) from the UCLA
Registry for Genetic Studies of Autism, for linkage to the HLA region ( chromosome
6) and 19 other autosomal markers. No evidence oflinkage was obtained between
the disease and the HLA region using the lod score method. When an association test
was performed by comparing the number of shared HLA haplotypes in autistic
siblings to what would be expected by chance, a significant result was still not found.
The largest lod score calculated from these 34 families was 1.04 for haptoglobin, a
marker whose gene lies on chromosome 1 6. When the families were divided into two
groups, ie. families with only affected males and families with at least one affected
female, a marker suggestive of linkage was identified in the second group of families.
This marker was linked to the ABO blood group locus on chromosome 9 and the
calculated lod score was 1.54.
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1.8.5.2 HLA (Warren et al. , 1991/1992/1996a; Daniels et al., 1995)

Investigators have reported associations between alleles of the HLA complex
and autism when compared to normal controls. These autism-associated alleles include
the null allele of the C4B gene (Warren et al., 1991), the extended haplotype B44-S3O
DR4 (Warren et al. , 1992; Daniels et al. , 1995), the third hypervariable region of HLA
DRB1 (Warren et al. , 1996a) and two alleles of the DR beta 1 gene (Warren et al. ,
1996b). The third hypervariable region of HLA-DRB 1 has shown the strongest
association with autism. Warren et al. (1996a) calculated that the relative risk of
developing the disorder if you have this marker was 19.8 for allele 1 of this marker and
4.2 for allele 3. This region is essential for the presentation of peptides to T
lymphocytes by antigen-presenting cells (APC), and is therefore necessary for the
development of cell-mediated and antibody immune responses to pathogens and other
foreign antigens (Warren et al., 1996b).

1.8.5.3 Chromosome 15 (Gillberg et al. , 1991b; etc.)

A number of case studies have reported the association of autism with partial
trisomy / tetrasomy and duplication of chromosome 15 (see section 1.5.1.2). Hotopf
and Bolton ( 1995) offered a number of explanations for these finding, hypothesising
that autism has a heterogeneous genetic basis or, alternatively, that autism may have a
consistent genetic basis in an aberration of chromosome 15.

1.8.5.4 Fragile X (Hallmayer et al. , 1994)

The association of the Fragile X syndrome (FraX) with autism is well known
(see section 1. 5. 1. 2). The gene responsible for FraX is FMR-1 (Oberle et al. , 1991;
Verkerk et al. , 1991) and the syndrome is usually caused by an amplification of the
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CGG trinucleotide repeat region of this gene (Rousseau et al. , 1991). Hallmayer et
al. (1994) examined the possibility that a mutation elsewhere in the FMR-1 gene was
involved in the aetiology of autism. This was achieved by carrying out linkage
analysis on 35 multiplex families using microsatellite markers that were tightly linked
to the FMR-1 gene (DXS548, FRAXAl , FRAXA2, CGG repeat). Using four
different dominant models of varying penetrance values and a recessive model, linkage
to the FMR-1 gene was excluded (lod score between -24 and -62) in all models.

1.8.5.5 X-Chromosome (Hallmayer et al. , 1996)

Due to the increased ratio of autistic males to females, even in multiplex
families (see section 1. 4.3), a search for an autism susceptibility gene on the X
chromosome has been conducted. This was the first reported application of the sib
pair approach to the search for genetic influences in this disorder. Thirty-eight
multiplex families were tested for linkage to 35 microsatellite markers using
multipoint sib-pair analysis, and linkage to the entire X-chromosome could be
excluded for As = 4. A maximum lod score of 1.24 was obtained between DXS424
and DXS1001 for a As = 1.5. Another lower peak (0.93) was observed at DXSYXl .
Overall, a moderate to major gene effect for autism was excluded on the X
chromosome. A susceptibility gene increasing the sibling risk between 1. 5 to 3 fold
could, however, not be excluded, in particular a gene of small effect located between
DXS424 and DXS1001 (Hallmayer et al. , 1996).

1.8.5.6 X-Chromosome (Petit et al. , 1996)

An association study was completed on 90 autistic children from a Child
Psychiatry Day Care Unit in France and unrelated controls. Eight markers on the X74

chromosome were tested using x2 analysis. DXS287 was the only marker that
showed a different allele distribution between control and patient groups. This
difference was enhanced in the more severely autistic and least retarded children.
Investigators noted that if this locus on the X-chromosome is specific for autism, the
result would have to be replicated on another group of autistic children, as well as a
non-retarded autistic population. Also, the accuracy of the result could be increased if
the parents were typed and the haplotype relative risk method (HRR) was employed.

1.8.5. 7 Harvey-Ras Factors (Berault et al. , 1995)

Herault et al. (1995) compared five polymorphic markers in a sample of 50
autistic children and 50 controls, and found that the HRAS marker B3/B3
homozygous genotype was significantly less frequent in autistic children than in
controls. The HRAS gene (chromosome 1 l p l 5. 5) codes for the ras protein, which is
active in neuron development, and the researchers hypothesise that it may be the basis
of autism. However, this has been only a "preliminary study and a further study with
a larger population and a wider IQ distribution must be performed".

1.8.5.8 Serotonin (Cook et al. , 1997b)

Since serotonin transporter inhibitors have been shown to be partially efficient
in the treatment of autistic symptoms such as restricted and repetitive behaviours,
language use and aggression (Gordon et al. , 1993; McDougle et al., 1996), Cook et
al. (1997b) considered the serotonin transporter (HTT) as a candidate gene in autism.

They examined possible linkage and linkage disequilibrium between two
polymorphisms reported for the serotonin transporter gene (a VNTR in the second
intron ofHTT and a short variant of the HTT promoter) with autism, using the TDT
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test. TDT analysis of 86 US families showed no evidence for linkage or linkage
disequilibrium between autism and the VNTR, however, preferential transmission of
the short variant of the HTT promoter was found (TDT x 2 = 4.69, 1 d.f. , P =0 .0 30 )
(Cook et al., 1 998). It should also be noted that another haplotype at HTT was found
to be preferentially transmitted in a sample of German subjects with autistic disorder
(Klauck et al. , 1997). These results need clarification by further studies with different
populations and larger groups of autistic individuals.

1.8.5.9 Whole Genome Scan (International Molecular Genetic Study of Autism
Consortium, 1998)
A two-stage genome search for susceptibility loci in autism was performed by
the International Molecular Genetic Study of Autism Consortium (IMGSAC; 1998).
They used 99 affected relative pairs, which included 87 affected sib-pairs and 1 2
affected non-sib relative pairs. Fifty-six of the sib-pair families were from the United
Kingdom (UK). A least one individual in each pair had a clinical diagnosis of autism,
satisfying the ADI criteria (see section 2.1.2) for autism and showing abnormalities
before the age of 3 years. The other individual had to have either a clinical diagnosis .
of Asperger syndrome, Pervasive Developmental Disorder (PDD), autism
unaccompanied by language delay, or had one of these clinical diagnoses but fell 1
point below the threshold on one of the behavioural domains of the ADI algorithm
(IMGSAC, 1 998).
In stage one of the genome screen, 3 54 microsatellite markers were typed in
39 families. Using ASPEX (for the sib-pair families; Hinds and Risch, 1 996) and
GeneHunter (for the relative-pair families; Kruglyak et al. , 1996), pairwise and
multipoint MLS were calculated. Sixty-two markers had an MLS >0 .5. In stage
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two, 60 additional families were genotyped using a subset of 175 markers that
focused on the regions of interest identified in stage 1. Based on all 87 sib-pair
families, approximately 32% of the genome was excluded for 'As = 2.5, which included
the entire X-chromosome. In these sib-pair families, regions on six chromosomes (4,
7, 10, 16, 19 and 22) were identified that had lod scores (MLS) > 1. The most
significant result was found on chromosome 7q between the markers D7S530 and
D7S684, with a MLS of 3.55 in the subset of UK families and an MLS of 2. 53 in all
families. The next most significant result was near the telomere on chromosome 16p,
with an MLS of 1. 97 in the UK families and 1. 51 in all families. Linkage
disequilibrium was tested for 13 markers in the regions of interest on chromosome 7
and 16. This was achieved using the transmission disequilibrium test (TDT), as
implemented in the ASPEX programme. There was no evidence of linkage
disequilibrium in either of these regions. The investigators explained that the large
distance between these markers (5-10 cM) could have affected these results.

1.8.5.10

Whole Genome Scan (Bass et al. , 1998)

A genome screen has also been completed by Bass et al. (1998) and reported
at The American Society of Human Genetics 481h Annual Meeting in Denver,
Colorado in 1998. They reported analysing 49 affected sib-pairs and 3 affected
cousin pairs using 430 markers that were around 7cM apart. Results from this
analysis identified a number of regions with a p-value < 0. 05 or a MLS

;?::

1, including

sections on chromosomes 1, 2, 3, 7, 18 and 20. The exact chromosomal location of
these findings was not explained in this report.
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1.8.5.11

Whole Genome Scan (Philippe et al. , 1999)

The third published genome-wide screen for autism susceptibility loci was
performed with 264 microsatellite markers in 51 multiplex families, using non
parametric linkage analysis. Families with at least two siblings fulfilling the DSM-IV
criteria for autistic disorder and the ADI algorithm for ICD-10 childhood autism were
recruited from Sweden, France, Norway, USA, Italy, Austria and Belgium. Using
two-point and multipoint affected sib-pair analysis they revealed 11 chromosomal
regions with a maximum lod score (MLS) greater than 0.6 (P<0.05). Four of these
regions overlapped with regions on chromosomes 2q, 7q, 16p and 19p identified in
the IMGSAC genome scan. Another overlapped with the 15q 11-q 13 region identified
in previous candidate gene studies. The remaining six regions were on chromosomes
4q, 5p, 6q, 1Oq, 18q and Xp. The most significant result overall was obtained for a
region close to marker D6S283 (MLS=2.23), however this result was not statistically
significant for linkage (MLS>3).

1.9

Conclusion

In summary, autism is described as a chronic developmental disorder
characterised by behavioral, communication and social abnormalities that manifest in
the first years of life. While the aetiology of autism is unknown, there is general
agreement that it results from early neurodevelopmental dysfunction.
Family studies demonstrate that the prevalence for autism among siblings of
autistic children vary between 2% and 9% (Jorde et al. , 1991). Since the prevalence
of autism in the general population is about 4-5 in I 0,OOO births, the recurrence risk
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for autism among siblings is 50-200 times greater than in the general population
(Bolton et al. , 1994).
Studies have also reported an association with autism of a number of other
genetic conditions. These include: fragile X syndrome; chromosome 15 anomalies;
tuberose sclerosis; and phenylketonuria, just to name a few. These associations
though, are not sufficient to explain the strong familial clustering of autism.
It has been suggested that the increase in prevalence of autism in families is
due to genetic factors and a number of twin studies have supported this theory. These
studies estimate that the concordance rate in monozygotic twins is approximately
77%, while the concordance rate reported for dizygotic twins is about 0% (Folstein
and Rutter, 1977; Ritvo et al. , 1985; Steffenburg et al. , 1989; Bailey et al. , 1995).
The dizygotic concordance rate is not significantly different from the approximate
sibling recurrence rate of 3%.
This evidence of a genetic component in the aetiology of autism allows
molecular genetic strategies to be used to determine the biological basis of autism.
Since autism is most likely a complex disorder involving several interacting genes of
unknown mode of inheritance, non-parametric linkage analysis utilising the multipoint
sib-pair approach is, at present, one of the best methods for identifying susceptibility
loci in this disorder. This method detects how frequently two affected sibs share the
same chromosomal region identical-by-descent (IBD). Sib-pair analysis is very useful
in studying autism because it is independent of both the affection status of parents and
the mode of inheritance. The power of sib-pair method to detect linkage depends on
the risk ratio

The risk ratio As is the increase in the risk of the disorder in sibs of

an affected individual, compared with the general population prevalence.
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Assumptions about genetic model parameters, such as number of alleles at a
given locus, gene frequencies, and penetrances are not required in sib-pair analysis
(Risch, 1 990b). In the case of autism, the overall As (increase in risk to siblings) is
approximately 50-200. Due to the high As value in autism, affected sib-pair analysis
may be a powerful tool for mapping susceptibility genes in this disorder, depending on
how many individual genes determine the total value of As.

1.10 Rationale of the Study

In this study, multipoint sib-pair analysis was employed to identify
susceptibility genes involved in the aetiology of autism. From our simulations we
concluded that at least 3 loci are involved in the disorder and, assuming As = 75, the
study has the power to detect up to 5 loci of equal effect on autism using this method
of analysis (section 1.7).
From additional computer simulations (see Table 5), we showed that it is
plausible to expect that we can identify any loci (MLS>3) with As � 3 , using a
microsatellite map consisting of markers spaced approximately 1 OcM apart and at
least 1 00 multiplex families. If 200 families are used in the genome scan,
susceptibility loci with As � 2 should be detectable using the sib-pair method.
Also, to ensure a more reliable diagnosis of autism and a smaller chance of
obtaining false positive and negative results, we only used individuals diagnosed with
the "core" syndrome of autism (ie. no individuals with Asperger syndrome or
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pervasive developmental disorder-not otherwise specified, were included). This
homogeneous set of families should enhance our chances of detecting linkage.

1.11

Research Aims and Significance

The objective of the study is to search for DNA markers linked to autism in a
large sample of clinically well-characterised families. In the longer term, such markers
will allow the identification of a gene or genes that are responsible for familial forms
of autism.

1.11.1 Specific Aims

This linkage study on autism is a large-scale project that began in 1992 and is
run in collaboration with universities in Australia and the United States of America.
This PhD project addresses certain goals set out in the overall study design. The goal
of the large-scale project is to complete the ascertainment and collection of samples in
180 families, create an exclusion map of the entire genome based on these families,
identify regions not excluded and investigate them in greater detail by saturating them
with markers. More specifically the aims of the large-scale project are:
I.

Recruit and evaluate approximately 140 U. S.A. and 40 Australian
families with at least two autistic sibs, using strict diagnostic criteria.
A research diagnosis is made using the Autism Diagnostic Interview
(ADI) and with the Autism Diagnosis Observation Schedule (ADOS).
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Only those children satisfying the pre-specified cut-off scores in all
three-symptom areas of the ADI and with an age-of-onset prior to
three years are considered affected for the purposes of the project.
II.

Immortalise cell lines from the affected sibs and their parents in these
180 families. For families with one parent missing, unaffected sibs are
included, as available, to increase genetic information.

III.

Genotype at least 350 highly polymorphic (PIC > 0.70) microsatellite
loci at approximately 10 cM intervals in 90 sib-pair families, including
affected sibs and parents, and unaffected sibs when a parent is missing.

IV.

Construct an exclusion map using multipoint sib-pair analysis assuming
As values between 1.5 and 10 for the 90 families of the initial screen.
Through this, regions that cannot be excluded will be identified.

V.

For those regions not excluded in (IV), the remaining 50 U. S.A. and
40 Australian families will be genotyped. Additional microsatellite
markers in these regions will be identified and all previously recruited
families will be genotyped with these markers. Thus, the regions not
initially excluded will be either excluded or confirmed as candidate
regions containing autism susceptibility gene(s). Confidence intervals
for any susceptibility loci identified will be constructed.

VI.

Candidate regions for susceptibility genes will be saturated with
microsatellites. The confidence regions will be further narrowed using
multipoint linkage analysis. Final candidate regions will be examined
for linkage disequilibrium with these markers using the transmission
disequilibrium test with the 180 sib-pairs and their parents.
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The aims specific to the present PhD project are divided into two parts
depending on the families analysed:
A.

U. S.A. Families
I.

Isolation of DNA from cell-lines of some of the 90 U. S.A. multiplex
families.

II.

A systematic scan of chromosomes 19-22, as part of the first stage
screening on 90 multiplex families from the U. S.A.

III.

Refined study of candidate regions identified previously, such as the
HLA region on chromosome 6 and the long arm of chromosome 15.

IV.

Construction of exclusion maps.

V.

Replication of the data obtained by us and the Stanford group, of
regions showing positive lod scores (chromosome 1, 10, 15, 17 and
18).

B.

Australian Families
I.

Establishment of immortalised cell lines for some of the 40 Australian
families with 2 or more children diagnosed with autism and extraction
of DNA from whole blood and white blood cell (WBC).

II.

Duplication of positive findings (lod score > 1) that were obtained in
the initial genome scan on the U. S.A. families and replicated by the
Perth group (see part V. above).

III.

Duplication of the analysis of chromosomal regions showing positive
. lod scores in other studies, eg. chromosome 7q (IMGSAC, 1998),
using the Australian group of families.
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1.11.2 Significance

The identification of genes responsible for autism may lead to an accurate and
reliable biological marker being discovered. Since autism cannot be diagnosed
confidently before the age of 4 - 5 years with current techniques, a biological marker
could help identify children at risk for autism at a younger age if it was used in high
risk families. This would help in treatment and/or intervention strategies, which are
most effective with early diagnosis and intervention.
A marker would also help in the determination of the boundaries of the autistic
phenotype. At present there is much debate as to whether siblings of autistic children
who have communication or cognitive disabilities suffer from a mild form of autism,
and if these are part of an autistic spectrum.
Thirdly, genetic research will provide essential information about the
regulation of brain development. This will allow the development of a more effective
treatment for autism and its spectrum disorders.
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CHAPTER 2
SUBJECTS AND METHODS

2.1

2.1.1

Clinical Methods

Ascertainment of Families

Families from the U. S.A. were recruited nationwide by advertisement
targeted at local and national parent support groups and referrals from clinicians.
The Australian families were recruited through peak agencies, clinic/assessment
centres/hospitals, private agencies/self help or parent groups, special needs schools
and prior autism research teams. Once families were identified, they were contacted
via "mail-outs" by the above mentioned organisations. These "mail-outs" included
information on the research project and asked whether or not they would like to
participate in the study.
Families willing to partake were asked to contact the research group and a
preliminary screen was performed over the telephone to indicate whether or not the
specific family was suitable for the study. If this telephone-screen indicated that a
family may be suitable, the aims of the project were explained and they were asked
to sign a consent form allowing the clinicians on the project to view all participating
family members clinical records. If these records verified that a family had a
minimum of two children with a preliminary diagnosis of autism, they were
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investigated further using standardised diagnostic procedures (see below; Le Couteur
et al., 1989b; Lord et al., 1994 ; Lord et al., 1989).

2.1.2

Diagnosis

Uniform, reliable and well-documented diagnostic tools are important to
allow legitimate comparisons between studies. For this study, two standardised
instruments were used for gathering the diagnostic information: the Autism
Diagnostic Interview (ADI; Le Couteur et al., 1989b and Lord et al., 1994) and the
Autism Diagnostic Observation Schedule (ADOS; Lord et al., 1989). The ADI is an
investigator-based interview, which reviews four specific areas relevant to autism:
social interaction and behaviour, language and communication, interests and daily
routines and age of onset. It is designed to provide a definition of autism for research
and can not be used to disprove a clinical diagnosis. The ADOS is a behaviour
observation instrument, which involves particular tasks that elicit specific behaviours
in the child over a 20 -4 5 minute time frame. ADI and ADOS were obtained for all
children within a family regardless of the clinical history.
The ADI was used in this research project for the following reasons:
(I)

The interviewer asks the parent or caregiver to elicit certain examples of the
child's behaviour, social activity etc. These can be used to evaluate particular
signs of autism and allowed the interviewer to interpret the quality of the
child's behaviour, rather than relying on the parent's description.

(II)

The interview has been specifically structured to include questions about all
the behaviours used to diagnose autism.
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(III)

Information on past and present signs and symptoms is collected in a
systematic way. This is important, since the application of the diagnostic
criteria requires data only from the year period between the ages of 4 and 5.
This in turn allowed children who have been evaluated at different ages to be
compared on a common scale.

(IV)

The ADI includes all the information on the individual needed to apply the
ICD-1 0 criteria.

(V)

Both the ADI and the ADOS were videotaped, allowing other diagnosticians
to independently verify each assessment. This permitted ongoing quality
control of diagnosis.
A recent study on the reliability of administering and scoring ADIs between

two diagnostic groups has shown a good interrater reliability, with a kappa
coefficient for autistic verses non-autistic groups of 0.90 (Spiker et al., 1994 ). Also,
research by Lord et al. ( 1 994) and Fombonne ( 1 992) has indicated that the ADI has
good reliability and validity for diagnosing autism and distinguishing this diagnosis
from mental retardation.
Certified interviewers, who had completed the ADI training course given by
Catherine Lord and Michael Rutter, conducted the ADI and ADOS evaluations.
Donna Spiker, PhD, Linda Lotspeich, MD, and Patty McCague evaluated the
majority of the U.S.A. families, whereas Amelia Nikolova, Wayne Hill, Robyn
Young and Patty McCague interviewed the Australian families. To achieve the
greatest possible blindness of evaluators, different interviewers were used for each
child in a family whenever possible. Also, to check the reliability of the ADI
administration and scoring, all interviews were videotaped and some randomly
selected and independently scored by a second blinded, trained diagnostician.
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An autistic individual was defined as one that had scores above the pre
specified cut-off points in the four areas in the ICD- 1 0 system (ie. social impairment;
language and communication impairment; unusual and restricted interests and
routines; age of onset prior to three years). Multiplex families with at least one
parent and two or more siblings who met full ADI definitions of autism were
required in this study. Children were classified as unaffected if their scores were
below the cut-off points in all four areas. Children falling into the ambiguous or
uncertain diagnostic category (ie. with scores above the cut-off point in one, two, or
three areas) were excluded from the linkage analysis, even though they met clinical
definitions of syndromes related to autism (eg. pervasive developmental disorder).
The unaffected and uncertain children were only used to reconstruct parental
genotypes if parents were missing from the pedigree, and to check the accuracy of
the data. Since there were no reliable diagnostic criteria for diagnosing autism in
adults, the affection status of all parents Wil.S considered unknown. This conservative
strategy tried to minimise the misclassification errors that have proved to be a major
obstacle in psychiatric genetics. The ADI area scores for children in the first 37
multiplex families collected are shown in Table 6.

2.1.3 Intelligence Test Scores

Intelligence test scores (IQ) and mental age data were obtained from existing
school or clinical records for the U.S.A. affected children. When available,
nonverbal IQ scores were obtained from the performance subtests of the Wechsler
Scales or Stanford-Binet Intelligence - 4 th Edition, or the full Leiter International
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Table 6: ADI Area Scores for Children in Autism Multiplex Sibling Families
(N = 37 Families, 1 1 7 Children)*
Autistic (N = 83)

Not Autistic (N = 26)

Uncertain (N = 8)

(In 37 families)

(In 22 families)

(In 6 families)

Range

1 7-44

0-9

0- 1 4

Median

36

Social total

1.5

L anguage total (V) 3

No. of children

58

26

8

Range

1 1 -29

0-8

0-7

Median

21

0.5

0

No. of children

25

0

0

Range

9- 1 6

Median

15

Language total (NV)"

Ritual total

Range

3-12

0-2

0-4

Median

8

0

1.5

83 ( 1 00)

0 (0)

6 (75)

Onset present?<

N (% Yes)

* Social cut-off point = 1 2, range = 0-42; language cutpoint = 10 for verbal subjects,
range = 0-30, and cut-off point for nonverbal subjects is 8, range = 0- 16; rituals cutpoint = 3,
range = 0- 12.

•v = verbal: having phrase speech by age 5 years.
hNV = non-verbal: not having phrase speech by age 5 years.

cMeets onset criteria; developmental delays or deviance < 3 years

Performance Scale or Merrill-Palmer Scale. When these scores were unavailable,
scores from such tests as the Stanford-Binet Intelligence Scale - 3 Edition, Slossen
rd

Intelligence Scale, or McCarthy Scales were used. For a small number of children,
mental age estimates and ratio IQ scores were based on nonverbal scores from
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various developmental inventories (eg. Daily Living Domain of the Vineland
Adaptive Behavior Scale, the full Bayley Scales, or Developmental Profile II).
If both individuals in the affected sib-pair had a mental age (MA) less than 1 8
months and/or a nonverbal IQ below 3 0, families were removed from the study
because of the difficulties in diagnosing individuals in this group.
In the Australian families, affected individuals were classified under different
categories of mental retardation as outlined in ICD- 1 0 (World Health Organisation,
1 993). Those individuals classified as mildly mentally retarded generally displayed
delay in motor skills and had reasonable school achievement but still required
support. Moderately mentally retarded children had difficulties in understanding
instructions and displayed academic problems. Severely mentally retarded autistic
children generally exhibited a lack of speech with no participation in the ADOS,
whereas profoundly mentally retarded individuals displayed the same characteristics
as those with severe mental retardation but with passiveness.

2.1.4

Ethical Considerations

This study has met the requirements of the Ethics Committees at Edith
Cowan University, WA; Graylands Hospital, WA; The University of Western
Australia; and Stanford University, U.S.A. Protocols and justification for the use of
human subjects were renewed annually through the Human Subjects Committee at
Stanford University. The subjects used in this project were from families in which
there were two or more siblings with autism. Families were identified as"potentially
eligible based on diagnostic information provided by the parents. There were no
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gender or ethnic restrictions on recruitment. The research staff who interviewed the
parents about their children and videotaped a structured behaviour observation of
each child collected the relevant information required for diagnosis. Additional
records (medical and diagnostic evaluations) were collected from the parents or from
appropriate medical or educational personnel, after the parent(s) signed a "release of
information form". To ensure confidentiality, all data were coded and stored in the
computer by subject number; records containing names were stored in securely
locked cabinets, available only to trained project staff Project personnel could
access computerised data with a password only. All staff on the project had been
given specific training about issues of confidentiality in clinical research.

2.2

2.2.1

Clinical Characteristics of Autism Multiplex Families

U .S.A. Families

A total of 98 affected sib-pairs from the sub-group of 90 US.A. families were
analysed in the first part of the study. These families encompassed a total of 1 87
affected children, 3 0 unaffected sibs, and 1 57 parents. The affected siblings in these
families ranged in age at the time of the ADI administration from 2.9 to 4 0.9 years
(mean = 9.8 yrs, S.D. = 7.3, median = 7.3, 25th - 75th percentiles = 4.9 - 1 1.3 years).
The male to female ratio for this sub-group was 3.6 : 1 for the affected individuals and
0.8 : 1 for the unaffected individuals. Of these 90 families; two have four affected
children, three families have three and 85 families have two affected children. For
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families with n affected children, where n was greater than 2 , n- 1 sib-pairs were
formed by matching the first child in the pedigree with each of the subsequent
children; these pairs were fully independent. Both parents were available for
analysis in 67 families. In those families were one parent was absent, unaffected
siblings were included when possible (8 families) to reconstruct missing parental
genotypes for identity-by-descent (IBD) tallies.
The mean nonverbal IQ was 66 (S.D. = 28, range = 1 6- 1 60) for the affected
children in this group of 90 US.A. autistic families. One hundred and eight children
(56%) had scores below 70 in this same group of families, and were classified as
mentally retarded. The mean mental age was 68 months (sd = 55 months, range =
13-373 months). All families had at least one affected sibling with an IQ above 3 0
and a mental age greater than 1 8 months.
The second set of U.S.A. families used to conduct genotyping studies of
regions not excluded by the first 90 families, consisted of 49 multiplex families that
were ascertained in a manner similar to the first set. These families were not used as
part of this PhD project. For more information on these families refer to Risch et al
( 1999).

2.2.2 Australian Families

Forty-one Australian families were recruited for analysis. These families
consisted of a total of 86 affected children, and 73 parents. Thirty-seven of these
families had two affected children and four families had three affected siblings. Both
parents were available for analysis in 32 families. The ratio of males to females in
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the affected individuals was 3.0: 1. When the AD I was administered to the affected
siblings in these families they ranged in age from 3 to 46 years (mean = 12 yrs, S.D.
=

8, median = 10, 25th - 75th percentiles = 7 - 13 years).
In this group of 45 ASPs from Australia, the majority of children were

classified as being either mildly (35%) or moderately (32%) mentally retarded (see
section 2.1.3). Nine percent of these children with autism were severely mentally
retarded and 24% were classified as normal. No individuals were classified as
profoundly mentally retarded and therefore all families were kept in the study.

2.3

Laboratory Methods

The laboratory methods used in this PhD project are stated below. Whilst
some cell lines were established and DNA extracted by myself, the majority were
prepared by collaborators in Standford University and by co-worker Boyd Salmon at
the Medical Research Institute in Royal Perth Hospital. I did the majority of
genotypes, stated as part of this project.

2.3.1

DNA Isolation

Blood samples were obtained from all available family members at the time
of evaluation. Blood was collected by venipuncture, with 20ml obtained from most
patients. These samples were immediately transported to the laboratory. Cell
cultures were started upon arrival and transformed with Epstein-Barr virus (EBV)
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into lymphoblastoid cell lines, providing a renewable source of DNA. Genomic
DNA was extracted either from whole blood (if an adequate supply had been drawn
from the individual) and/or from immortalised cell-lines, by using standard
proteinase K digestion and salting out procedures (Miller et al., 1988).

2.3.1.1 Cell Lines

Epstein-Barr virus (EBY) transformed lymphoblast cell lines were
established using standard procedures (Anderson and Gusella, 1984). B
lymphocytes were isolated from peripheral blood in cell culture by using EBV to
immortalise cells. The peripheral blood cells may then be cryogenically stored for
subsequent DNA extraction. The procedure of Anderson and Gusella (1984) differs
slightly from the original procedures. The method was greatly improved by the use
of cyclosporine A, a drug that proved very efficient in preventing the regression of
newly established lymphoblastoid cell lines (Ventura et al., 1988).
Lymphoblastoid cell lines were established from 10ml of whole blood that
had been collected in a I 0ml venipuncture vial containing heparin. The first step was
to isolate the peripheral blood lymphocytes (a class of white blood cells) from the
whole blood and place these in liquid nitrogen (lqN) for future use. Blood was
centrifuged at 2000 rpm for 7min, collecting the huffy coat in a Nunc tube under
sterile conditions using a transfer pipette, cooling on ice, and then adding
dimethylsulphoxide (DMSO; ACS grade, ICN Biomedicals) at a concentration of
I 00µ1/ml. The cell lines were established by defrosting the aliquoted huffy coat in
warm water and adding 7ml of 12% FCS/RPM I (Fetal Calf Serum / 16.36g/L RPM!
1640; 2g/L sodium bicarbonate; 20ml/L penicillin / streptomycin; pH 7.2; stored at
2
-20°C; Trace Biosciences [see Appendix 6.2 for solution protocol]) in a small 25cm
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tissue culture flask. Infection was achieved by mixing cells with O. 1-1ml of active
EBV supernatant. The virus activates the enzyme telomerase, preventing the
telomeres from shortening during each cell replication. This stabilises the telomeres
and allows the cells to continue to proliferate, making them immortal. Cell lines
were incubated at 37°C in a 5% C02 atmosphere and fed every third day with 12%
FCS/RPMl. When a sufficient number of transformed cells (-50-100 million cells)
were obtained, they were either transferred to a 50ml Falcon tube containing fresh
culture medium (5ml of 12% FCS/RPM l), aliquoted out into 5 Nunc tubes and
frozen in lqN with 10% DMSO, or placed in a 50ml Falcon tube containing no
medium for DNA extraction (see below).

2.3.1.2 Salting-Out Method of DNA Extraction

DNA from lymphoblastoid cell lines was isolated and purified using standard
procedures (Miller et al., 1988). DNA is purified from whole blood or cell
suspensions following cell membrane lysis and precipitation in the presence of high
salt concentrations. Subsequent alcohol washes further purify the DNA, making it
suitable for use in PCR. The salting-out method is simple, rapid and inexpensive and
provides high, reproducible yields of pure genomic DNA.
If sufficient blood was drawn from the individual, DNA could also be
extracted from whole blood. The procedure involved centrifuging approximately
10ml of whole blood that had been collected in a venipuncture vial with the
anticoagulant ethylenediaminetetraacetic acid (EDTA), in a 50ml Falcon tube
containing -40ml of red cell lysis buffer (RCLB: lOmM Tris, pH 7.6; lOmM NaCl;
5mM of MgCh; stored at 25°C) at 2000 rpm for 7min. The supernatant was removed
and the above step repeated 2 to 3 times to remove all red blood cells. The pellet was
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then incubated overnight at 37°C with 3 0µ1 of proteinase K (20mg/ml of dH2 0,
stored at -20°C; Prokay™ : Biotech Laboratories), 2ml of red cell lysis buffer
(RCLB: lOmM Tris, pH 7.6; lOmM NaCl; 5mM of MgCh; stored at 25°C) and 13ml
of white cell lysis buffer (WCLB: lOmM Tris-HCl, pH 7.6; I OmM EDTA, di
Sodium salt; 50mM NaCl; 0.2% SDS; stored at 25°C). If cell lines were used the
DNA isolation procedure began at this incubation step, without the addition of
RCLB. On the next day, 7ml of 6M NaCl was added to the proteinase K mixture
with vigorous mixing and centrifuged at 5000 rpm for 45min. The DNA was then
precipitated out of the resulting supernatant with an equal volume of cold
isopropanol (AR grade, stored at -20° C) and placed in a 1 .5ml microcentrifuge tube
using a transfer pipette. The DNA was washed once with 70% ethanol (AR grade,
°
stored at -20 C) and then again with 1 00% ethanol (AR grade, stored at -20°C). The

DNA pellet was dried, then resuspended in 1 ml of sterile water and incubated
overnight at 37°C to dissolve the DNA.

2.3.1.3 Measurement of DNA Concentration
The optical density (OD) of the DNA solution was measured at 260nm and
280nm using a DU R 640 Spectrophotometer (Beckman), which was blanked at both
wavelengths using distilled water. A 260/280 ratio greater than 1.5 indicated the
presence of relatively pure DNA. Readings at 260nm allowed the calculation of the
concentration of the nucleic acid in the sample, since an OD of 1 corresponds to
approximately 50µg/ml of double-stranded DNA (Sambrook et al., 1989). Using
these calculated concentration values, DNA was diluted to 5ng/µl using dH2 0 and
this "working" DNA solution was stored at 4 °C. DNA samples were labelled with
the family ID number, the individuals' sample numbers and the concentration of the
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sample. The original "stock" DNA solutions were aliquoted into 3 separate Nunc
tubes and stored at -20°C.

2.3.1.4 Evaluation of DNA Samples

Agarose gel electrophoresis was used to evaluate the quality of the DNA by
viewing the amount of shearing present in the sample. Pure DNA should show a
discrete single band without smearing (see Figure 6). Preparation and examination
of agarose gels were carried out according to Sambrook et al. (1989). In brief, a
0.8% agarose gel (4g of agarose powder [Promega] in 500ml of l xTAE buffer
[0.04M Tris-acetate; 0.001M EDTA], with 0.05µ1/ml of ethidium bromide [Sigma
Molecular Biology]) was poured onto an 80ml mini-gel tray, small toothed combs
were inserted at the top and middle of the gel, and the gel allowed to set for
approximately 40 minutes (due precautions were taken at all times in regard to the
chemical hazard generated by ethidium bromide). The combs were removed and the
gel placed in a mini-sub electrophoresis tank (BIORAD) with l xTAE buffer. The
sample consisting of 1Oµl of 5ng/µl DNA and 1µl of 6 x Ficoll loading buffer
(0.25% bromophenol blue; 0.25% xylene cyanol FF; 15% Ficoll [Type 400;
Pharmacia] in water) was in tum loaded on to the gel. DNA samples of known
concentrations and a Lamba size control (APstl 9: 0.5µg/µl, HpaII cut [Fisher
Biotec]) were also loaded as standards. The gel was run at a constant 50 Volts for 1
hour, then viewed under UV light on a Hoefer Mighty Bright ultraviolet
transilluminator (Hoefer Scientific Instruments). The gel was then photographed
with a Polaroid camera.
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Figure 6 : Agarose gel of genomic DNA

2.3.2

Microsatellite Analysis

2.3.2.1 Microsatellites

The human genome contains many polymorphic microsatellite markers.
Microsatellites are short (less than 500 bp) tandem repeats interspersed throughout
the genome at about 30 kb distances, with repeat sequence motifs of one to five
nucleotides (Weber, 1990a). The high degree of polymorphism displayed is due to
the variability in the number of tandem repeats and it is noted that the greater the
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number of repeats at a locus, the more likely that the locus is polymorphic (Weber,
1990b). The number of times a sequence is reiterated at a particular locus has been
shown to be sufficiently stable within pedigrees, but polymorphic among members of
a population (Weber and May, 1 989). Hence, microsatellites are very useful genetic
markers (see section 1 . 8. 1 .2).
Microsatellites can be analysed efficiently using the PCR technique due to the
small size of the microsatellite amplification products ( 1 00 to 500 bp; Edwards et al.,
1992). These amplification products can also be easily detected on polyacrylamide
gels.

2.3.2.2 Selection of Microsatellites and Synthesis of Primers
In recent years, microsatellite maps covering the whole human genome have
been developed. For the majority of the genotyping experiments in this study,
existing polymorphic microsatellites that have been mapped meiotically by Genethon
(Gyapay et al., 1994), the Cooperative Human Linkage Centre (CHLC; Murray et
al., 1994 ), and other groups (Buetow et al., 1994 ; Collins et al. , 1996) have been
used. The majority of the marker distances used in the analysis were obtained from
the Genetic Location Database (LDB; http://cedar.genetics. soton.au.uk), generated
by the Wessex Human Genetics Institute and the Genetic Epidemiology Research
Group. These map locations have been obtained by integrating data of different
types (genetic linkage maps, physical maps, cytogenetic data and mouse homology)
and constructing a single "summary" map (Collins et al., 1996). A total of 3 62
microsatellites were chosen for stage one of this study and were genotyped in 90
US.A. familles by two collaborative groups (Stanford University in the {!.S.A. and
the Edith Cowan University/Graylands Hospital in Perth, Australia). One hundred
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and fifty seven additional markers were typed in these 90 families in stage two of the
project. These additional markers were chosen to ( 1 ) saturate genomic regions where
evidence of linkage (lod score > 1 ) had been obtained during stage one; (2) follow-up
specific candidate regions, such as chromosome regions 6p and l5q, as well as some
reported by the IMGSAC ( 1 998) (chromosome region 7q); (3) fill in regions with
large gaps in the initial screen that had not been excluded in the preliminary analysis.
A total of 50 stage one microsatellites and 50 stage two microsatellites were
run on the 90 US.A. families as part of this PhD project. A further 4 1 Australian
families were genotyped using a subset of 24 markers. The microsatellites analysed
in this PhD study are listed in Appendix 6. 1 , together with the heterozygosity values
( amount of polymorphism) and the number of nucleotides in the repeat sequence for
each marker. Assuming a sex-averaged total autosomal map length of 3500cM, the
average distance between all markers used in stage one of the study was 1 0cM (see
Appendix 6. 1 ).
The use of these markers was facilitated by commercially available pairs of
oligonucleotide primers, with one of each pair (usually the forward primer) labelled
with a fluorescent dye on its 5' end. In those cases where the markers were analysed
using radioactive methods (see Appendix 6. 1 ) the primers were unlabelled. The
fluorescent primers were available as sets that allowed multiplexing (analysis of
more than one primer at a time) to occur both in the PCR reaction and during
electrophoretic separation (see ABI PRISM™ Linkage Mapping Set [PE Applied
Biosystems, 1 994] for more detail). Forward and reverse primer pairs were supplied,
or custom synthesised if not commercially available, by commercial suppliers
(Bresatec, Australia; Applied Biosystems (ABI), Australia; Research Genetics, USA)
and couriered in either a lyophilised form at ambient temperature or diluted to 8-
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lOµM with dH20. Upon arrival, lyophilised primers were resuspended in dH20 to a
stock concentration of 1µg/µl. These primers were further diluted to a working
concentration of 1OOng/µl, in most cases, by adding 50µ1 of forward primer to 50µ1
ofreverse primer and 400µ1 dH20. Primers supplied at 8- lOµM were generally
diluted to 4-5µM by adding equal volumes of forward and reverse primers (see
Appendix 6.1 for dilution protocol of each microsatellite used in this PhD project).
Both the "stock" and the "working" solution of primers were stored at -20°C.

2.3.2.3 PCR Amplification and Different Methods of Labelling the PCR
Products for Subsequent Detection

Microsatellites were amplified using the polymerase chain reaction (PCR).
PCR is an in vitro method for enzymatically synthesising defined sequences of DNA.
The reaction uses two oligonucleotide primers that hybridise to opposite strands and
flank the target DNA sequence that is to be amplified. The elongation of the primers
is catalysed by Taq DNA Polymerase, a heat-stable DNA polymerase (Saiki et al.,
1988) that has been isolated from the thermophilic eubacterium Thermus aquaticus.
A repetitive series of cycles involving template denaturation, primer annealing, and
extension of the annealed primers by Taq DNA Polymerase results in exponential
accumulation of a specific DNA fragment, where the ends of the fragment are
defined by the 5' ends of the primers (Ausubel et al., 1991).
There are a number of different methods for detecting the target DNA
sequence. Examples include; silver staining of conventional PCR products,
incorporation of radioactive (a-P32) labelled deoxycytosine triphosphate (dCTP)
nucleotides into the PCR reaction, incorporation of fluorescently-labelled
deoxyuridine triphosphate (dUTP) into the PCR products and labelling the 5' end of
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the primer with a fluorescent tag. Most primers used in this study were labelled with
a fluorescent tag at the 5' end, and the PCR products were identified using the ABI
PRISM 310 DNA Analyser (capillary electrophoresis) or the ABI PRISM 373 DNA
Analyser (gel electrophoresis). In the cases where the primers were not fluorescently
labelled, radioactive nucleotides were incorporated into the PCR products and
products were separated on polyacrylamide gels and detected by autoradiography.
For a diagrammatic representation of the overall genotyping method see Figure 7.
The PCR procedure used in this study was a slight modification from the
original (Mullis and Falcona, 1987). Polymerase chain reactions (Erlich et al., 1991)
were carried out using different protocols depending on the thermocycler utilised and
the condition optimised for each specific microsatellite. Generally, PCR reactions
carried out in a MJ Research thermocycler were performed in 5µ1 total volume and
contained lOng DNA, 200µM dNTPs, 0.13-2.0µM or 1.0-20ng/µl of each primer
(the forward primer had been fluorescently labelled using either HEX, TET and
FAM dyes), 50mM KCl, lOµM Tris-HCl, 1.5mM MgCh, and 1.25U Taq
Polymerase (Perkin Elmer) (refer to Appendix 6.1 for the reaction mixture of each
microsatellite).
The solutions were pipetted into a capillary tube (Biotech) using a
programmable pipettor (Corbett Research), and processed in a thermocycler (MJ
Research). After denaturation for 5-1Omin at 94° C (5min for standard AmpliTaq and
1Omin for AmpliTaq Gold (Perkin Elmer); see Appendix 6.1), 27 cycles were carried
out, each cycle consisting of 30sec at 94°C, 75sec at 55°C, and 15sec at 72° C. A
final extension step was performed for 5min at 72°C. The DNA polymerase
AmpliTaq Gold is activated by heat and allows "hot start" PCR to be introduced into
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Figure 7: Outline of the genotyping method. The electropherograms in the bottom section
show the results from one family with two affected sibs that were produced by the analysis
programme Genotyper (see 2.3.2.6) (diagram from Maestrini et al., 1998).

existing amplification systems with little to no modification of cycling parameters or
reaction conditions. Hot start PCR can improve amplification of most templates by
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lowering "background" and increasing the amplification of specific products. This is
achieved by the covalently bound moiety to the polymerase. When the enzyme is
heated to approximately 94° C, the moiety is detached from the polymerase and the
polymerase becomes active. Since this temperature is above the minimum required
for the primers to anneal, it prevents the primers annealing to non-specific regions
(mis-priming) and, in turn, prevents the formation of artifact peaks, which can
complicate the analysis.
The majority of microsatellites were amplified using the 2400 or 9600 Perkin
Elmer Thermocyclers. PCR conditions differed slightly between markers (see
Appendix 6.1), however they basically involved a final reaction volume of 5µ1, in
which 2µ1 was DNA (5µg/ml). The remaining volume contained 250µM dNTPs,
0.04- l .92µM or 13-25ng/µl of each primer (the forward primer had been
fluorescently labelled using HEX, TET and FAM dyes), 50mM KCl, lOµM Tris
HCl, l .56-3.12mM MgCh, and l .25U Tag-Polymerase or Amplitaq Gold (Perkin
Elmer). All PCR reactions were performed in 200µ1 tubes on a 24 or a 96 well plate,
under either a standard or a touchdown cycling programme (see Appendix 6. 1). The
touchdown cycling programme was used when amplification resulted in poor yields
of a specific product using the standard programme. The touchdown programme
differs from the standard programme by reducing the annealing temperature in the
second group of cycles. By reducing the annealing temperature, the primers are
prevented from annealing to non-specific regions. The lower temperature also
prolongs the activity of the DNA polymerase, increasing the total yield of product.
The standard programme involved an initial denaturation time of 5min at 94°C for
standard Taq polymerase and l 5min at 94°C if Amplitaq Gold was used in the
solution. This was followed by 10 cycles of 15sec at 94°C, 15sec at 55°C and 30sec
1 04

at 72 °C. Then 2 0 cycles of 1 5sec at 89°C, 1 5sec at 55°C, 3 0sec at 72 °C were
performed with a final elongation step of 1 Omin at 72 °C. The touchdown
programme also entailed an initial denaturation at 94°C for 1 Omin or 5min depending
on the type of Taq polymerase used. The first 1 5 cycles of this programme
comprised 2 0sec at 94°C, 60sec at 63 °C - 55°C (-0.5°C annealing temp. /cycle) and
°
3 0sec at 72 °C. The second 1 5 cycles involved 20sec at 94°C, 60sec at 55 C and

3 0sec at 72 ° C, with a final extension at 72 °C for 5min. For microsatellites where
radioactive labelling was used, the reaction mix was a slight modification of the
original procedure by Saiki et al. ( 1988) and included 0.05µ1 of l OmCi/ml a-P32
dCTP nucleotides per reaction (see Appendix 6. 1 for PCR conditions).
After completion of PCR reactions, products analysed on the Perkin Elmer
3 1 0 DNA Analyser were diluted with water and an aliquot (see Appendix 6. 1 ) added
to 1 2 µ1 of formamide and 0.8µ1 of GS500 Tamra standard dye (Figure 8). Samples
loaded on to the Perkin Elmer 373 DNA Analyser were multiplexed to a total volume
of 1.5µ1 and combined with 0.5µ1 of the internal lane size standard (Tamra GS500;
Applied Biosystems), 2.5µ1 of deionised formamide and 0.5µ1 of Blue Dextran
EDTA ( 1 mg Blue Dextran per 1 ml EDTA [20-50mM, pH 8.0]). Formamide was
added to disrupt the hydrogen bonds within the PCR products and prevent the
products from re-annealing at a lower temperature once they were denatured. At
least 50% of the final sample loaded on to the gel was formamide. The samples
loaded on to the 3 1 0 DNA Analyser contained an excess of formamide to allow up to
1 Oµl of PCR products to be run in each injection. PCR products loaded on to the
SE1 600 Poker Face II sequencer were combined with 8µ1 of formamide loading
buffer in a 0.65ml microcentrifuge tube. All samples were denatured for 5min at
94°C before loading on to the detection apparatus.
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Figu re 8: Load ing samples onto the Perkin El mer 3 1 0 DNA analyzer

2.3.2.4 Electrophoretic Separation and Detection of the PCR Products of
Different Length
The PCR products for each microsatellite (ie. the alleles) were discriminated
by length fractionation using polyacrylamide gel electrophoresis (PAGE). PAGE
operates via the movement of negatively charged DNA towards the positive
electrode, under the influence of an electrical current. In the case of capillary
electrophoresis (see below) the al leles separate according to size in a polymer
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solution instead of a polyacrylamide gel, however the principle of separation is
similar.
The Perkin Elmer 310 Genetic Analyser uses real-time four-colour
fluorescent detection technology (Connell et al., 1987) to detect the alleles for each
individual. The dye-labelled DNA fragments electrophorese through the polymer,
and DNA fragments separate according to size. As the labelled samples travel
through the capillary and into the detector window they are illuminated. The
fluorescent dyes attached to the fragments are excited by the laser and emit light at a
specific wavelength for each dye. The colours and wavelengths of fluorescence of
the four dyes are; blue for the 6-FAM dye at 531nm, green for the TET dye at
545nm, yellow for the HEX dye at 560nm, and red for the TAMRA dye at 580nm.
The signal is collected on to a charge-coupled device (CCD) camera and digitised by
a photomultiplier tube (PMT). The resulting fluorescence data are transmitted to a
Macintosh computer (Apple Computer) for analysis.
A small number of microsatellites used in this PhD project were analysed on
an ABI PRISM 373 Genetic Analyser. Collaborators at Stanford University used a
similar machine to visualise and size all of their PCR products (Perkin Elmer 377
DNA Analyser). The Perkin Elmer 373 system operates in a similar way to the
Perkin Elmer 377 system, except that it contains different filters and the products are
run for a longer period of time. The ABI Prism 373 system also uses real time, four
dye, one-lane technology to detect the DNA fragments for each microsatellite.
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2.3.2.5 Preparation of Detection Systems for Analysis

The ABI Prism ™ 310 DNA Analyzer (Figure 9)
A detailed description of the running of the GeneScan application for this
apparatus can be found in the ABI Prism™ 310 Genetic Analyzer User's Manual
(1995)[Chapter 4, Running GeneScan], distributed by PE Applied Biosystems Inc.
In brief, the polymer (Performance Optimized Polymer 4, PE Applied
Biosystems) was added to a 1ml glass syringe and set into position, being sure no air
bubbles were present in either the syringe or the block. The buffer (1Ox Genetic
Analyzer Buffer with added EDTA, PE Applied Biosystems) was diluted to lx with
distilled water and poured into the buffer vial located on the autosampler, as well as
the buffer reservoir attached to the pump block. Distilled water was also added to a
buffer vial and an Eppendorf tube located on the autosampler. GeneScan capillaries
were cut down to 30cM length and the laser detection window on the capillary
washed with 70% methanol to remove any particulate or fluorescent matter that may
also be detected by the laser. The autosampler was then re-calibrated and the
samples (PCR products with formamide and standard added) placed into the
autosampler tray. Finally a GeneScan Injection List was prepared which states the
sample names and the assignment to an autosampler position. The Injection List also
specifies the order of samples and the modules containing the parameters to be used
for the run. In this project most samples were injected into the capillary for 5-10sec
and run through the capillary and past the laser detection window for l7min. This
gave enough time for microsatellites up to the size of 350bp to be accurately
separated and analysed. After 96 samples have been analysed, the polymer and
buffer were exchanged for fresh media. After 200 runs the GeneScan capillary was
also replaced.
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3 1 0 DNA analyzer

The ABI Prism ™ 373 DNA Analyzer (Figure JO)
The protocol for the preparation of gels generally followed the instructions of
the manufacturer (GeneScan 672 Software User' s Manual, 1 993). A detailed
de cription of the procedure can be found in the 373 DNA Sequencer User' s Manual
( 1 996)[Chapter 2, Prepari ng Gels] , distributed by PE Applied Biosystems Inc.
Special care wa taken to eliminate any particulate or fluorescent matter from the
acrylamide gel solutions and to keep the glass plates extremely clean and free of
dust, as the laser system detected any fluorescence present interrupting the reading of
the fluorescent DNA fragments. All solutions were filtered and only ultrapure, high
grade reagents and distilled, deionised water were used to prepare the solutions.
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In brief, 75ml of fresh 6% acrylamide-urea gel solution (6% acrylamide,
8.3M urea [Molecular Sigma Biology], lxTBE; see Appendix 6.2 for protocol) was
poured into a 1 50ml beaker, and to this, 400µ1 of 1 0% ammonium persulphate
(Molecular Sigma Biology) and 45µ1 of TEMED (N, N,N',N'
tetramethylethylenediamine; Molecular Sigma Biology) were added. The acrylamide
solution was carefully poured between the two plates by holding them in an upright
position and resting the lip of the solution vessel against the edge of the notched
plate. The plates were then placed in a horizontal position and a 48-tooth comb
secured with two large binder clamps. Gels were left to set for a minimum of two
hours to ensure complete polymerisation prior to use.
Before the gel was placed in the electrophoresis chamber, the comb and the
clamps were removed and both sides of the plates were rinsed with water (to clean
away the excess acrylamide and urea), and then air-dried. To ensure that no peaks
were produced by fluorescent particles either on the plates or in the gel, the gel and
plates were scanned before loading the samples. lxTBE buffer (89mM Tris-base,
89mM Boric acid, 2mM EDTA; pH-8.3 at ambient temp.) was then placed in the
upper and lower buffer chambers and the sample wells were flushed with this
running buffer using a pipette. The run parameters were set at Filter set B, field 2500
volts, a current of 40mAmp, power at 30 watts, a laser setting of 40mW, and a PMT
voltage between 600-800 Volts. Once the wells were loaded with the samples, the
gel was run for 1 0 hours.
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Figure 10: ABI Prism

373 DNA analyzer

SE1600 Poker Face II
The protocol for preparation of these sequencing gels was similar to that used
for the 373 DNA Sequencer (see above). Since radioactive products were detected
using this system, care taken to prevent any fluorescent particles in the acrylamide
gel solutions and on the glass plates was not required. Hot tap water and l iquid
Pyroneg (Diversey) detergent was used to wash the plates before use and 70%
ethanol assisted in drying. The smaller of the two plates was treated with Sigmacote
(Molecular Sigma Biology). This silicone solution prevented the gel from sticking
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tightly to both plates, and reduced the possibility that the gel would tear when
removed from the mould after electrophoresis.
A 6% polyacrylamide gel was used since it provides best resolution for
products with sizes within the range of 100-350 base pairs. The gel mix was
prepared in a 250ml beaker and contained 70ml ofliquid acrylamide (19: 1
acrylamide:bis-acrylamide; Gradipore Liqui-Mix; see Appendix 6.2 for protocol),
170µ1 of TEMED and 170µ1 of 25% ammonium persulfate. Using a 50ml syringe,
the solution was quickly drawn up and injected between the glass plates, which were
held on an incline of approximately 20°. Once the gel mix had reached the top of the
plates, the plates were laid down horizontally and the wedge removed. A "well
forming" spacer was then inserted and the gel left to set at room temperature for
approximately one hour. If the gel was to be used the following day, the top and
bottom of the gel were kept moist with paper towels and sealed in plastic wrap. It
was then stored flat at 4°C.
The electrophoresis tank used was a SE1600 Poker Face II sequencer (Hoefer
Scientific Instruments). This was attached to a 3000Xi-electrophoresis power supply
(Bio-Rad). The first step was to fill the lower buffer chamber with lxTBE buffer
(see Appendix 6.2 for protocol) to a depth of approximately 2cm. The masking tape
on the glass plates was then removed and an aluminium and perspex backing plate,
which provides even heat distribution across the gel, was clamped against the smaller
glass plate. This was done with two side clamps of the same length as the larger
glass plate. This apparatus was placed in the lower buffer tank and secured, and the
upper buffer tank was filled with lxTBE buffer. The "well-forming" spacer was
removed and the well flushed with 1xTBE buffer to remove excess urea and prevent
distorted migration of DNA due to unpolymerised acrylamide. The top "safety lid"
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and top and bottom connectors were then plugged into the unit, and the electrodes
were connected to the power pack.
Before loading the PCR products, each gel was pre-warmed for 20 minutes at
1400 volts. A 66-well comb or a 44-well comb was placed in the well formed by the
"well-forming" spacer, and 1 to 2µ1 of each sample was loaded into each well ( l µl
was loaded if the 66-well comb was used, 2µ1 for the 44-well comb). The top "safety
lid" was replaced and the gels were run for 1.5-3.5 hours at 1400 volts depending on
the size range of the alleles.
After gel electrophoresis, the glass plates were detached using a wedge and
the upper plate (without the gel), as well as the spacers, were removed. Each gel was
fixed by gently flooding with at least 200ml of 10% methanol (AnalaR, BDH
LabSupplies) and 10% acetic acid (AnalaR, BOH LabSupplies) for 15 minutes.
After removing any excess moisture by placing the plate on a slight incline, a piece
of blotting paper, slightly larger than the gel, was placed over it. The adhering gel
was peeled off the glass plate, covered with plastic wrap, and dried under vacuum on
a slab gel dryer (Savant SGD4050) for 1 hour at 80°C. The dry gel was placed in an
X-ray cassette (Amersham Hypercassette™) with a sheet of X-ray film and held
overnight at room temperature. The X-ray film was developed using a Curix
benchtop automatic processor (Agfa).

2.3.2.6 Allele Assignment

The size of the microsatellite PCR products was determined by reference to
the internal lane size standards by applying the method of Carrano et al. (1989). The
310 GeneScanTM Analysis 2.1 (PE Applied Biosystems, 1996) software
automatically recognises the fragment size distribution of the size standards labelled
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with the TAMRA dye. The size of the unknown DNA fragments labelled with the
other three dyes (HEX, TET and FAM) is determined by correlation with the internal
GeneScan size standard Tamra (GS SOO; see Figure 11). The GeneScan Analysis
software generates a calibration or sizing curve based upon the migration times of the
known sized fragments in the standard, relative to which the unknown fragments are
mapped and converted from migration times to sizes. Since the DNA fragments of
the standard are being electrophoresed under the same conditions as the sample, this
is a very precise way to size unknown DNA fragments. It is also very replicable and
allows genotypes run in different lanes and on different gels to be compared.
The data collected by the GeneScanTM Analysis 2. 1 software were analysed
by the GenotyperR 2.0 software (PE Applied Biosystems, 1 993-6) to determine the
microsatellite allele sizes for each individual at each locus. Products detected
radioactively were sized relative to a control PCR product run on the same gel whose.
alleles had already been assigned a number. This was achieved by numbering each
allele in a "top-down" fashion, such that the largest fragment was numbered one, the
second largest numbered two, and so on. This procedure allowed easier
identification of the allele number for the newly run products.
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Figure 1 1 : Tamra GeneScan-500 size standard

2.3.3

Verification and Processing of Genotyping Data

Most data in this study (except those obtained using the radioacti ve
procedure) were collected using an automated procedure. The data for the sizes of
each allele were produced by the GeneScan R Analysis 2. 1 software (PE Applied
Biosystems, 1 996) and analysed by the Genotypel 2.0 software (PE Applied
Biosystems, 1 993-96). The analysed data were then transferred into "Cyrillic for
Pedigree Drawing" programme (Chapman, 1 993- 1 996) where the haplotypes were
checked and then automatically moved into MUNK (Chapman, 1 993- 1 996) where it
could be directly analysed by the linkage programme ASPEX (see section 2.4 ) . This
automatic d�ta collection, transfer and storage system produced reliable scoring of
allele sizes, and human error caused by manually entering the data was minimised.
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To ensure the accuracy of results, an independent party manually checked
random genotypes. Two monozygotic twin pairs were also included in the analyses
as a positive control and to estimate the rate of genotyping error. Chromosomal
regions showing positive lod scores were also replicated in either the Perth or
Stanford laboratory depending on where the results originated, using the same 90
U.S.A. families. As an added quality control on the accuracy of marker typing, the
order and distances of microsatellites were calculated using the data collected from
our sample of individuals. Since the genetic map positions for those markers have
already been determined in other large collections of families (eg. the CEPH
families), the correlation between these maps showed the accuracy of our data. The
programme used to construct these genetic maps is a component of the linkage
programme ASPEX (see below).
To ensure that the methodology was sufficiently sensitive to detect a real
excess of sharing when such excess was present, the pseudoautosomal marker
DXYS I 54 was included in the analysis. This marker does not recombine between
the X and Y chromosome, making it completely sex-linked. Since 73% of the
U. S.A. ASPs are concordant for sex (63% males and 10% females), we would
expect, at locus DXYS154, excess sharing of alleles inherited from the fathers, but
not of those inherited from the mothers. This provided an additional positive control.
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2.4

2.4.1

Statistical Analysis

Statistical Model

The power of the overall study to detect susceptibility loci to autism has
been determined under an oligogenic model, with the assumption that autism is
caused by at least three genes. Using multipoint analysis formulae described by
Risch ( 1990b), the expected maximum lod scores (EMLS) for various values of As
and numbers of sib pairs (N) were calculated (Table 5). Based on the assumptions
that all parents are typed and the polymorphic information content (PIC) of all 3 50
markers (I OcM map) is 0.70, it is reasonable to expect that we can identify loci with
As=2.0 or more in a sample of 1 00 affected sib pairs. With these values we can also
expect to exclude 87% of the genome for a locus with As=2.0. Calculations show
that with the typing of extra markers and the addition of l00 more multiplex families,
we should be able to exclude the entire genome for a As greater than or equal to 2.0
(ie. a gene of moderate effect on the disease), if a gene of this influence is not present
in the disorder (Table 7).

Table 7: Expected Proportion of Genome Excluded , PIC=O. 70
N

As =2.0

As =2.0

10cM map

5cM map

1 00

0.87

0 .92

200

0.99

0.99
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2.4.2 Linkage Analysis

Statistical analyses were based entirely on identity-by-descent (IBD) data
since at least one parent was available for all sibling pairs. These data were
calculated by identifying the parental origin of each sibling allele, and comparing the
corresponding alleles for each member of an affected sibling pair, at a given locus,
for each parent. If both alleles could be uniquely identified, the pair was scored as
either identical or non-identical by descent from that parent at that position. If the
match was ambiguous, the position was scored as uninformative.
In a family with more than two affected siblings, the first affected sibling was
paired with each remaining affected child, allowing the contribution of several
independent sib-pairs within the one family. While this did not bias the observed
sharing results, it did mean that data -from large families carried more weight than
data from small families.
Multipoint sib-pair analysis (see section 1.8.3 ) was employed (Risch, 1 990b;
Risch, 1993) in this study to test for a susceptibility gene(s) to autism. This method
of analysis has already been used to construct an exclusion map of chromosome 17
for type 1 diabetes (Williams et al., 1994), to suggest evidence of a susceptibility
locus in chromosome 6 for schizophrenia (Schwab et al., 1995), and to construct an
exclusion map of the X chromosome for autism (Hallmayer et al., 1996). The
multipoint sib-pair method of linkage analysis has also suggested evidence for
susceptibility loci in autism, with a lod score of 2.53 calculated in one region on
chromosome 7 assuming As = 5 (IMGSAC, 1998).
The multipoint lod score at a particular locus was determined by finding the
nearest informative markers flanking the locus on either side, for both the maternal
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and paternal alleles. The probability of the given marker data (ie. the probability of
sharing vs. non-sharing of alleles), assuming the locus was in a particular IBD state,
was calculated from the IBD states of these flanking alleles, and the recombination
distances to the locus. These probabilities were then used to determine the odds of
the marker data (lod score) given a disease gene of known penetrance at the locus,
versus the odds of the marker data if the disease gene had zero penetrance. The
calculation of marker allele frequencies was not required in this method of analysis,
since all statistical analyses were based entirely on IBD data.
Multipoint lod scores were calculated for a fixed model (ie. fixed value of
As), allowing an exclusion map to be formulated. For a fixed value of As, negative
lod scores can be obtained if the model gives a poorer representation of the marker
data than does no gene effect. The conservative lod score criterion of -2 was used in
this study for exclusion of a locus with a given As value (Hauser et al., 1 996).
Maximum lod scores at each locus were also obtained by maximising the likelihood
of the marker data at each point, as a function of the genetic model (As value). These
results never drop below zero, the value obtained when As = 1.
Regions identified as possibly containing susceptibility loci (Lod Score > 1)
were analysed further using two-point linkage analysis. Two-point linkage analysis
calculates the probability that a marker and a disease locus are linked and does not
consider the adjacent markers on the genetic map. This was evaluated by calculating
the number of alleles shared versus the number of alleles unshared at each marker
across sib-pairs and comparing with a chi-square (x2 ) distribution.
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2.4.3 Linkage Disequilibrium Analysis (LD)

Linkage disequilibrium was examined in chromosomal regions showing
suggestive evidence of linkage (lod > 1 ) using the transmission/disequilibrium test
(TDT) of Spielman et al. ( 1 993 ; see section 1 .8.4 ). This programme identified all
parents who were heterozygous at the marker locus, and defined two alleles for each
affected child, the one transmitted to the affected child and the one that was not. All
transmitted alleles from these heterozygous parents were then tallied with all non
transmitted alleles. A significant difference (by the x2 test) in the frequencies of
alleles in these two groups indicated that an allele (or alleles) was (were)
preferentially transmitted to affected children, and hence associated with disease
susceptibility.

2.4.4

Computer Programme

All statistical analyses, including the multipoint and two-point sib-pair
analyses and the TDT analyses, were performed with the ASPEX computer package
(Hinds and Risch, 1996). It was also used to confirm the relationship between
members of each family, and to search for and eliminate unlikely double crossovers
in the multipoint analyses in regions that had dense markers.
The programme used in the ASPEX computer package to perform multipoint
exclusion mapping using affected sibling pair data for discrete traits (Hinds and
Risch, 1996).was SIB IBD. This programme produces a default output file that
summarises the sharing at each locus, broken down by parent. The markers were
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sorted into order along the chromosome, as specified in the loc (location) parameter.
A loc file was generated at the beginning of each analysis of a chromosome and
states the markers used, the distances between each marker in Morgans, as well as
the lambda value specified in the analysis.
A multipoint exclusion map was also generated by the programme and the
genetic recombination distance (offset) and the lod scores were specified for each
marker at each lambda value. Multipoint lod scores calculated at specified points
between and at each marker for different lambda values (1.5 < As > 10) were graphed
using the "Microsoft Excel for Windows 95" computer programme (Microsoft, 19851996), to view areas of linkage and/or exclusion. Lambda values or the sibling risk
ratio (As) were used to quantify the effect of a locus. For this study, loci with a small
genetic influence on the disease corresponded to a As :s; 2, whereas a large gene effect
coincided with a As :::: 5 . A moderate influence on the disease gene corresponded to a
As value between those stated for a small and large gene effect (3 :s; As :s; 4).

121

CHAPTER 3
RESULTS

Two collaborative groups (Stanford University in US.A and Graylands
Hospital/Edith Cowan University in Perth, Australia) performed a hierarchical search
of the genome for autism susceptibility genes on 90 U.S.A multiplex families. A
10cM map containing 362 markers was used in the initial screen. Genomic regions
of interest were investigated further during the second stage, with a denser map
containing 157 additional markers. Using the ASPEX computer programme,
multipoint sib-pair analysis was performed on the genotype data to detect linkage.
Exclusion maps were generated under different lambda values to show the regions of
the genome which show no evidence of linkage. Regions indicating suggestive
linkage (lod > 1) were analysed further using two-point linkage analysis.
A total of 50 microsatellites in the initial screen and 50 additional markers in
the follow-up screen were analysed as part of this PhD project on the 90 US.A.
families. An additional group of 41 Australian multiplex families were analysed
using a subset of 24 microsatellites. The results below are presented in the order in
which they were obtained (see Figure 12). The analysis of the US.A. families is
shown first by displaying the results of the systematic scan of part of the genome,
followed by the refined study of candidate regions and concluding with the results
from the duplication of the positive regions identified by us and the Stanford group.
The section on the study of the Australian families presents our findings for
the regions identified as possibly significant during the initial scan on the US.A
families and by the IMGSAC (1998). Finally, the results from the linkage
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disequilibrium (LD) analysis are presented on regions where results suggestive of
linkage have been obtained in the combined U. S.A. and Australian group of families.

STAGE 1

GENOME SEARCH
ON 90 U.S.A. FAMILIES
USING MULTIPOINT LINKAGE ANALYSIS
(362 Microsatellites)
�
�

STANFORD UNIVERSITY
Chrl-18
STAGE 2

EDITH COWAN UNIVERSITY /
GRAYLANDS HOSPITAL
Chrl 9-22
/

Additional
157 Microsatellites
typed

•
•

IN CANDIDATE REGIONS
Chr6 & 15
(Perth Group)
REGIONS MLS> 1 IN STAGE 1
DUPLICATED WITH A MORE DENSE MAP
Chrlp, lq, 7p, IOq, I I p, 13q, 15q, 17 p, 18q , 20p & 22
(Perth and Stanford Groups)

•

REGIONS MLS> 1 IN STAGE 1
TESTED WITH 49 ADDITIONAL U. S.A. FAMILIES
(149 Microsatellites)
(Stanford Group)

•

REGIONS MLS> 1 IN STAGE 2 and
IMGSAC (1999) POTENTIAL REGION
TESTED WITH 40 AUSTRALIAN FAMILIES
Chrlp, 7q & 22
(Perth Group)
Figure 1 2 : Flow-chart of the linkage study on autism (Note: Perth Group includes
collaborators from E.C.U. and Graylands Hospital)
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3.1

Linkage Results from the U.S.A. Families

3.1.1 Genotyping Error Rate

To ascertain the accuracy of the results that follow as well as the degree to
which potential biases might be confounding the results, the genotyping error rate for
this study was determined. A marker completely linked to sex was also run to ensure
that the method was sensitive enough to determine excess in sharing at a specific
locus if indeed present for this disease.
In the analysis a number of controls were employed to identify potential
typing errors in the results. Firstly a pair of monozygotic twins were genotyped with
the other sib-pair families to determine the genotyping error rate in the entire genome
scan. Additionally, random genotypes, as well as regions showing positive Iod
scores (MLS > 1.0), were manually checked by an independent party using the same
protocol. For the entire genome scan, a genotyping error rate of 1 % was calculated.
This result was derived from the analysis of the monozygotic twins where 1 0 loci out
of a total of 946 were found to be genotypically discordant (Risch et al. , 1999).
The error rate for the genotypes included in this Ph.D. study was calculated
by the analysis of random genotypes by an independent party. Five hundred and
sixty-eight genotypes in total were re-analysed and 7 errors in total were found. This
corresponds to a genotyping error rate of approximately 1 .2%.
To ensure this method of analysis was sufficiently sensitive to detect
susceptible genes, if present, DXYS 1 54 was analysed in the U.S.A. sib-pair families
(see 2.3.3) to see if linkage to sex was detected. Since the majority of ASPs are
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brother pairs we would expect to an excess of sharing of alleles inherited from the
fathers, but not of those inherited from the mothers. In total, there were 58 paternal
alleles shared and 22 paternal alleles not shared, giving a x2 of 1 6.2. This
corresponded to a lod score of 3.52, displaying significant linkage of this marker to
sex. By contrast, there was no difference in the sharing of maternal alleles (42 alleles
were shared and 4 5 alleles were not shared). Since 73% of the U.S.A. ASPs are
concordant for sex, these results indicate that the methodology was sufficiently
sensitive to detect an excess of sharing of this magnitude when present.

3.1.2

Systematic Scan of Chromosomes 19-22

A systematic scan of part of the genome, namely chromosomes 19-22 , was
completed as part of the first stage screening on 90 multiplex families from the
United States of America. Multipoint linkage analysis on the 50 microsatellites
genotyped was performed under different lambda values (ie. A-s = 2 , 3 , 4 , 5 & 1 0)
using the ASPEX programme. The results of these analyses are depicted graphically.
The figures show the lod scores calculated at each marker typed and at a number of
intervals between these markers. The order of the microsatellites on the figu res
follows that given in the Genetic Location Database (LOB; see section 2.3.2.2) and
the distance between the markers is stated in cM. A dividing line at lod score -2
shows the values of A-s (below this line) that could be excluded from linkage to an
autism susceptibility gene in that interval.
The allele sharing data at each locus are shown in table format. The
"Paternal" and " Maternal" tables show the number of shared alleles that were
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inherited from each parent, the number of alleles inherited from the respective parent
that are not shared, the percentage of alleles shared at this locus, and whether or not
there is a significant difference between shared and non-shared alleles at the
designated 5% level of significance (x2 test). The "Combined" table shows the
summary of allele sharing at each locus irrespective of parent of origin. In the cases
where there was no way of differentiating whether the allele was maternal or paternal
in origin, these results were included in the "Combined" sharing table. The "Most
Likely Model" table has five columns tabulating the percentage sharing and the lod
score obtained by the maximum likelihood calculation (MLS). The middle three
columns show the ratio of sharing of zero, one and two alleles. The results for each
chromosome are described below.

3.1.1.1 Chromosome 19

Genes of Large Effect
As depicted in Figure 13, genes with effects corresponding to a As :2: 5 could
be excluded from linkage to autism for over 90% of chromosome 19. The region
that could not be excluded was between the markers D19S420 and D19S4 l8.

Genes ofModerate Effect
Twenty seven percent of chromosome 19 could be excluded from linkage to a
gene of moderate effect (3 s As s4). This region included markers D19S22 l,
D 19S226 and D 19S4 l4.

Genes of Small Effect
No region on chromosome 1 9 could be excluded from the presence of genes
of small effect on autism (As s 2).
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Most Likely Lad Scores
The paternal and maternal alleles that were shared between sib-pairs at all
markers on chromosome 19 showed a significant difference only for the paternally
inherited alleles at marker D l 9S2 lO when assessed by the x2 test (Table 8). The
percent sharing at this marker was 65.9% (x2 = 4.45, p = 0.035). When the
percentage of alleles shared was calculated without taking in account parental origin
of the alleles, the results did not deviate significantly from what was expected under
the null hypothesis of no linkage (50%).
The percentage sharing and the lod score (MLS) obtained by the maximum
likelihood calculation for each locus, also did not show any significant linkage on
this chromosome. The highest lod score calculated was 0. 73 at D l 9S220.

Table 8 : Most Likely Lod Scores for Chromosome 19 (U.S.A. Families)

Locus
D1 9S209
D1 9S2 1 6
D1 9S221
D1 9S226
D1 9S414
D1 9S220
D1 9S420

1�1 9S41 8

1 9S21 0
Locus

D1 9S209
D1 9S2 1 6
D1 9S221
D1 9S226
D1 9S414
220
420
41 8
210

+

Paternal

-

26
23
30
29
17
29
26
24
29

22
24
31
28
27
25
27
18
15

+

-

58
56
56
61
46
·67
59
47
58

%
54.2%
48.9%
49.2%
50.9%
38.6%
53.7%
49. 1 %
57. 1 %
65.9%

Combined

47
45
60
58
52
51
56
43
44

%
55.2%
55.4%
48.3%
5 1 .3%
46.9%
56.8%
5 1 .3%
52.2%
56.9%

x:

0.33
0.02
0.02
0.02
2.27
0.30
0.02
0.86
4.45
2

x

1 .15
1 .20
0.14
0.08
0.37
2.17
0.08
0. 1 8
1 . 92

1 27

-

+

Maternal

%
56.4%
61.1%
47.3%
5 1 .6%
54.2%
60.3%
53.3%
47.8%
50.0%

24

31
33
26
32
26
35
32
22
27

21
29
30
22
23
28
24
27

Most -Likely Model
%shr
56.9
52. 7
5 1 .5
5 1 .6
53.4
57.8
53.4
54.2
57. 1

zO

0. 1 9
0.22
0.24
0.23
0.22
0.18
0.22
0.21
0.18

z1

0.49
0.5
0.5
0.5
0.5
0.49
0.5
0.5
0.49

z2

0.32
0.28
0.26
0.27
0.29
0.33
0.28
0.29
0 . 33

X*
0.89
2 .67
0. 1 6
0.06
0.33
2.48
0.27
0 . 09
0.00

M LS
0.50
0.08
0.03
0.03
0.1 3
0.73
0.1 3
0.1 7
0.49

Figure 1 3: Chromosome 1 9 multipoint results using USA families
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3.1.2.2 Chromosome 20

Genes of Large Effect
Genes of large effect on chromosome 20 could be excluded from linkage to
autism in over 86% of the chromosome (Figure 14). Two areas could not be
excluded, namely an 8. 8cM region between D20S 1 1 7 and D20S95, as well as a
6.2cM region between D20Sl 1 5 and D20Sl89.

Genes ofModerate Effect
A high percentage of chromosome 20 ( 69%) could also be excluded as
containing a gene of moderate effect. The region not excluded spans all markers
between D20S 1 1 7 and D20S 1 86.

Genes of Small Effect
Forty four percent of chromosome 20 could be excluded from the presence of
genes of small effect on autism. This includes a 22. 1 cM region involving D20S 1 1 8
and D20S 1 95, a 22.3 cM region between D20S 178, D20S 196 and D20S 1 00, and a
1 6 . 1 cM region surrounding D20S 173 and D20S 171 .

Most Likely Lad Scores
No significant deviation from the null hypothesis of 50% sharing was noted
in the percentage of paternal alleles shared between sib-pairs at all markers on
chromosome 2 0 (Table 9). Significant sharing, however, was noted for the
maternally inherited alleles at both markers D20S1 89 (x2 = 4 .57; p = 0.033 ) and
D20S1 00 (x2 = 3 .92; p = 0.04 8 ) . The percentages of alleles shared at these markers,
however, were not significant at the 5% level of significance in the combined data
set.
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Maximum likelihood calculations also showed no susceptibility region on this
chromosome. Linkage results for 62% of the chromosome (between markers
D20S118 to D20S171) did not deviate significantly from the distribution that would
be expected by chance (50% sharing). The amount of sharing identical-by-descent
for the remaining 38% of the chromosome was also non-significant, with the greatest
amount of sharing calculated at D20S95 (57.3%), corresponding to a MLS of 0.67.
Table 9: Most Likely Lod Scores for Chromosome 20 (U.S.A. Families)
Locus
D20S1 1 7
D20S95
D20S1 1 5
D20S1 89
D20S1 86
D20S 1 1 8
D20S1 95
D20S1 07
D20S1 1 9
D20S1 78
D20S1 96
D20S1 00
D20S
D20S

+

-

30
37
25
24
31
21
26
29
22
23
22
22
2
0

27
23
19
27
28
32
29
28
30
31
37
26
24
24

Locus

+
D20S1 1 7
D20S95
D20S1 1 5
D20S1 89
20S1 86
20S1 1 8
D20S1 95
D20S1 07
D20S1 1 9
D20S1 78
D20S1 96
D20S1 00
D20S1 73
D20S1 71

3
2
50
60
69
47
55
61
58
49
59
54
45
48

Paternal

%
52.6%
6 1 .7%
56.8%
47. 1 %
52.5%
39.6%
47.3%
50.9%
42.3%
42.6%
37.3%
45.8%
47.8%
45.5%

Combined
%
5 1 .2%
60
56.3%
56
54.3%
42
56. 1 %
47
55.2%
56
43.5%
61
47.4%
61
54.0%
52
52.7%
52
46.7%
56
45.7%
70
55. 1 %
44
49.5%
46
47. 1 %
54

-

aili

3.27
0.82
0. 1 8
0. 1 5
2.28
0.16
0.02
1 .23
1.19
3.81
0.33
0.09
0.

x

2

0.07
2.00
0.70
1 . 58
1 . 35
1 .81
0.31
0.72
0.33
0.47
0.94
1 .02
0.01
0.35
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34
24
36
38
26
28
32
36
26
36
32
22
25

o/oshr

52 .8
57.3
57.2
56.4
55.4
50.0
50.0
5 1 .8
5 1 .6
50.0
50.0
50.0
50.0
50.0

-

32
32
22
20
28
29
31
24
22
25
32
18
21
27

Maternal

%
50.0%
5 1 .5%
52.2%
64.3%
57.6%
47.3%
47.5%
57. 1 %
62. 1 %
5 1 .0%
52.9%
64.0%
5 1 .2%
48. 1 %

M ost -Likely
zO
z1
0.22 0.50
0. 1 8 0.49
0. 1 8 0.49
0. 1 9 0.49
0.49
0.2
0.25 0 . 50
0.25 0.50
0.23 0.50
0.23 0 . 50
0.25 0 . 50
0 .25 0.50
0.25 0.50
0.25 0 . 50 .
0.25 0 . 50

�

0 .06
0.09
4 . 57
1 .52
0. 1 6
0. 1 5
1 .14
3.38
0.02
0.24
3.92
0.02
0.08

M odel
z2
M LS
0.09
0.28
0.67
0.33
0.60
0.33
0.50
0 . 32
0.37
0.31
0.00
0.25
0.00
0.25
0.04
0.27
0.03
0.27
0.00
0.25
0.
0 .25
0.00
0.25
0.00
0.25
0.00
0.25

Fig u re 1 4 : Chromosome 20 m u ltipoint resu lts using USA fam i l ies
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3.1.2.3 Chromosome 21

Genes of Large Effect
Genes that have a large effect on autism could be excluded from the entire
length of chromosome 21 using microsatellite markers spaced approximately l OcM
apart (Figure 15).

Genes ofModerate Effect
A gene of moderate effect could also be excluded from 84% of chromosome
21. This includes the region between D21 S1256 to D21 S266, excluding the first
8cM between D21Sl 256 and D21S1253.

Genes of Small Effect
However, a gene a small effect on the disorder could only be excluded from
30% of chromosome 21. The exclusion region was 13cM in total and was defined by
markers D21S1253 and D21S263.

Most Likely Lod Scores
The percentage sharing of alleles at all markers on chromosome 21 did not
differ significantly from the null hypothesis (50% sharing), even when the paternal
and maternal inherited alleles were viewed separately (Table 10). The only
significant result was at locus D21 S1253 which showed the percent of paternal
alleles shared to be lower than what would be expected by chance (25% sharing, x2 =
9.00, p = 0.0027).

The maximum likelihood calculations showed no significant linkage of
chromosome 21 to an autism gene, with the MLS scores over the entire chromosome
infrequently differing from zero. This is the value obtained when As = 1, i.e., the
increase in risk to siblings approaches the population prevalence of the disorder.
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Fig u re 1 5 : Chromosome 21 m u lti point results usi ng USA fam i l ies
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Table 1 0 : M ost Likely Lod Scores for Chromosome 21 (U.S.A. Famil ies)
Locus

-

+

D21 S1 256
D21 S1 253
D21 S263

11
9
15

D21 S1 252
D21 S266

22
19

Paternal

%

26

19

D21 S1 253
D21 S263

36
38

D21 S1 252
1 S266

%

7

68.2%

25.0%
39.5%

9.00
1 . 68

15
23

64.3%
48.9%

42.3%

1 .23
0.03

27
22
33

24

57.9%

22

17

56.4%

Combined

D21 S1 256

-

15

5 1 .4%

-

+

0.04

18

+

x

M aternal

47.8%

12
27
23
30

Locus

2

I

2

2.91
3.43
0 . 02
1 .42
0.64

M ost -Likely M odel
%shr

57.8%

x2

1 . 09

53.4

46.2%
44.7%

0.46
0.95

55

42
47
54

50.5%

0.01

50.0
50.0
51 .8

41

35

53.9%

0. 47

5 1 .3

%

x

zO

z1

z2

0.22

0.5

0.29

MLS
0.06

0.25
0.25

0.5
0.5
0.5

0.25
0.25

0.00
0.00

0.27

0.03

0.5

0.26

0.01

0.23
0.24

3.1.2.4 Chromosome 22

Genes of Large Effect
Only seventeen percent of chromosome 22 could be excluded from
containing a gene of large effect on autism. As illustrated in Fi gure 16, the exclusion
region is located from approximately 2cM centromeric of D22S272 to D22S274.

Genes ofModerate Effect
Most of chromosome 22 (96%) could not be excluded from linkage to a gene
of moderate effect on autism. The area that could be excluded was -3cM telomeric
ofD22S423 to D22S274.

Genes of Small Effect
No region on chromosome 22 could be excluded from the presence of genes
of small effect on autism.
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Most Likely Lad Scores
The percentage of alleles shared by the affected sib-pairs at each locus on
chromosome 22 is shown in Table 1 1. Whilst the percentage of shared alleles
inherited from the mother did not deviate significantly from the expected value of
50%, the null hypothesis was rejected at a number of loci on chromosome 22 when
the percentage of shared paternal inherited alleles was calculated. These loci include
all markers between D22S3 l5 and D22S272. The most significant result was at
D22S278 with 82.1 % of alleles shared IBD in the 90 U.S.A. sib-pairs analysed (x2 =
1 1.57, p = 0.00067). When the results of the allele sharing from both parents were
combined, significant deviation from the null hypothesis was still calculated at eight
loci. The three most significant results were at D22S273 (65.9%, x2 = 8. 58, p =
0.0034 ), D22S280 (62.9%%,

x2 = 7.76, p = 0. 0053 ) and D22S278 (7 1. 2%, x2 =

1 0.59, p = 0.00 1 14).
The maximum likelihood results for chromosome 22 are shown in Table 1 1.
Ten markers had MLS scores greater than 1 on this chromosome, with D22S929
exceeding the genome wide significance level of 3 (3.08). The percentage of allele
sharing at this marker was 65.4%. This marker was linked to the disorder
Neurofibromatosis 2 in 1987 by Seizinger et al.

Two-Point Lad Scores
Two-point lod scores at this locus, however, showed a lower probability of
linkage with a MLS of 1 .52 calculated at D22S929 (Table 1 2). The highest two
point lod score was 2.46 at D22S278 (7 1 .9% sharing). This marker is located
1 2.3cM telomeric from D22S929, the marker showing significant linkage to autism
in the multipoint sib-pair analysis.

135

Fig u re 1 6 : Chromosome 22 m ultipoi nt resu lts usi ng USA fam i l ies
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Table 1 1 : M ost Likely Lod Scores for Chromosome 22 (U.S.A. Families)
Locus

Paternal

M aternal

+

-

D22S420

28

20

58.3%

1 . 33

26

22

54.2%

0 .33

D22S31 5

33

17

66.0%

5.12

26

32

44.8%

0 . 62

D22S929

35

14

7 1 .4%

9 . 00

27

22

55. 1 %

0.51

D22S1 1 63

39

17

69.6%

8.64

28

25

52.8%

0. 1 7

D22S1 1 50

37

13

74.0%

1 1 . 52

22

21

5 1 .2%

0 . 02

D22S275

27

10

73.0%

7.81

21

21

50.0%

0 . 00

D22S273

28

9

75.7%

9.76

25

17

59.5%

1 . 52

D22S280

39

17

69.6%

8.64

33

25

56.9%

1.10

D22S281

39

16

70.9%

9.62

27

31

46.6%

0.28

D22S277

40

18

69.0%

8.34

33

30

52.4%

0.14

D22S278

23

5

82. 1 %

1 1 .57

18

11

62. 1 %

1 .69

D22S283

34

19

64.2%

4.25

35

27

56.5%

1 .03

D22S272

23

11

67.6%

4.24

25

26

49.0%

0 . 02

D22S423

13

15

46.4%

0.14

21

20

5 1 .2%

0 . 02

D22S274

27

22

55. 1 %

0.51

21

27

43.8%

0 .75

Locus
+

-

D22S420

55

D22S31 5

%

2

+

-

x

Combined

2

%

x

Most -Likely M odel
2

%

x

43

56. 1 %

1 . 47

60

50

54.5%

D22S929

63

37

D22S1 1 63

69

D22S1 1 50

zO

z1

z2

58.2

0.17

0.49

0 . 34

0.65

0.91

58.1

0.18

0.49

0 . 34

0.86

63.0%

6.76

65.4

0. 1 2

0.45

0.43

3.08

44

61.1%

5.53

60.8

0.15

0.48

0 . 37

1 .68

60

35

63.2%

6.58

60.7

0. 1 5

0.48

0 . 37

1 . 65

D22S275

48

31

60.8%

3.66

60. 1

0.16

0.48

0 . 36

1 .47

D22S273

56

29

65.9%

8.58

62.5

0.14

0.47

0 . 39

2. 1 9

D22S280

73

43

62.9%

7.76

62 .5

0.14

0.47

0 .39

2.21

D22S281

67

48

58.3%

3. 1 4

60.2

0.16

0.48

0 . 36

1 .45

D22S277

73

48

60.3%

5. 1 7

59.9

0. 1 6

0.48

0 . 36

1 .37

D22S278

42

17

7 1 .2%

1 0.59

60.8

0. 1 5

0 .48

0 . 37

1 .57

D22S283

71

48

59.7%

4.45

6 1 .6

0. 1 5

0.47

0 . 38

1 .8 1

D22S272

49

38

56.3%

1 . 39

57.6

0. 1 8

0.49

0 . 33

0.74

D22S423

34

35

49.3%

0.01

58.8

0. 1 7

0.48

0 . 35

0.97

D22S274

50

51

49.5%

0.01

50.5

0.24

0.5

0.26

0.00
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%shr

M LS

Table 1 2 : Two-Point Lod Scores for Chromosome 22 (U.S.A. Families)

Locus

Paternal

+

-

D22S420

28

20

D22S31 5 I 33
D22S929

D22S1 1 63

M aternal

+

-

58%

x
1 . 33

26

22

54.20%

x
0 . 33

17

66%

5.12

26

32

44.80%

0 . 62

35

14

71 %

9.00

27

22

55. 1 0%

0.51

39

17

70%

8.64

28

25

52. 80%

0.17

37

13

74%

1 1 .52

22

21

5 1 .20%

0 . 02

27

10

73%

7.81

21

21

50.00%

0 . 00

D22S273

28

9

76%

9.76

25

17

59.50%

1 . 52

39

17

70%

8.64

33

25

56.90%

1 .10

D22S281

39

16

71 %

9 .62

27

31

46.60%

0 .28

D22S277

40

18

70%

8.34

33

30

52.40%

0. 1 4

D22S278

23

5

82%

1 1 .57

18

11

62. 1 0%

1 .69

D22S283

34

19

64%

4.25

35

27

56.50%

1 . 03

D22S272

23

11

68%

4.24

25

26

49.00%

0 . 02

13

15

46%

0. 1 4

21

20

5 1 .20%

0 . 02

D22S274

27

22

55%

0.51

21

27

43.80%

0 . 75

D22S1 1 50

D22S275
D22S280

D22S423

%

Combined

Locus
+

-

%

55

43

D22S3 1 5

60

D22S929

2

2

%

Most -Likely M odel
-

0 . 32

Pat

Mat.

0.49

_2

0.21

0.50

0 . 30

63.3

0. 1 3

0.46

0.40

0.6

-0.4

5 . 53

6 1 .5

0. 1 5

0.47

0.38

63%

6 .58

63.4

0. 1 3

0.46

0.40

1 .6

-0.3

1 .26

31

61%

3.66

60.8

0. 1 5

0.48

0 . 37

56

29

66%

8.58

67. 1

0. 1 1

0.44

0.45

1 .2

-0.4

0.80

73

43

63%

7.76

63.2

0.1 4

0 .47

0.40

D22S281

67

48

58%

3.14

58.4

0.17

0.49

0 . 34

0.0

1 .73

73

48

60%

5. 1 7

60.3

0.16

0.48

0 . 36

D22S278

42

17

71 %

1 0.59

71 . 9

0 .08

0.40

0 . 52

71

48

60%

4.45

60.0

0. 1 6

0.48

0 . 36

D22S272

49

38

56%

1 . 39

56.5

0.19

0.49

0 . 32

34

35

49%

0.01

50

0.25

0.5

0.25

D22S274 � 5 1

50%

0.01

50

0 .25

0.5

0.25

2

zO

%shr

56%

x
1 .47

56.2

0. 1 9

50

54%

0.$1

54.6

63

37

63%

6.76

D22S1 1 63

69

44

61%

D22S1 1 50

60

35

D22S275

48

D22S273
D22S280

D22S420

D22S277

D22S283

D22S423
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0.3

1 .7

2. 1

1 .9

1 .7

0.0

-0.2
-0.6
0.1

M LS
0.33
0.20

1 .52
1 .48

2.04

1 .4

-0.7

0.70

2.4

0.9

0.1

0.6

0.2
-0 .

2.46

0.0

0.0

0.0
0.0

0.00

1 .5

-0.3

1 .1 3
1 .01

0.00

3.1.3

Candidate Regions

The 90 US.A. multiplex families were also used to conduct a refined analysis
of genomic regions that have produced positive results in previous studies carried out
by other groups. These regions included the HLA region on chromosome 6 and a
large section of chromosome 1 5. In this analysis the entire length of chromosome 1 5
was studied.

3.1.3.1 HLA Region on Chromosome 6
In total, 8 markers with an average inter-marker distance of 3 cM were
genotyped in the HLA region on chromosome 6. Multipoint sib-pair analysis results
under different gene effects (As) are presented in Figure 17. The entire HLA region
on chromosome 6 could be excluded from linkage to a gene of moderate effect for
autism (As � 2). All markers showed a distribution of sharing that would be expected
under a model of no linkage (ie. z0=0.25, z l =0.50, z2 =0.25) (Table 13). Therefore
the amount of sharing of alleles at each locus did not exceed 50%, corresponding to a
most-likely lod score of zero at each marker. When viewed separately by
transmitting parent, the shared alleles at each locus also did not exceed what was
expected by chance, with the majority of markers showing a percentage sharing
lower than 50%.

3.1.3.2 Chromosome 15
Nineteen microsatellites that were approximately 7.5cM apart from each
other and spanned the entire length of chromosome 1 5 were analysed in the 97
US.A. affected sib-pairs. The results for this chromosome were very similar to those
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displayed by the HLA region on chromosome 6. Linkage to a susceptibility gene
that has a large effect on autism could be excluded throughout the entire
chromosome (As � 5) (Figure 1 8). ASPEX results also showed that linkage to a gene
of moderate effect could be excluded for 8 1 % of the chromosome between the region
spanning D 1 5Sl65 and D15Sl20. However, a gene of small effect was only
excluded from 1 0% of this chromosome near markers D15Sl 1 7, D 1 5 S 1 52 and
D 1 5S205. When viewing the maximum likelihood calculations for this chromosome
(Table 14), it can be seen that allele sharing greater than 55% was not observed for
any of the chromosome 1 5 markers. The highest lod score within this region was
0.22 at D 1 5Sl58. Allele sharing by parental origin also showed no significant
deviation from the null hypothesis of no linkage.

Table 1 3 : M ost Likely Lod Scores for Chromosome 6 (U.S.A. Families)
Locus
D6S285
D6S1 029
D6S276
D6S 1 0 1 4
D6S497
D6S439
D6S1 0 1 9
D6S426

+

-

27
12
27
29
18
20
20
30

26
17
36
30
19
23
23
39

Locus
+

D6S285
D6S1 029
D6S276
D6S 1 0 1 4
D6S497
D6S439
D6S1 0 1 9
S426

Paternal

56
33
60
52
39
37

44
64

-

%

50.9%
4 1 .4%
42.9%
49.2%
48.6%
46.5%
46.5%
43.5%

x:

0.02
0 . 86
1 .29
0.02
0.03
0.21
0.21
1 .17

Combined

55
45
72
59
52
47
53
77

%

50.5%
42.3%
45.5%
46.8%
42.9%
44.0%
45.4%
45.4%

x

2

0.01
1 .85
1 .09
0.44
1 .19
0 . 84
1 .20

1 40

+

-

28
16
32
21
20
17
21
33

28
23
35
27
32
24
27
37

o/oshr
50
50
50
50
50
50
50
50

M aternal

%

50.0%
4 1 .0%
47.8%
43.8%
38.5%
4 1 .5%
43.8%
47. 1 %

Most-Likely
zO
21
0.25
0.5
0.5
0.25
0.25
0.5
0.25
0.5
0.25
0.5
0.25
0.5
0.25
0.5
0.5
0.25

M odel
z2
0 . 25
0.25
0 . 25
0.25
0 . 25
0.25
0.25
0.25

x2

0.00
1 .26
0. 1 3
0 . 75
2.77
1 .20
0.75
0.23
M LS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Fig u re 1 7: Chromosome 6 m ultipoint resu lts usi ng USA fam i l ies
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Figure 1 8: Chromosome 1 5 multipoint results using USA fam i l ies
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Table 1 4: M ost Likely Lod Scores for Chromosome 1 5 (U.S.A. Families)
Locus
+

D 1 5S541
11
D 1 5S1 28
22
D1 5S1 56 I 8
D 1 5S1 65 I 1 4
5
D 1 5S1 1 8
D1 5S2 1 4
2
01 5S1 32
11
D1 5S209
10
0 1 5S1 1 7
26
6
D1 5S1 59
01 5S1 53
28
01 5S1 31
20
D1 5S1 52
7
D1 5S205
36
01 5S1 58
9
01 5S1 27
35
D1 5S1 30
18
8
D1 5S2 1 2
D1 5S1 20
22
Locus
+

D1 5S541
D 1 5S1 28
D1 5S1 56
D1 5S1 65
D1 5S1 1 8
D1 5S2 1 4
01 5S1 32
D1 5S209
D1 5S1 1 7
D1 5S1 59
D1 5S1 53
D 1 5S1 31
D 1 5S1 52
D 1 5S205
D 1 5S1 58
D1 5S1 27
D1 5S1 30
D1 5S2 1 2
D1 5S1 20

20
46
16
36
13
6
18
25
50
16
61
42
11
74
16
70
43
20
49

9
15
4
13
10
4
8
11
32
6
33
21
8
31
7
34
19
7
20

Paternal
%
55.0%
59.5%
66.7%
5 1 .9%
33.3%
33.3%
57.9%
47.6%
44.8%
50.0%
45.9%
48.8%
46.7%
53.7%
56.3%
50.7%
48.6%
53.3%
52 .4%

Combined
%
45.5%
24
56.8%
35
11
59.3%
30
54.5%
46.4%
15
17
26. 1 %
23
43.9%
53.2%
22
4 1 .7%
70
53.3%
14
62
49.6%
50.6%
41
35.5%
20
5 1 .4%
70
55.2%
13
5 1 .5%
66
40
5 1 .8%
52.6%
18
52 .7%
44

x

2

0.20
1 . 32
1 . 33
0 . 04
1 .67
0.67
0.47
0 . 05
0.62
0.00
0.41
0.02
0 . 07
0.37
0.25
0.01
0 .03
0 . 07
0. 1 0

x

2

0.36
1 .49
0 .93
0. 55
0. 1 4
5.2 6
0.61
0. 1 9
3.33
0. 1 3
0.01
0.01
2.61
0. 1 1
0.31
0. 1 2
0. 1 1
0. 1 1
0.27

143

+

-

7
23
8
22
8
4
7
15
24
8
32
22
4
38
7
34
25
12
26

13
19
7
17
5
13
15
11
38
6
28
20
12
39
6
31
21
11
23

o/oshr
5 1 .9
53.0
54.0
52. 1
50.0
50.0
50.0
50.0
50.0
50.6
=52 .4
53.9
50.0
50.3
54.2
5 1 .5
5 1 .8
50.8
54.6

M aternal
%
35.0%
54.8%
53.3%
56.4%
6 1 .5%
23.5%
3 1 .8%
57.7%
38.7%
57. 1 %
53.3%
52.4%
25.0%
49.4%
53.8%
52 .3%
54.3%
52.2%
53. 1 %

Most-Likely
z1
zO
0.23
0.5
0.22
0.5
0.21
0.5
0.23
0.5
0.25
0.5
0.25
0.5
0.25
0.5
0.25
0.5
0.25
0.5
0.24
0.5
0 .23
0 .5
0.21
0.5
0.25
0.5
0.25
0.5
0 .2 1
0 .5
0 .23
0.5
0.23
0.5 .
0 .24
0.5
0.21
0.5

x

2

1 . 80
0.38
0.07
0.64
0.69
4 . 76
2.91
0 . 62
3. 1 6
0.29
0.27
0. 1 0
4.00
0.01
0 . 08
0. 1 4
0 . 35
0 . 04
0. 1 8

M odel
z2
M LS
0.03
0 .27
0.08
0 .28
0.10
0 .29
0.03
0 .27
0.00
0.25
0.00
0.25
0.00
0 .25
0.00
0.25
0.00
0.25
0.00
0.26
0.07
0 .27
0. 1 8
0.29
0.00
0.25
0.00
0 .25
0.22
0.29
0.03
0.27
0.03
0.27
0.01
0.26
0.21
0.3

3.1.4 Duplication of Positive Regions Detected by the Stanford and Perth
Research Groups

At the completion of stage one of the project, 346 autosomal and 14 X-linked
markers had been analysed in all 97 affected sib-pairs from the US.A. The results
from the multipoint analysis on this data identified eleven regions that gave a
maximum lod score greater than or equal to one (MLS � I ). These included
chromosome I p (MLS = I. 87), I q (MLS = 1. 19), 7p (MLS = 1. 00), 1 Oq (MLS =
1.00), 1 l p (MLS = 1.25), I 3 q (MLS = 1.49), 1 5 q (MLS = 1.75), 17p (MLS = 1.30),
l8q (MLS = I.00), 2 0p (MLS = 1.09) and 22q (MLS = 3.08). MLS curves for each
of these chromosomes were generated from maximum likelihood calculations and
are shown in Risch et al. ( 1999). Results for chromosome 22 are also presented in
section 3 . 1.2.4.
The analysis of six of these regions (I p, lq, I Oq, 15q, 17p & 1 8q) was
duplicated in this study using the same families as an additional control. The genetic
maps utilised, however, contained different microsatellites to those analysed in stage
one of the project (refer to Appendix 6. 1 for the microsatellites analysed in each
chromosomal region and the distances between each marker). The results of these
analyses are stated below.

3.1.4.1 Chromosome l p
A region on the short arm of chromosome 1 showed a MLS > 1 when
analysed by the Stanford group (MLS = 1.87). When three markers within this
region were re-analysed by the Perth group, positive linkage to this region was still
found and no area could be excluded for any gene effect (As) (Figure 1 9). Based on
1 44

the calculated sharing probabilities in the interval between D 1 S 1 63 1 to D 1 S534 (zo

= 0. 1 3 , zl = 0.46, z2 = 0.4 1 ), this region had a MLS of 1 .55 (Table 1 5). The MLS at
D 1 S 1 63 1 was 1 .26 (60. 9% sharing). Although slightly lower than that calculated by
the Stanford group, this linkage result (MLS > 1 ) still suggests that a susceptibility
locus to autism may reside in this region. We performed two-point analysis as an
additional test for linkage at this locus (Table 1 6). Results again were suggestive of
an autism gene near D 1 S 1 63 I (MLS = 1 . 1 3 , 60. 1 % sharing). The percentage of
allele sharing at this locus in the combined data set was also significant at the
designated 5% level of significance (x2 = 5.1 4, p = 0. 0234 ) .
Table 1 5 : M ost Likely Lod Scores for Chromosome 1 p (U.S.A. Families)
Locus
D1 S551
D1 S1 631
D1 S534
Locus
D1 S551
D1 S 1 631
S534

+
22
32
26
+
40

68
61

Paternal

13

%

17
19

-

62.9%
65.3%
57.8%

2

x
2.31
4.59
1 .09

Combined
%

".l.A

44
42

54. 1 %
60.7%
59.2%

x

2

0.49
5. 1 4
3.50

+

-

17
36
34

20
27
22

o/oshr

56. 1
60.9
60.7

M aternal
%

45.9%
57. 1 %
60.7%

�I
1 .29
2.57

Most -Likely Model
zO
z1
z2
M LS
0. 1 9 0.49 0.31
0.25
1 .26
0 . 1 5 0.48 0.37
0. 1 5 0.48 0.37
1 .1 4

Table 16: Two-Point Lod Scores for Chromosome l p (U.S.A. Families)
Locus

Paternal

+

-

D1 S551

22

13

62.9%

D1 S 1 631

32

17

D 1 S534

26

19

Locus

M aternal

+

-

2.31

17

20

45.9%

0.24

65.3%

4.59

36

27

57.1 %

1 .29

57.8%

1 .09

34

22

60.7%

2.57

%

x

2

Combined

x

2

Most -Likely M odel

+

-

D 1 S551

40

34

54. 1 %

0.49

D 1 S1 631

68

44

60.7%

D1 S534

61

42

59.2%

%

%

2

o/oshr

zO

z1

z2

54.2

0.21

0.50

0.29

0.1 1

5.14

60.7

0.15

0.48

0.37

1 .1 3

3.50

59.4

0.16

0.48

0.35

0.78

x

145

M LS

Fig u re 1 9 : Chromosome 1 p m u ltipoint results using USA fam i l ies
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3.1.4.2 Chromosome l q
A region on chromosome 1 q suggesting linkage to an autism gene in stage
one of the genome scan (J\1:LS = 1. 19), was re-analysed in the same affected sib-pairs
using microsatellite markers mapping in the same area. Whilst no region in this
section of chromosome 1 could be excluded from linkage to autism, the multipoint
lod scores calculated at all As values were less than one (Figure 20). Maximum
likelihood calculations were also lower than those calculated in stage one of the
study (Table 17). A J\1:LS of 0.7 1 (5 8.8% sharing) was calculated at D 1 S 1 609. The
percentage of alleles shared by sib-pairs at each locus was also not significantly
different to that expected under the null hypothesis of no linkage ( 5 0%). Our
findings make it unlikely that a gene for autism resides in this region of the genome.

Table 1 7: M ost Likely Lod Scores for Chromosome 1 q (U.S.A. Fami lies)
Locus

Paternal

+

-

%

D1 S3462

18

22

45.0%

D1 S235

26

18

D 1 S 1 609

36

22

Locus

Maternal

+

-

0.40

26

19

57.8%

1 . 09

59. 1 %

1 .45

24

23

51 . 1 %

0 . 02

62. 1 %

3.38

24

20

54.5%

0 . 36

x

2

Combined

%

x

2

Most -Likely Model

+

-

%

D1 S3462

46

43

5 1 .7%

0.10

54. 8

D1 S235

53

44

54.6%

0 . 84

D1 S1 609

60

42

58.8%

3. 1 8

x

2

147

%shr

zO

z1

z2

0.2

0 . 50

0.30

0.21

54.6

0.21

0.50

0 . 30

0.20

58.8

0. 1 7

0 . 48

0 . 35

0.71

MLS

Figure 20: Chromosome 1 q m u ltipoint results using USA fam i l ies
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3.1.4.3 Chromosome l Oq

Re-analysis of a 1OcM region of chromosome 1Oq excluded this area from
containing a gene conferring susceptibility to autism. This region showed a MLS =
1.00 when analysed by the Stanford research group. Through the analysis of three
markers approximately 5cM apart, chromosome 1Oq was excluded from linkage to a
gene of large effect on the disorder (Figure 21). A gene of small to moderate effect,
however, could not be excluded over this entire region of chromosome 1Oq.
Multipoint analysis using the "most-likely" model showed no significant excess of
allele sharing in the combined data set with the calculation of a MLS = 0. 76 (58.3%
sharing) at D 10S606 (Table 18). Significant excess sharing, however, was noted for
the maternally inherited alleles at locus D10S2327 (x2 = 4. 57, p = 0.033).
Table 1 8 : M ost Likely Lod Scores for Chromosome 1 0q (U.S.A. Famil ies)
Locus
D1 0S1 432

D1 0S606

D1 0S2327
Locus

D1 0S1 432
D1 0S606

D1 0S2327

+
25

30

17

Paternal

-

%

+

-

24

24

50.0%

0.00

%

x

2

14

64. 1 %

3. 1 0

18

62.5%

3.00

20

21

48.8%

0.02

20

45.9%

0.24

25

12

67.6%

4 . 57

Combined

+

-

49

38

42

32

50

2

x

M aternal

39

%

x-

'

%shr

-56 .3%

1 . 39

-56.2%
-56.8%

Most -Likely Model
zO

z1

z2

0. 1 9

58.3

0. 1 7

0 .49

0.32

1 . 36

56.8

1 . 35

57.6

0. 1 8

0 .49

149

0.49

0 . 34
0 .33

MLS

0.49

0.76

0.54

Fig u re 2 1 : Chromosome 1 Oq m u ltipoi nt resu lts using USA fam i l ies
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3.1.4.4 Chromosome 15q
Results similar to those obtained for chromosome 1 Oq (3. 1 .4. 1 ) were also
found in the region of chromosome 1 5 q, identified by the Stanford group as possibly
containing a gene for autism (MLS = 1.75). The results from this analysis are shown
in Figure 1 8 and Table 14 and are explained previously in section 3.1.3.2. The area
previously identified in stage one of the study as possibly containing a susceptibility
gene to autism was between markers 0 1 SS 1 59 and 0 1 SS 130. Our results (section
3 .1.3 .2) clearly show the exclusion of a gene of moderate to large effect in this
region and the results of the maximum likelihood calculations did not differ
significantly from those expected by chance.

3.1.4.5 Chromosome 17p
When chromosome l 7p was re-examined in the 90 U.S.A. multiplex families
using three different microsatellites, suggestive linkage (MLS > 1 ) to an autism gene
was excluded at all loci. This region previously showed a MLS = 1.30 when
analysed by the Stanford research group. Two of these markers (0 1 7S93 8 and
0 l 7S94 5) could be excluded from linkage to a gene of small effect on the disorder
(Figure 22). The marker, which could not be excluded as linked to a gene of small
effect, was D l 7S849. This marker also showed significant excess of sharing in the
paternal and combined data sets (x2 = 5. 1 6 & 4.05 respectively; Table 19). The MLS
that was calculated at this marker on chromosome l 7p was 0.8 1 (60.4% sharing)
(Table 1 9), which was not significant at the genome-wide level of significance.
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Table 19: Most Likely Lod Scores for Chromosome 1 7p (U.S.A. Families)
Locus

Paternal

-

Maternal
+

-

%

x

5.16

22

18

55.0%

0.40

47.7%

0.09

29

27

5 1 .8%

0 . 07

4 1 .8%

1 .47

28

27

50.9%

0.02

+

-

%

x

D1 7S849

26

12

68.4%

D 1 7S938

21

23

D1 7S945

23

32

2

Most -Likely Model

Combined

Locus

2

+

-

%

x

D1 7S849

49

31

6 1 .3%

4.05

D1 7S938

51

51

50.0%

D1 7S945

52

60

46.4%

2

zO

z1

z2

60. 4

0. 1 6

0.48

0.36

0.81

0.00
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0.00
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Fig u re 22 : C h romosome 1 7p m ultipoint resu lts using USA fam i l ies
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3.1.4.6 Chromosome 18q
Four markers spanning the region of chromosome 18 that showed a MLS of
1 .00 for the Stanford group were tested using the same families. Both D l8S474 and
D 1 8S6 l could be excluded from linkage to an autism gene of small to large effect on
the disorder (Figure 23). However, the region between these markers could not be
excluded. The MLS calculated in this region was 1.05 at D1 8S64 (60.5% sharing)
based on the estimated sharing probabilities at this marker (zO = 0. 1 6, z l = 0. 4 81 z2 =
0. 37) (Table 20). When viewed separately, the percentage of shared compared to
non-shared alleles inherited from the father were not significant at any locus when
related to a x2 distribution. Similar results were obtained for the sharing of
maternally inherited alleles except at marker D1 8S64 , which showed significant
excess of sharing (x2 = 5.00, p = 0. 02 5).

Table 20: M ost Likely Lod Scores for Chromosome 1 8q (U.S.A. Families)
Locus
+

-

D1 8S474

23

D1 8S64

Maternal

Paternal

%

x2

+

-

%

26

46.9%

0. 1 8

27

22

55. 1 %

0.51

21

18

53.8%

0.23

30

15

66.7%

5 . 00

D1 8S68

22

21

51 .2%

0 . 02

29

18

6 1 .7%

2 . 57

D1 8S61

26

27

49. 1 %

0.02

26

23

53. 1 %

0. 1 8

Locus

-

D1 8S474

52

50

D1 8S64

53

D1 8S68
D1 8S61

2

%shr

5 1 .0%

x

0.04

35

60.2%

52

40

53

51

%

2

Most -Likely M odel

Combined
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x
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z1

z2

53.5

0.22

0 . 50

0.29

0. 1 1

3.68

60.5

0.16

0.48

0.37

1 .05

56 .5%

1 .57

57.3
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0.49

0 . 33

0.57
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Figure 23: Chromosome 1 8q m u ltipoint results using USA fam i l ies
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3.2

3.2.1

Linkage Results from Australian Families

Extension Study of Positive Regions Detected Using U.S.A. Families

An "extension study" refers to the process of testing additional families in the
hope of reaching the genome-wide significance level (Lander and Kruglyak, 1995).
After re-analysis of regions of the genome showing MLS 2: l in stage one of the
study which was performed on the 97 U.S.A. sib-pairs, two regions still showed
suggestive evidence of linkage to an autism susceptibility gene. These included a
region within chromosome 1p and a large part of chromosome 22. These regions
were genotyped in the sub-set of 41 families using the same microsatellite markers
and identical analysis procedures. Due to the small number of availabie Australian
families at present, the U.S. A. and the Australian families were analysed together
rather than treating the Australian families as a "replication" data set. The results
from this analysis are described below.

3.2.1.l Chromosome l p

With the addition of the Australian families the overall lod scores dropped
slightly with 20% of this region on chromosome l p excluded from linkage to a gene
of large effect on autism (Figure 24). This compares to no exclusion of any gene
effect when the first 90 U. S.A. multiplex families were analysed. When the
Australian data were added to the maximum likelihood calculations, the maximum
lod score at this region dropped from 1.55 (6cM centromeric ofD1�1631) to 1.21
(8cM centromeric of D 1 S1631) (Table 21). Two-point linkage analysis on this

1 56

region showed a reduction in the MLS at D 1 S1631 from 1.13 to 0.58 (Table 22).
The MLS at this region on chromosome I p was 0.88 at D1S534. This marker, when
analysed using multipoint and two-point analysis, also had a percentage of allele
sharing significantly different to that expected under the null hypothesis of no
linkage (x2 = 3.98, p = 0.046).
Table 21: Most Likely Lod Scores for Chromosome l p (All Families)
Locus

Paternal

+

-

D1 S551

38

23

62.3%

D1 S1 631

44

35

D1 S534

42

32

Locus

+

-

M aternal

+

-

3.69

32

31

50.8%

0.02

55.7%

1 .03

49

37

57.0%

1 .67

56.8%

1 . 35

55

39

58.5%

2.72

%

x

2

%

x

2

M ost -Likely M odel

Combined
%

x2

%shr

zO

z1

z2

I MLS

D1 S551

71

55

56.3%

2.03

57.4

0. 1 8

0.49

0.33

0.62

D1 S 1 631

93

72

56.4%

2.67

56.9

0. 1 9

0.49

0.32

0.75

D1 S534

98

72

57.6%

3.98

58. 1

0. 1 8

0.49

0.34

1 . 04

Table 22: Two-Point Lod Scores for Chromosome l p (All Families)
Locus

Paternal

,M

+

-

62.3%

3.69

32

31

50.8%

0.02

35

55.7%

1 . 03

49

37

57.0%

1 . 67

32

56.8%

1 . 35

55

39

58.5%

? 7-, II

+

-

D1 S551

38

23

D1 S 1 631

44

D1 S534

42

Locus

+

Maternal

-

%

X

x

2

M ost -Likely M odel

Combined
%

%

x

2

%shr

zO

z1

z2

M LS

D1 S551

71

55

56.3%

2 . 03

56.5

0. 1 9

0.49

0.32

0.45

D 1 S 1 631

93

72

56.4%

2.67

56.4

0.1 9

0 .49

0 . 32

0.58

D1 S534

98

72

57.6%

3 . 98

57.7

0. 1 8

0.49

0.33

0.88
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Fig u re 24: C h romosome 1 p m u ltipoi nt results using a l l fam i l ies
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3.2.1.2 Chromosome 22
Chromosome 22 results showed similar trends to those seen in chromosome
1 p when the Australian autistic families' data were added. With the new data set,
2 0% of the chromosome could be excluded from linkage to a gene of large effect on
the disorder (37%) (Figure 25). Genes of small to moderate effect on autism,
however, could not be excluded from a location on chromosome 22.
Maximum likelihood calculations using the most-likely model showed a drop
in MLS below the genome-wide significance level for linkage (lod > 3) at the marker
locus D22 S929. With the addition of the Australian families the lod score was
reduced from 3.08 to 2.70 (Table 23). Percentage sharing compared to non-sharing
between alleles in the combined data set was significantly different for a number of
markers on this chromosome, including D22 S929 (x 2 = 6.92, p = 0.009), D22 S l 1 63
(x 2 = 7. 1 1 , p = 0.008), D22Sl 1 50 (x 2 = 8.26, p = 0.004), D22S273 (x 2 = 1 0.4 5, p =
0.00 1 ), D22S280 (x 2 = 7.4 1 , p = 0.006), D22S2 8 l (x 2 = 4.03, p = 0.04 5) and
D22S278 (X 2 = 1 0. 59, p = 0.001).
When these alleles were divided into those inherited from the father and the
mother, significant differences were noted only for the paternally inherited alleles.
The number of alleles shared by siblings compared to those not shared was most
significant at D22 S l 1 50 (x 2 = 1 3.6, p = 0.0002), with 73% of alleles inherited from
the father by one sibling being identical to the other member of the sibling pair.
When maximum likelihood calculations were performed on just the paternally
inherited alleles, the MLS for this chromosome again exceeded the genome-wide
level for significant linkage (lod > 3 ). This was noted at D22S2 80 with a MLS of
3 .2 . D22 S2 80 is located 8.6cM telomeric of D22S929, the marker where the most
significant linkage result was detected using only the 90 U . S.A. sib-pairs (MLS =
159

3.08). However, maximum likelihood calculations using the data on sharing of
maternal alleles produced negative lod scores throughout most of the chromosome
(except D22 S420, MLS = 0.5). When the multipoint lod scores for the paternal and
maternal inherited alleles were graphed under different lambda values, a similar
trend was observed (Figures 26 and 27, respectively). As seen in these figures, the
region most positive in the paternal multipoint graph (D22 S3 I 5 to D22 S28I ) was
also the region most negative in the maternal multipoint graph. Sixty three percent
of chromosome 22 could be excluded from containing a maternally inherited gene of
large effect on autism. No region of this chromosome could be excluded from
containing a paternally inherited gene for autism. These results indicate that a
paternally derived gene could reside in the chromosome 22 region.
When two-point linkage analysis was run on this chromosome, the lod scores
calculated showed a shift in MLS to marker D22 S273. The calculated MLS was
2.47 with 67.4% sharing (Table 24). This marker is located 6. l cM distal from
D22 S929. Percentage sharing at markers between D22S929 and D22S278 was still
significantly different to that expected ·by chance when the paternally inherited
alleles were analysed. Alleles inherited from the mother at all loci were not different
to what was expected under the null hypothesis of no linkage.
Although the addition of the results of the Australian families to the
chromosome 22 data reduced the overall lod scores, they were still above 1 for some
markers and therefore suggestive of linkage to an autism gene. To increase the
power to detect linkage, we combined our data with those obtained by the Stanford
group. Chromosome 22 was re-analysed by the Stanford group to determine if the
high positive linkage results obtained on this chromosome in stage one of the project
could be duplicated. The results of the Stanford group were obtained using a number
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of different microsatellite markers and these were analysed in the entire group of 1 39
US.A. multiplex families. The additional 49 US families were collected for stage
two of the project and used by the Stanford group to saturate regions giving positive
linkage evidence in stage one of the project (Risch et al. , 1999). The results of this
analysis are shown in Table 25. With the addition of these new US.A. families, the
maximum likelihood lod scores dropped significantly. The MLS for this
chromosome was still at the marker locus D22S929 (the marker showing significant
linkage to autism in the multipoint sib-pair analysis using the first 90 U.S.A.
families), however it dropped well below the threshold for suggestive linkage with a
value of O. 3 7. The presence of a gene on this chromosome could not be excluded
since the percentage sharing, throughout the entire chromosome, was still above that
expected by chance. Also, the percentages of shared alleles at the some loci were
still significantly different in the combined data set when compared to a x 2
distribution. These loci include D22S 1 1 63 (x2 = 4.44, p = 0.035), D22S273 (x2 =
4.26, p = 0.039), D22S278 (X2 = 5.33, p = 0.02 1 ) and D22S283 (x2 = 4.4 1 , p =
0.036). Significant sharing was also noted in the percentage of paternal alleles
shared between sib-pairs at all loci between D22S429 and D22S2 8 1 , as well as at
D22S278 and D22S277. The most significant result was at D22 S278 (x2 = 8. 9 1 , p =
0.003 ), with 82% of alleles inherited from the father by one sibling being identical to
the other member of the sibling pair. No significant deviation from the null
hypothesis of 50% sharing, however, was noted in the percentage of maternal alleles
shared between sib-pairs at all markers on chromosome 22 in this combined data set.
This strengthens the indication that if a gene for autism does reside on chromosome
22, it is most probably paternally derived.
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Figure 25: Chromosome 22 m u ltipoi nt results using a l l fam i l ies
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Table 23: Most Likely Lod Scores for Chromosome 22 (All Families)

Locus
D22S420

D22S31 5
D22S929

D22S1 1 63
D22S1 1 50
D22S275

D22S273
D22S280
D22S281
D22S277
D22S278
D22S283
D22S272
D22S423

D22S274
Locus

Paternal

'

+

-

Maternal

+

-

%

33

25

57%

1.1

36

25

59%

2.0

40

22

65%

5.2

34

39

47%

0.3

43

20

68%

8.4

36

29

55%

0.8

51

22

70%

1 1 .5

35

32

52%

0. 1

48

18

73%

1 3.6

29

27

52%

0.1

38

17

69%

8.0

29

31

48%

0.1

31

12

72%

8.4

31

18

63%

3.5

52

25

68%

9.5

42

35

55%

0.6

50

22

69%

1 0.9

39

42

48%

0. 1

51

26

66%

8. 1

39

43

48%

0.2

23

5

82%

1 1 .6

18

11

62%

1 .7

44

27

62%

4. 1

42

40

51 %

0. 1

30

15

67%

5.0

31

36

46%

0.4

21

19

53%

0. 1

26

31

46%

0.4

33

24

58%

1 .4

27

31

47%

0.3

Combined

+

-

%

x�
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xz

%shr
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0. 1 7

0.48

0.35
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0.49

0.33
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Figure 26: Chromosome 22 multipoi nt results (paternal inheritance) using all families
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Figure 27: Chromosome 22 multipoint results (maternal inheritance) using all families
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Table 24: Two-Point Lod Scores for Chromosome 22 (All Families)
Locus

+

-

Paternal
%

x

2

+

Maternal

-

%

x

2

D22S420

33

25

57%

1 .10

36

25

59.00%

1 . 98

D22S3 1 5

40

22

65%

5.23

34

39

46.60%

0 . 34

D22S929

43

20

68%

8.40

36

29

55.40%

0 . 75

D22S1 1 63

51

22

70%

1 1 .52

35

32

52.20%

0. 1 3

D22S1 1 50

48

18

73%

1 3.64

29

27

5 1 .80%

0 . 07

D22S275

38

17

69%

8 . 02

29

31

48.30%

0 . 07

D22S273

31

12

72%

8.40

31

18

63.30%

3.45

D22S280

52

25

68%

9.47

42

35

54.50%

0 .64

D22S281

50

22

69%

1 0.89

39

42

48. 1 0%

0. 1 1

D22S277

51

26

66%

8.12

39

43

47.60%

0.20

D22S278

23

5

82%

1 1 .57

18

11

62. 1 0%

1 .69

D22S283

44

27

62%

4 . 07

42

40

51 .20%

0.05

D22S272

30

15

67%

5 . 00

31

36

46.30%

0.37

D22S423

21

19

52%

0. 1 0

26

31

45.60%

0.44

D22S274

34

24

59%

1 . 72

28
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47.50%

0. 1 5

Locus

Combined

Most -Likely M odel

+

-

%

x

D22S420

70

51

57.9%

D22S3 1 5

75

62

D22S929

80

D22S1 1 63

2

%shr

zO

z1

z2

Pat

M at.

MLS

2 . 98

58.0

0. 1 8

0.49

0.34

0.2

0.4

0.66

54.7%

1 .23

54.8

0.20

0.50

0.30

0.6

-0.4

0.27

50

6 1 .5%

6 . 92

6 1 .7

0. 1 5

0.47

0.38

1 .6

-0. 1

1 .54

88

56

61.1%

7. 1 1

6 1 .4

0. 1 5

0.47

0.38

2.1

-0.5

1 . 60

D22S1 1 50

78

46

62.9%

8.26

63. 1

0.14

0.47

0.40

2.5

-0.6

1 . 84

D22S275

67

48

58.3%

3.14

58.3

0. 1 7

0.49

0.34

1 .2

-0.5

0.68

D22S273

65

33

66.3%

1 0.45

67.4

0. 1 1

0.44

0.45

1 .8

0.7

2.47

D22S280

95

61

60.9%

7.41

6 1 .0

0. 1 5

0.48

0.37

1 .8

-0.2

1 . 64

D22S281

90

65

58. 1 %

4.03

58.2

0. 1 7

0.49

0.34

1 .6

-0.7

0.89

D22S277

90

69

56.6%

2.77

56.6

0. 1 9

0.49

0.32

1 .2

-0.5

0.60

D22S278

42

17

7 1 .2%

1 0.59

7 1 .9

0 . 08

0.4

0.52

2.4

0.1

2.46

D22S283

88

69

56. 1 %

2. 30

56.2

0. 1 9

0.49

0.32

0.7

-0.2

0.51

D22S272

62

52

54.4%

0 . 88

54.5

0.21

0.5

0.3

0.5

-0.3

0. 1 9

D22S423

47

50

48.5%

0.09

50.0

0.25

0.5

0.25

0.0

0.00

D22S274

64

57

52 .9%

0.40

53.0

0.22

0.5

0.28

0:0

-0. 1

0.09
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Table 25 : M ost Likely Lod Scores for Chromosome 22 (Combined Data)
Locus
Paternal
Maternal
"i.
+
+
%
%

D225420
8
225264
37
D225 31 1
29
D225686
28
21
GCT1 0
D225 3 1 5
49
D225429
� 30
25
D225929
D225 1 1 63
32
89
36
1 50
31
l[mH
D225275
24
D225273
24
D225280
36
D225281
33
D225685
35
D225683
42
D225278
18
D225277
18
225283
16
25445
27
272
13
3
35
74
12

Locus

D225420
D225264
D22531 1
D225686
GCT1 0C1 0
D225 3 1 5
D225429
D225929
D2251 1 63
D225689
D2251 1 50
D225275
D225273
D225280
D225281j
D225685
D225683
D225278
D225277
D225283
D225445
D225272
D225423
D225274

+

19
74
60
60
39
93
52
41
55
60
50
42
47
64
56
61
77
32
34
33
55
24
77
24

10
24
25
20
12
39
15
12
13
19
13
10
8
20
15
23
27
4
7
9
18
5
29
6

-

44.4%
60.7%
53.7%
58.3%
63.6%
55.7%
66.7%
67.6%
71 . 1 %
65.5%
70.5%
70.6%
75.0%
64.3%
68.8%
60.3%
60.9%
81 .8%
72.0%
64.0%
60.0%
72.2%
54.7%
66.7%

Combined

21
61
59
45
32
84
41
30
35
57
34
29
29
51
45
54
68
16
22
18
42
21
65
16

0.22
11
2.77
37
0.30
28
1 .33
32
2
16
1�
.14
42
5.
22
4.57
16
8.02
22
24
5.25
7.36
17
18
5 .76
8 . 00
20
28
4 . 57
6.75
22
25
2.48
3.26
35
8.91
13
16
4.84
1 .96
17
26
1 .80
10
3.56
0.56
40
2.00
10
2

0.1 0
.25
0.01
2.14
0.69
0.46
1 .30
1 .70
4.44
0.08
3.05
2.38
4.26
1 .47
1 .20
0.43
0.56
5.33
2.57
4.41
1 .74
0.20
1 .0 1
1 .60

54. 8
�,'
50.4%
°

57. 1 %
54. 9%
52.5%
55.9%
57.7%
61 . 1 %
51 .3%
59.5%
59.2%
61 .8%
55.7%
55.4%
53.0%
53. 1 %
66.7%
60.7%
64.7%
56.7%
53.3%
54.2%
60.0%
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11
37
31
25
18
43
26
18
21
38
19
19
18
31
29
30
41
11
15
9
22
15
34
8

zO
%shr
54.6
0.21
0.23
52.3
52.0
3
52. 5 ±TI3
0.23
52.3
52.3
0.23
0.22
53. 1
0.21
54.5
0.22
52.8
52.6
0.22
52.6
0.22
0.22
52.6
0.21
54.6
0.22
53.4
0.23
52.2
0.23
52.3
0.22
53. 1
0.22
53. 1
0.22
53.1
0.21
54.0
0.21
54.0
0.21
54.0
0.21
54. 1
0.21
54.5

50.0%
50.0%
47.5%
56. 1 %
47. 1 %
49.4%
45.8%
47. 1 %
51 .2%
38.7%
47.2%
48.6%
52.6%
47.5%
43. 1 %
45.5%
46. 1 %
54.2%
51 .6%
65.4%
54.2%
40.0%
54. 1%
55.6%

z1
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5

z2
0.30
0.27
0 .27
0.28
0.27
0 .27
0.28
0.30
0.28
0.28
0.28
0.28
0.30
0.28
0.27
0.27
0.28
0.28
0.28
0.29
0.29
0.29
0.29
0 . 30

Most -Likely Model

•'di

0.0
0.00
0.1 5
0.86

0.
0 . 33
0.12
0.02
3.16
0.1 1
0.03
0.1 1
0. 1 5
0 . 96
0.45
0.47
0.17
0 .03
2.46
0.33
1 .00
0.49
0.22

ML5
0.32
0.08
0.06
0.1 0
0.09
0.1 0
0.1 9
0.37
0.1 4
0.1 2
0.1 2
0.1 2
0.36
0.1 9
0.09
0.09
0.1 6
0.16
0.1 6
0.20
0.23
0.23
0.25
0.21

3.2.2 Replication of Potential Susceptibility Regions

A genome screen by IMGSAC ( 1 998) on 39 multiplex autism families, with
follow up in an additional set of 60 families, found suggestive evidence of linkage to
six chromosomal regions. The long arm of chromosome 7 from D7S530 to D7S684
( 1 6.6cM apart) was the most significant region, with a multipoint MLS of2.53 (p =
0.0022) calculated when all families were analysed. When the subset of 66 UK
families were used, a MLS of 3.55 (p = 0.00057) was detected. Based on the sharing
probabilities in this region (zo = 0.05, z 1 = 0.50, z2 = 0. 45), the significant linkage
result in the UK families corresponds to a gene effect (As) of 5. 0.
Results from our genome scan in the same region showed a maximum lod
score of 0.62 at the marker D7S684 (Risch et al. , 1999). This result was based on a
total of 139 families and 147 affected sib-pairs. A slightly more positive result was
found at marker D7Sl804 (MLS = 0.93 ) which was located 1 0.3cM proximal of
D7S684.
Using our Australian sub-set of families we examined 7 markers in the region
found to be positive by IMGSAC (1998). These microsatellites were the same as
utilised by the IMGSAC group to produce their suggestive evidence of linkage to the
chromosome 7q region. The results of the analysis are shown in Figure 28. No
region within this section of chromosome 7 could be excluded from linkage to a gene
of large effect, with a MLS of 0.62 at D7S684 (Table 26). The MLS calculated using
the Australian families was equal to that found in the U.S.A. data set. Significant
excess of sharing was also found at D7S684 for the paternally inherited alleles, when
compared to a x2 distribution (x2 = 5.40, p = 0.02; Table 26). However, if a
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susceptibility locus does reside in this region, its effect is likely to be small since no
suggestive linkage (MLS > I ) was detected at any marker on chromosome 7q.

Table 26: M ost Likely Lod Scores for Chromosome 7 (Australian Famil ies)
Paternal

Locus

+

-

%

D7S524

10

7

58.8%

D7S527

10

9

D7S486

7

D7S530

Maternal

+

-

%

0.53

8

5

6 1 .5%

0.69

52.6%

0 . 05

9

7

56.3%

0.25

5

58.3%

0.33

11

7

61 . 1 %

0 . 89

8

9

47. 1 %

0.06

8

8

50.0%

0.00

D7S684

12

3

80.0%

5.40

5

5

50.0%

0 . 00

D7S25 1 3

6

5

54.5%

0.09

9

8

52.9%

0 . 06

D7S483

9

8

52.9%

0.06

13

6

68.4%

2 . 58

x

2

Combined

Locus

+

-

%

D7S524

18

12

D7S527

20

D7S486

x

2

Most -Likely Model
2

%shr

60.0%

1 .20

59.3

17

54. 1 %

0 .24

18

12

60.0%

D7S530

16

17

D7S684

17

D7S25 1 3
D7S483

z1

z2

0. 1 7

0.48

0 . 35

0.25

57.9

0. 1 8

0.49

0.34

0.21

1 .20

58.7

0.17

0.48

0.35

0.25

48.5%

0 . 03

50.0

0.25

0 . 50

0 .25

0.00

8

68.0%

3.24

63.7

0. 1 3

0 .46

0.41

0.62

16

14

53.3%

0. 1 3

59.7

0.16

0.48

0 . 36

0.31

22

14

61 .1 %

1 . 78

62.8

0.14

0.47

0.39

0.57

x
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zO

MLS

Fig u re 28: Chromosome 7q m u ltipoi nt resu lts usi ng Australian fam i l ies
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3.3

Linkage Disequilibrium Results

Linkage disequilibrium can be used in an exploratory fashion to investigate
regions of the genome with suggestive evidence of linkage. Using the genotyping
data from the combined US. A and Australian families, transmission/disequilibrium
tests (TDT) were run on chromosomes 1 p and 22q to calculate linkage
disequilibrium. The results from these analyses are shown below (Table 27 and 28).
For each marker, the table lists the number of alleles (Al) and the percentage
of parents who are heterozygous at that position (%Het). The table also lists the
most significant results on allele transmission frequency at each locus in the form of
a x2 score (x2 Max).

Table 27: TDT Tests on Chromosome l p Using All Families
Al

%Het

x2 Max

D 1 S55 l

7

72.0

2.06 (p = 0.6 1 9)

D I S 1 63 1

10

8 1 .5

3 . 85 (p = 0.542)

D 1 S534

12

85.4

2.5 1 (p = 0.787)

Locus
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Table 28: TDT Tests on Chromosome 22 Using All Families
Locus

Al

%Het

x2 Max

D22S420

14

65 .6

0.72 (p = 0.990)

D22S3 l 5

17

79.8

6.00 (p = 0.4 1 9)

D22S929

II

78.3

4.45 (p = 0.465)

D22S 1 163

9

76.1

12.34 (p = 0.005)

D22S l l 50

13

73.4

3 .77 (p = 0.676)

D22S275

10

80.0

2.28 (p = 0.770)

D22S273

9

68.5

2 . 1 3 (p = 0.856)

D22S280

10

79.8

2.47 (p = 0.752)

D22S28 I

11

83.5

3 .00 (p = I .OOO)

D22S277

17

86.5

4.00 (p = 0.756)

D22S278

7

77.0

2.00 (p = I .OOO)

D22S283

16

86.5

5 . 3 1 (p = 0.2 8 1 )

D22S272

13

66. 1

2.25 (p = 0. 867)

D22S423

16

8 3 .7

5 . 83 (p = 0 . 1 7 1 )

D22S274

11

77.5

3 .33 (p = 0.60 1 )

There was no evidence of linkage disequilibrium between the markers on
chromosome 1 p and autism, however this could be due to the large inter-marker
distances (- 19cM). In contrast to this, significant linkage disequilibrium was
detected on chromosome 22q at marker D22S 1 1 63 (P = 0. 005). This marker
(D22S l 1 63 ) is only 4.9cM away from D22S929, the marker showing significant
linkage (MLS ;?: 3 ) to autism in the multipoint sib-pair analysis using the first 90
US.A. families (see Appendix 6. 1 ) . These TDT results provide further evidence that
a susceptibility gene for autism may reside in this region on chromosome 22.
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CHAPTER 4
DISCUSSION

In this study, a large genome-wide screen was conducted by collaborating
groups from Stanford, USA and Perth, Australia with the aim of detecting
susceptibility loci for autism. Linkage to markers in genes that may be involved in
possible pathobiochemical pathways of the disorder was also examined. The project
is the largest genome screen of autism families conducted to date, with a total of 519
markers analysed in the initial set of 90 U.S.A. multiplex families and 149 markers
studied in the second set of 49 U.S.A. multiplex sibships. An additional sample of
41 Australian families was analysed with 24 microsatellites in regions showing
suggestive evidence of linkage to autism. The results of this PhD project formed part
of an overall study whose findings were published recently in the American Journal
of Human Genetics (Risch et al. 1999; see Appendix 6.3), the Journal of Autism and
Developmental Disorders (Rogers et al., 1999), and the American Journal of Medical
Genetics (Salmon et al., 1999).

4.1 Findings from the Study

4.1.1 Genome Scan

4.1.1.1 Susceptibility Loci

Since the first linkage study in autism, by Spence et al. (1985), there has been
a number of advances in molecular biology techniques that have allowed genome
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screens for susceptibility loci to be performed on a much larger scale. However, to
date, there have been a limited number of linkage and association studies in autism
and only three published genome scans (in addition to our study) that systematically
span the entire genome (see section 1 . 8.5). Table 29 shows a summary of the
positive findings reported in these studies. Only regions displaying significant
associations or suggestive linkage results (MLS � 1 ) are shown.

Table 29: Chromosomal Regions Showing Positive Linkages and Associations to
Autism (NOTE: MLS scores shown in brackets represent those results calculated by
IMGSAC (1998) using the UK families only).
Chromosome (Locus)
1

2
3

4 (D4S4 1 2)

6 (HLA-DRB l )

Cytogenctic
Position (in cM)

MLS or
TDT y2

-

;:: 1

Bass et al. ( 1 998)

;:: 1

Bass et al. ( 1998)

;:: 1

p l6.3 (4.8)

1 .55 ( 1 . 10)

p2 1 . 3 (56.7)

TDT x = 19.8
2

6 (D6S283)

q2 1 -23 ( 1 3 2.8)

7 (D7S487)

q3 l -3 5 ( 1 35. 1 )

9 (ABO blood group)
10 (D l0S l 97)

q34. l -34.2 (138. l)
ql 1 .2 (5 1 .9)

15 (GABRB3 locus)
15 (D l 5 S l 56)

q l l .2-q l 2 (4. 1 )
q l l -q l 2 (9.6)

TDT x = 28.63
2.5

p l3 .3 ( 17.3)

1 . 5 1 ( 1. 97)

17 (5-HTTLPR; serotonin)
18

q l l .2-qI2 (57.4)

-

TDT ,,/ = 4.69
;:: 1

1 9 (Dl 9S49)

p 1 3 . l (48.2)

0.99 ( 1 . 1 1)

q l l (5.0)

1 .3 9 ( 1 . 36)

7

7 (D7S530)

1 1 (c-Harvey-ras gene)

q l 4-q2 1 (4 1 . 1)

16 (haptoglobin)

q22.2 (86.7)

19 (D l 9S226)

p l3 . 3 (24. l )

20

-

22 (D22S264)

X (DXS424)

Philippe et al. ( 1 999)

IMGSAC ( 1998)

1.10

Pericak-Vance et al. ( 1 998)
Spence et al. ( 1 985)
IMGSAC ( 1 998)

Herault et al. (1 994); Herault et

al. ( 1 995); Comings et al. ( 1996)

Cook et al. ( 1 998)
Pcricak-Vance et al. ( 1997)
Philippe et al. ( 1 999)
IMGSAC ( 1 998)

1 .04

Spence et al. ( 1985)

1 . 37

Philippe et al. ( 1 999)

;:: 1

Bass et al. ( 1 998)

1 .24

1 74

Warren et al. ( 1 996a)

2.53 (3.55)

2

q24-q26 ( 1 25. 1 )

IMGSAC ( 1 998)

Bass et al. ( 1 998)

1 .54
1 . 36 (0.69)

p l 5 . 5 (6.2)

Bass et al. ( 1998)

;:: 1

1 .2 1

q3 1 -3 5 (144.7)

1 5 (Dl 5 S l 18)
16 (D l6S407)

2.23

-

Publication

Cook et al. ( 1998)
Bass et al. ( 1998)
IMGSAC ( 1 998)

IMGSAC ( 1 998)

Hallmayer et al. ( 1996)

Our genome scan of 97 affected U.S.A. sib-pairs revealed 1 1 chromosomal
regions linked to autism with MLS values greater than 1 (Table 3 0). These included
two regions on chromosome 1 ( 1 p [MLS = 1. 87], 1 q [MLS = 1.1 9] ) and one region
on each of chromosomes, 7p (MLS = 1.00), lOq (MLS = 1 .0), 1 lp (MLS = 1.25),
13q (MLS = 1.49), 15q (MLS = 1.75), 1 7p (MLS = 1.30), 1 8q (MLS = 1.00), 2 0p
(MLS = 1.09) and 22q (MLS = 3.08). While maximum lod scores as low as 1.0 are
not regarded as conclusive evidence for linkage, they may indicate intervals worthy
of further investigation (Elston, 1992; Hauser et al. , 1 996). The proportion of
regions that represent false-positive findings is, however, difficult to assess. Hauser

et al. ( 1 996) demonstrated by simulation that, when studying 1 00 nuclear families
using a genetic map with an average intermarker distance of 1 0cM, there is a 2.4%
false positive rate for regions with a lod score of 1. 0. This represents approximately
8 false positives, on average, in a genome scan of 3 00 markers. A lod score of 2.0
represents no more than one false positive in the same data set. In our genome scan,
where 362 microsatellites were used in the initial analysis (- 1 OcM map), this would
be equivalent to around 9 false positive localisations using the same assumptions.
The observation of 1 1 regions with a lod score of � 1. 0 is therefore not different to
what could be expected by chance.
To help discriminate between the false positive and genuine results, more
markers in these regions were analysed in the same group of families, to provide
more dense or completely different chromosomal maps. The maximum lod scores
for all the suggestive regions, except those on chromosomes 1 p and 22q, dropped
below 1. 0 (Table 3 0). It has recently been demonstrated that, for true positive
localisations, the positive findings span wider genetic areas than false positive
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localisations of similar lod scores (Terwilliger et al. , 1997). The two chromosomal
regions showing MLS > 1 with the addition of more markers (regions 1 p and 22q)
were also flanked by further markers with lod scores > 0 . 5 . This increases the
probability that these regions represent true positive localisations.

Table 30: Maximum Lod Scores (MLS) at Regions Previously Suggestive of Containing
Susceptibility Loci for Autism, After the Addition of More Markers Within the Region.
Chromosome

MLS in Stage 1

MLS in Stage 2

lp

1 . 87

1 .55

lq

1.19

0.71

7p

1 .00

1 .00

l Oq

1 . 00

0.76

l lp

1 .25

0.90

13q

1 .49

0.70

1 5q

1 .75

0.22

1 7p

1 .30

0.8 1

1 8q

1 .00

1 .00

20p

1 .39

0.80

22q

1 .40

3 .08

Chromosome 22q

The original analysis of 6 markers on chromosome 22 indicated that a gene
might reside in a region on chromosome 22q (MLS = 1 .40), and subsequent analysis
using a more dense marker map still resulted in positive lod scores. A literature
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search was undertaken to see if any relevant genes resided in this region. The gene
for Neurofibromatosis 2 (NF2), designated Schwannomin (SCH), was found to be
located in this region on chromosome 22 (22q12.2). A marker known to link to NF2,
D22 S929, was analysed for linkage to autism and the calculation of a MLS of3.0 8
indicates that this gene may be involved in the disorder.
NF2 is a neurocutaneous disorder characterised by tumours within the central
and peripheral nervous system (see section 1.5. 1.2). There are many similarities
between neurofibromatosis and autism. In particular, they are both associated with
brain dysfunction and mental retardation (Gillberg et al. , 1987; Wadsby et al. , 1989).
They both show characteristic impairment of cognitive functioning, displaying a
verbal/language disability (Rutter, 1983 ; Eldridge et al. , 1989). Two genetic studies
have also noted an association of autism with neurofibromatosis. Gillberg and
Forsell ( 1 984 ) reported mild cases of NF l in 3 out of 5 1 (6%) autistic children
collected through a community survey, and Gaffney and Tsai ( 1987) found the
occurrence of both disorders in 2 out of 14 ( 1 5%) autistic children seen in a child
psychiatric clinic over one year. However, a study (Mouridsen et al. , 1992)
comprising 34 1 children with autism and other types of childhood psychoses seen in
two university clinics of child psychiatry in Denmark (Copenhagen and Arrhus)
during a 25-year period found only one case (0 .3%) with both autism and
neurofibromatosis. This sample has a bias of hospital selection with only seriously
affected individuals who required hospitalization included in the study. This bias, as
well as the fact that there was no information about the diagnositic criteria used to
diagnose neurofibromatosis in these subjects, could have resulted in milder cases
being missed·. Due to these published associations and suggestive linkage between
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these two disorders in a sub-group of the analysed families in this study, NF2 should
be considered as a candidate gene in future studies.
Further evidence suggesting that a gene for autism may reside on
chromosome 22 comes from the full genome screen for autism by the IMGSAC
(1998). They calculated a W.,S of 1.39 (59.7% sharing) in a region close to
D22S264 (22q11.2) using all 99 affected sib-pair families. This locus is
approximately 21.ScM centromeric of D22S929. When only the UK families were
analysed, the MLS at this region was 1.36 with 63.7% sharing. Figure 29 shows the
relative positions of these positive findings on the chromosome 22 cytogenetic map.
The results from this study are shown in bold.
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Figure 29: Cytogenetic map of chromosome 22 showing positive linkage results
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To increase the power to detect true positive regions with statistical
parameters that are significant at the genome-wide level, more families (4 5
Australian ASPs) were added to the analysis. With the addition of the 4 1 Australian
families the lod score dropped below the genome-wide significance level to a MLS
of 2.7 (D22S929; 22q 12.2). The highest two-point lod score was calculated at
D22S273 (MLS = 2.47), a marker 6. lcM telomeric of D22S929. It was also noted
that with the addition of these families, the MLS scores for the paternally inherited
alleles were still very positive, with the highest multipoint MLS calculated at
D22S2 80 (MLS = 3.2) and the highest two-point MLS computed at D22 S 1 1 50 (MLS
= 2. 5). The percentage of maternally inherited alleles shared by the siblings,
however, was not greater than that expected by chance. If a gene resides in this
region on chromosome 22, it is most probably paternally derived.
TDT analyses on this chromosome using the combined US.A. (97 ASPs) and
Australian ( 45 ASPs) data showed significant association between D22S 1 1 63 and
autism. This marker is 4.9cM telomeric of D22S929, providing further evidence that
a susceptibility gene may reside in this region.
Multipoint linkage results from a further group of 50 affected US.A. sib
pairs were added to the combined U . S.A. (97 ASPs) and Australian (4 5 ASPs) data
on chromosome 22q. The lod scores in chromosome 22q dropped significantly with
the highest MLS of only 0.37 at D22 S929. The percentage sharing over this region
was still above that expected by chance, therefore a gene of small effect could not be
entirely excluded from the region on chromosome 22q.
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Chromosome lp

Overall, the most significant finding in the present study was on chromosome
1p. In the initial analysis of this region with 90 multiplex families, a MLS of 1. 55
was calculated between markers D 1 S1631 and D 1 S534 (1p 13.3). The lod score at
this locus dropped to 1.21 with the addition of the Australian families ( 45 ASPs).
However, with the addition of 50 affected U. S.A. sib-pairs to the original U. S.A. data
(97 ASPs) already analysed on chromosome 1p, linkage results showed an increase
in MLS to 2.15 with 60% allele sharing between the. siblings (results not shown, see
Risch et al. , 1999 [Appendix 6.3]). Since the lod scores at a region on chromosome
1p stayed positive (MLS � 1.0) with the addition of more markers and the expansion
on the number of families analysed, this suggests that a gene causing susceptibility to
autism may reside in this region.
Preliminary analysis by Bass et al. (1998) on 52 multiplex families also
identified chromosome 1 as a promising region with the calculation of a lod score �
1.0. The exact chromosomal position of this finding was not explained in the Bass et
al. (1998) report, therefore it remains unclear whether the positive region on

chromosome 1 identified in our study overlaps with that found by Bass et al. Our
results on this chromosome are shown diagrammatically on Figure 30.
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Figure 30: Cytogenetic map of chromosome 1 showing positive linkage results from the

present study

Possible candidate genes in the 1p region, expressed in the brain, include
glutathione-S-transferase 3 (GSTM3) and adenosine receptor A3 (ADORA3). The
adenosine receptor is of particular interest, since these receptors have been utilised as
targets for the development of clinically viable drugs against ischaemic brain
disorders. A gene for Waardenburg syndrome type II (WS2B) has also been mapped
to this region ( l p l 3.3) (Lalwani et al. , 1994). This neurocutaneous disorder is
characterised by deafness with pigmentary abnormalities, and, like autism, it is
associated with mental retardation (Fujimoto et al. , 1998).
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4.1.1.2 Excluded Regions
Results from this PhD study can exclude an average of94% of chromosomes
1 5 , 1 9, 20 and 2 1 from containing a gene of large effect on susceptibility to autistic
disorder. Genes of moderate effect can also be excluded from residing in 65% of
these chromosomes. A gene of moderate to large effect on autism was also excluded
in the HLA region of chromosome 6 (see section 4. 1.2) and large parts of 17q and
1 Oq. However, a gene of moderate to large effect on autism could not be excluded
from possibly residing on chromosomes lp, 7q, 1 8q or 22q.
Combining the results of the entire genome scan (Risch et al., 1 999), we were
able to exclude approximately 95% of the genome for a value 001,s = 3.0, using the
strict exclusion criterion of -2 (Hauser et al., 1996). Using a less strict exclusion
criterion of - 1 , 99% of the genome could be excluded for genes of moderate to large
effect. Figure 3 1 shows the diagrams of regions from other studies that may contain
a gene involved in the aetiology of autism, with our results in the same region shown
in bold. It can be seen from these diagrams that our results exclude chromosome 4p,
6, l5q, 1 6, l9p and Xq from containing an autism-causing gene. However, regions
on chromosomes 7q, 9q, lOq, 1 1 p, 17, 22q previously showing suggestive evidence
could not be formally excluded in this study and should be investigated further as
possible candidate regions for predisposing loci.
Chromosome 7q is of particular interest as a site of susceptibility loci in
autism, due to the significant lod score (MLS = 3.55) obtained in this region in the
IMGSAC ( 1 999) study (see section 1.8.5.9). This chromosome was also examined
in detail by Pericak-Vance et al. ( 1998). They examined 7q in 65 multiplex families
using sib-pafr analysis (SIBPAL), and identified 5 markers showing suggestive
evidence of linkage (p < 0.05), with their most significant result at D7S2527 (p =
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Figure 3 1 : Cytogenetic maps of chromosomal regions showing MLS� 1 (The results of the
present study are shown in bold)
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0.002). A maximum lod score of 1.21 was found at D7S487. A chromosomal
abnormality has also been identified on chromosome 7 that overlaps the potential
linkage region identified by IMGSAC (1998). A family with two male siblings who
have autism (as diagnosed using the ADI), and a female sibling with significant
developmental delays and expressive language disorder, each have an identical
paracentric inversion (Inv (7) (q22q3 l. 2)).

4.1.2

Candidate Regions

The HLA and I Sq 11-q13 regions were considered as possible candidates for
containing a gene(s) involved in the aetiology of autism, due to the positive
association being found in other studies (see section 1.8.5). The results from our
analysis of these regions have recently been published in relevant journals (see
Appendix 6.3).
Linkage results from the analysis of the HLA region on chromosome 6 in 90
U. S.A. sib-pair families demonstrated that a large to moderate gene effect could be
excluded for 100% of this region (see section 3. 1.3; Rogers et al. , 1999). With the
addition of 49 multiplex U. S.A. sibships, the data in this region remained negative
(Risch et al., 1999). A gene of small effect (As '.::'.: 2), however, could not be excluded
from this region. Similarly, TDT analysis did not produce any positive findings (see
Rogers et al. , 1999; Appendix 6.3). These results do not entirely exclude a possible
association between autism and the HLA region. However, if an association does
exist, it must be weak.
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The reported immunological abnormalities found in autistic children (Warren
et al. , 1 986; Stubbs and Crawford, 1977; Weizman et al. , 1982; Singh et al. , 1 993;
Plioply et al. , 1994 ) are unlikely to be related to susceptibility genes in the HLA
region. The immune system is connected to the brain in an integrated regulatory
circuit, which is only slowly beginning to be understood. One of the integral organs
in this network is the hypothalamus, which also plays an important role in cognitive
and emotional processes. An altered immune response during early childhood might
produce changes in brain development. Although it appears that genes in the HLA
region have little or no effect on this process, the possibility that genes of
immunological interest other than HLA might be involved in the pathophysiology of
autism has not been excluded.
A paper describing the results of the analysis of 5 markers in the proximal
region of chromosome l 5q in 90 multiplex U.S.A. families has been published in the
U.S.A. Journal of Medical Genetics (Salmon et al. , 1999; see Appendix 6.3 ). These
results exclude this region for the presence of a susceptibility gene of strong or
moderate effect (As > 2) on autism. Allele-sharing results at marker D1 5S156
(maximum lod score of 2.5 detected by Pericak-Vance et al. ( 1997) in this region)
was slightly increased in our data (57%), however other nearby markers which were
more informative (eg. D l 5S822) showed a decrease in sharing (4 8%). The
multipoint results across this entire region show no significant increase in sharing
( 5 1 %). The International Autism Consortium ( 1998) also scanned chromosome l 5 q
in 39 multiplex families and found n o evidence o f a major susceptibility gene for
autism, consistent with the results presented here.
The GABRB3 locus revealed linkage disequilibrium in the sample of autistic
individuals studied by Cook et al. ( 1 998; TDT 28.63 , p = 0.001 4 ). A marker within
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this locus (GABRB3CA) was tested in our families for association with autistic
disorder. We found no evidence of linkage disequilibrium with GABRB3CA. This
marker is 250kB distal from the microsatellite (GABRB3 I 55CA-2) at which Cook

et al. (1998) found suggestive evidence of linkage disequilibrium, therefore the two
markers may not be in linkage disequilibrium. An association study by Menold et al.
( 1998) also attempted to replicate the Cook et al. (1998) findings. Using 147 autistic
families, they failed to detect significant linkage disequilibrium between autism and
the GABRB3 155CA-2 marker. A study by Pericak-Vance et al. (1997), however,
obtained a lod score of 1. 4 at the GABRB3 locus when analysing 38 sib-pairs and 9
cousin pairs. Their peak lod score, assuming an autosomal recessive model, was 2. 5
for the microsatellite marker D l5S 156, which is located approximately 5cM distal to
the GABRB3 locus. When non-parametric linkage analysis was employed using the
affected sib-pair analysis, the lod score dropped to a MLS of 1. 1.
Our results clearly indicate that, for the majority of affected sib-pairs, there is
no major autism gene in the 15q l l-q l 3 region. Nonetheless, chromosome 15, in
particular l5q 11-q 13, must still be viewed as an area of interest, given the number of
reports showing association between autism and cytogenetic abnormalities in this
region.

4.2

Replication Studies

For linkage results to be credible, they must be replicated. Failure to replicate
some of the positive results in one study does not necessarily disprove a hypothesis,
since genes may have small effects on the disorder, which may turn out to be smaller
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in a second study if the sample collected selects against this gene. Thus positive
results may be replicated in some studies and not in others. To assess whether the
overall evidence for linkage is convincing, a meta-analysis of all studies may be
necessary. Table 3 1 lists those regions where other studies have suggested a gene
may reside, but which were not confi r med in this study.

Table 3 1 : Susceptibility Loci Not Replicated in this Genome Scan
Chromosome (Locus)

Cytogenetic Position

4 (D4S4 l 2)

p l 6.3

IMGSAC ( 1 998)

6 (HLA-DRB l )

p2 1 .3

Warren et al. ( 1 996a)

6 (D6S283)

q2 1 -23

Phil ippe et al. ( 1 999)

1 5 (GABRB3 locus)

q 1 1 .2-q 1 2

15 (D 1 5 S 1 56)

q 1 1 -q l 2

Pericak-Vance et al.. ( 1 997)

1 5 (D 1 5 S l 1 8)

q l 4-q2 1

Philippe et al. ( 1 999)

1 6 (haploglobin)

q22.2

Spence et al. ( 1 985)

19 (D 1 9S226)

p l3.3

Philippe e t al. ( 1 999)

19 (D 1 9S49)

p13.1

IMGSAC ( 1 999)

X (DXS424)

q24-q26

Publication

Cook et al. ( 1 998)

Hallmayer et al. ( 1 996)

There could be several reasons why we did not replicate the positive results
reported by IMGSAC ( 1 998), Philippe et al. ( 1 999) and other studies. These
include: false negative results due to a smaller sample size than required to replicate
studies, false positive results in the initial study, genetic heterogeneity between data
sets within or between studies, and differences in the diagnostic criteria used in these
studies. These points are discussed below.
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The accurate replication of previous results requires a very large sample of
families. Suarez et al. ( 1994) demonstrated that the number of families required to
reliably replicate linkage in a polygenic disease is approximately n(k-1), where n is
the number of sib-pairs that were needed to demonstrate the initial linkage and k is
the putative number of susceptibility genes. This is the case in autism where it is
generally accepted that multiple genes are involved in the aetiology. Multiple loci
that interact to increase disease risk are difficult to detect, since each parent may
carry several susceptibility alleles and multiple, distinct combinations of these alleles
might contribute to disease in different children and in different pedigrees. Thus, for
any one locus, the pattern of allele sharing among affected relatives is variable and
complex. With smaller samples, statistical support for linkage will vary because of
random (stochastic) variation in the proportion of families in whom disease is
associated with inheritance of a particular parental susceptibility allele· (Suarez et al. ,
1994). Therefore some samples will produce significant lod scores in the
chromosomal regions containing such genes and other samples will produce weakly
positive or negative scores in the same region. Scores in the same range may also be
observed by chance in regions that do and do not contain disease genes, making true
and false positive results difficult to distinguish statistically.
The type 1 error rate could also have been higher in the initial study (ie. the

IMGSAC [1998] study). The appearance of positive linkage results in the original
study could be due to reasons such as the use of multiple testing in the analysis
(Clerget-Darpoux et al., 1990). The presence of false positives in the IMGSAC
(1998) and Philippe et al. ( 1999) studies could be a reason why these results were not
found in ou( genome scan.
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The failure of replication between these studies could also be due to the
different populations utilised in the analysis. The failure of replication between
populations can be explained by inter-ethnic genetic heterogeneity, in which
predisposing genotypes and their interaction with the surrounding environment may
vary between populations (Risch and Botstein, 1996).

4.3

The Genetics of Autism - An Overview of Findings to Date

This study was designed under the assumption of an oligogenic model of
inheritance, with 2 to 6 susceptibility loci involved in the aetiology of autism. The
detailed and comprehensively defined nature of this project should have led to the
detection of these loci if our hypothesis was true. The results from the study show
that our hypothesis is most unlikely and they do not support the assumption of a
small number of loci (see Risch et al. , 1999).
Using the results from our genome scan, a statistical analysis was performed
assuming a multiplicative epistatic model of inheritance to determine the number of
loci most probably involved in this disorder (Risch et al. , 1999). The data most
closely approximate the expectations for a model with 20 susceptibility loci, with
models involving :::;10 loci unlikely and those with �15 more plausible. These results
are consistent with the observed recurrence risks between siblings and twins. The
very high (25-fold) MZ:DZ concordance ratio is also indicative of the involvement
of multiple interacting loci. Our results also show that whilst a multilocus
inheritance model does not preclude the possibility of one or a few loci with larger
effects, these effects can not be too large given the non significant linkage results that
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were found. Our genome scan therefore reveals that the inheritance pattern for
autism is multigenic, with :?: 1 5 susceptibility loci, each with a small effect on disease
risk (As < 2), most probably involved in the aetiology. These results go against the
Pickles et al. ( 1 995) model for autism which suggested that 3 interactive loci were
involved in the aetiology of autism, with a range of2- 1 0 loci probable (see section
1. 7). The results of Pickles et al. ( 199 5) were based on probands with a broad
autistic phenotype, whereas our findings were based on individuals with a "core"
diagnosis of autism.
No chromosomal region with significant evidence of linkage (MLS>3) was
identified in the present study, however the possibility of one or more susceptibility
loci of moderate effect on the disorder could not be excluded. On the basis of our
results, the most likely location for such a locus or loci is on chromosomes 1 p and
22q. Our results could also not exclude chromosomes 7q, 9q, 1 Oq, 1 1 p and 17,
regions previously suggested by other studies to contain disease-predisposing loci.
Whilst none of these regions show linkage results above the genome-wide level of
significance, the calculated lod scores are above 1 and therefore the regions should
be considered in future studies as candidates for further analysis. Figure 32 shows
those regions most likely to contain autism-predisposing loci, with our results shown
in bold.
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Figure 3 2: Cytogenetic maps of chromosomal regions most likely to contain suscP,J)tibility
loci for autism

Chromosome 1
36.3

Chromosome 7
22

36. 1
34.3

1 5.3
1 5. 1

32.3

13

3 1 .2
22.3
22. 1

1 1.2

1 3. 1
11
12
21.l
2 1 .3

I D 1 S l63 l

Risch et al. (1999)

1 1.2
1 1.3
21.2
22

23

3 1. 2

25

32
34

32. 1
32.3

36

42. 1
42.3
44

Chromosome 9

D7S487

D7S530
D7S684

Pericak-Vance et al. ( 1998)
[MLS

1 .2 1)

IMGSAC ( 1998)

[MLS = 2.53 (3.55))

Risch et al. (1999)

(MLS (D7S684) = 0.64)

Chromosome 1 0

24
22

15. 1

13

13

1 2. 2
1 1.2

12

1 1.2

2 1 .2

2 1 .2

22. 1

22. 1

22.3

22.3
23.2
24. 1
24.3
25.2
26. 1
26.3

32
34. 1
34.3

D9Sl74

ABO blood
group

Risch et al. (1999)
[MLS = 0.8)

Spence et al. ( 1985)

[MLS = 1.54]

Risch et al. (1999)
[MLS = OJ

j DlOS197
I Dl0S606

IMGSAC ( 1998)
[MLS = 1 .36 (0.69) )

Risch et al. (1999)
[MLS = OJ

Risch et al. (1999)
(MLS = 0.76)

Chromosome 1 7

Chromosome 1 1
1 5.5
1 5.3
1 5. 1
13
1 1.2

c-Harver-ras
gene

j D 1 1S2364

Herault et al. ( 1 994 ),
Herault et al. ( 1 995),
Comings et al. ( 1 996)

Risch et al. (1999)
[MLS = O)

Risch et al. (1999)
[MLS = 0.9)

13. 1
13.3
13.5
14.2
21
22.2
23. 1
23.3

1 1 .2

Dl 7S849

1 1 .2
21.1

5-HTTLPR;
serotonin

2 1 .3
23
25

25

Chromosome 22

1 1.2
12.2
13. 1
13.3

13

D22S264

D22S929

IMGSAC ( 1 998)
[MLS = 1 .39 ( 1.36))

Risch et al. (1999) [MLS = 0.371
us Fam's [MLS = 3.081

Aust. + us Fam's [MLS = 2.7)

Risch et al. (1999)
[MLS = O)

Cook et al. ( 1 998)
[TDT x2 = 4.691
Risch et al. (1999)
[MLS = OJ

4.4

Reliability of Results

The genome scan conducted by the Stanford and Perth groups was designed
to maximise the chance of detecting a gene of moderate to large effect on
susceptibility to autism. The important features of the study design include: (a) a
statistical method that reduced ascertainment bias; (b) collection of a homogeneous
set of families; (c) a map of highly polymorphic markers; (d) use of positive controls
throughout the genotyping; and (e) a robust, multipoint model-free method of
analysis. Problems do exist, however, with the current linkage maps and the
statistical programme used. Whilst the concept and design of this project provide
confidence in the validity of our conclusions, these problems should still be
considered. The design of this study and the problems that exist are discussed below.

4.4.1

Ascertainment

Historically, it has been assumed that the mode of ascertainment used in
obtaining data for linkage studies does not have any effect on the results, provided
that individuals were sampled on the basis of trait data and not marker genotypes
(Cox Matise et al. , 1996). However, studies by Vieland and Hodge ( 1 995, 1 996)
have shown the effect of ascertainment on maximum likelihood estimates of genetic
parameters. These authors claim that the most commonly used ascertainment
schemes for linkage studies (non-single ascertainment and proband-dependent
sampling, in· which the observed pedigree structure depends upon who the probands
were) result in asymptotically biased estimates of genetic parameters, for example
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the recombination fraction. Although this bias is small in many situations, the
calculated maximum likelihood based on the observed data can not be corrected to
accommodate the bias. This project was designed to avoid the bias effect shown by
Vieland and Hodge ( 1 995, 1996), by utilising a statistical method that did not require
the estimation of genetic parameters.
The ethnic origin of the families used could have affected the detection of
significant linkage in this study. By restricting the study to individuals likely to be
descended from a small founding population, a group of related individuals with a
reduced number of genetic and allelic contributions. to the disease can be identified.
A homogeneous group of strictly defined affected subjects should maximise the
chances of detecting linkage for any plausible genetic model (Risch et al. , 1 999).
Our sample contained 88% Caucasian, 5% African or African-U.S.A., 3% Hispanic,
and 4 % Asian in the U.S.A. sample of families. In the Australian group, the families
were primarily Caucasian. Although the majority of subjects included in the genome
scan were Caucasian in origin, they can not be classified as a homogeneous
population since they are of varied European and Middle Eastern background.
An example of a relatively homogeneous population isolate would be
families in the Botnia region of western Finland. This isolated population contains
Swedish-speaking inhabitants surrounded by a larger Finnish-speaking population,
and was believed to have been settled over 1 ,000 years ago, with little immigration
until at least the middle of the 14 th century (Virtaranta-Knowles et al. , 199 1 ). This
population has been used in search for inherited diseases including non-insulin
dependent diabetes mellitus (NIDDM; Mahtani et al. , 1996) and diastrophic
dysplasia (DTD; Hastbacka et al., 1992).
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How the families are grouped together in the analysis also has an effect on
the power of the overall study. Whilst it is generally accepted that an individual
must inherit more than one gene in order to express the autism phenotype (see
section 4.3), there are multiple ways in which these genes could interact to produce
the phenotype. For example, the same genes could act together in every instance or
they could work together in different combinations to cause autism. In the later
scenario, there may be considerable variation from family to family with respect to
which genes the affected individual has inherited. Another possibility is that a
certain number of ' core' genes are required for autism, with several other genes
influencing the severity or the expression of the phenotype. This could explain why
the severity of autism varies widely from one affected individual to another. It could
also explain the variance within families, where two siblings with autism may have
significantly different language and cognitive abilities, while their parents or other
siblings may have only social constraints or a preference for routines. How the genes
interact is important in the analysis of the families. If individuals with different
causative genes are grouped together, the overall power to detect one or more of
these susceptibility loci is reduced, especially if the loci have a small effect on the
disorder (As :S: 2).

4.4.2

Diagnostic Criteria

Subject misclassification has been proven to affect genetic linkage analysis
(Ott, 1991). Problems of phenotypic definition and diagnostic accuracy are
particularly important in genetic studies of psychiatric disorders. For this reason, this
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study adopted a conservative approach to phenotyping. Good inter-rater reliability
was observed for the first 44 multiplex families. The kappa coefficient between our
evaluators for autistic vs. non-autistic groups was 0.90. Both ADI and ADOS were
used to evaluate the children and any questionable cases were excluded from the
study. A total of 4 5 families were excluded from further analysis. One reason for
exclusion of some families was that the second affected sibling did not have a strict
diagnosis of autism by agreement of all diagnosticians.
Another reason for the exclusion of a family was low mental age or extremely
low IQ scores observed in all affected children. This approach was adopted to avoid
the difficulty in diagnosing autism in the very young or in profoundly retarded
children. It also helped to reduce potential heterogeneity in the sample. Families
with more than one child with both autism and low IQ scores may have distinct
aetiologies related to their severe to profound mental retardation. However, one
could also argue that, by excluding these families, which could represent the more
severe forms of autism caused by genes with a larger effect, the ability to detect
susceptibility genes is reduced.
The stringency of the design means that the families in this study included no
broadly-defined, questionable, or mild cases (eg. clinical diagnoses of PDD-NOS or
Asperger's Syndrome). This was done in order to enhance the chance of detecting
linkage by creating a more homogeneous set of families, as well as to gain
confidence that any false negative or false positive results obtained would not be due
to using too broad a diagnostic spectrum whose genetic basis is still uncertain. As
stated previously, a homogeneous group of strictly defined affected subjects should
maximise the chances of detecting linkage for any plausible genetic model (Risch et

al. , 1 999). However, some investigators argue strongly for the inclusion of "mild" or
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autism "spectrum" cases in genetic studies, which would increase the number of
families in the analysis, and in turn the number of informative meioses. However,
including individuals with a mild or less strict diagnosis of autism in the analysis,
while increasing the power of the study, may also increase the probability of false
positive results. The present study was designed to establish a balance between the
power to accurately discover true linkage results and the rate of false positive
findings.

4.4.3 Linkage Maps

In the design of this type of project, problems with current linkage maps and
the distances between microsatellites could limit the detection of genes of moderate
to large effect on a disorder. The average spacing between the autosomal markers
analysed in stage one of this study was 10cM, assuming a sex-averaged total
autosomal map length of 3500cM. Spacing of 20cM has been shown to be more
efficient than either a 10 or 40cM in the context of screening for a simple dominant
trait using affected relative pairs (Brown, Gorin, and Weeks, 1994). However, for a
complex disease, a map density with a mean separation of 10-20cM probably gives
the optimal balance between "effort" and power (Hauser et al. , 1996). Morton
(1996) also found that it is preferable to increase sample size rather than marker
density, since applying ever more dense sets of markers to the same cohort of
families does not help to narrow potential domains. The effects of increasing marker
map density liave been explored by other studies, both theoretical (Hauser et al. ,
1996; Holmans and Craddock, 1997; Chataway et al., 1998) and experimental
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(Davies et al. , 1996). Using computer simulations, Hauser et al. ( 1996) showed that
the most efficient way to type sibling pairs was with a 10-20cM map, with
subsequent follow-up of regions of interest. This two stage method was employed in
our study.
The design minimises the chance of a missed linkage within the interval
between flanking markers. Similarly, a linkage study of diabetes showed that
saturation mapping of the 6q region increased the MLS from 2.2 to only 2.4 for a
change in marker density from 8 to 2. 5cM (Davies et al., 1994). Simulations by our
group on 100 families have also shown that, by increasing the map density from
10cM to 5cM, you can only expect to exclude an additional 5% (87% to 92%) of the
genome for susceptibility loci of As = 2 (see Table 7). When 200 families are
analysed, increasing the map density from 1OcM to 5cM has a minor effect (99% to
99%) on the proportion of the genome that you could expect to exclude. Hauser et

al. (1996) stated that, unless the actual sibling population was dramatically
expanded, a dividend from the effort involved in typing more markers over a region
of interest was unlikely to be obtained. They recommended using singletons with
parents and additional affected siblings, when possible, for transmission
disequilibrium testing.
Errors in the order and distances between markers on a linkage map affect the
probability of detecting linkage. Accurate construction of meiotic maps requires the
use of correct data in the analysis (Buetow, 1991). In the database used to construct
the CEPH consortium map of chromosome 1, errors occurred at a rate of 0.6% for
genotypes at the same locus, even after extensive data checking by individual
laboratories. In version 4 of the CEPH data for chromosome 4, errors were detected
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at a rate of 1.4% for genotypes at the same locus produced by different laboratories
(23/817 discordant pairs).
Since more genotypes are necessary for the construction of high-resolution
maps, the opportunities for the above mentioned primary errors increase. A typing
error that negates a true recombination event or introduces false recombination
events could have a large effect on a meiotic map by substantially reducing the
accuracy of the resolved map order (Buetow, 1991). Since it is unlikely that even the
most rigorous laboratory quality-control procedures wilI be successful in eliminating
all erroneous observations from a data set, high-resolution linkage maps should be
used with caution. However it should also be noted that studies by Hauser et al.
(1996) have shown that multipoint analysis is robust to errors in the map distance
between the flanking markers, except when the errors are extreme.
Another problem of current linkage maps is the lack of microsatellite markers
near the telomeric and the centromeric regions of chromosomes (Wintero et al. ,
1992). Whilst minisatellites or variable number of tandem repeat (VNTR)
polymorphisms are preferentially clustered at the telomeric regions of chromosomes
(Royle et al. , 1988) or localised near the centromeres (Willard et al. , 1986),
microsatellites are mainly distributed throughout the chromosomal arms. To ensure
that resolution is sufficiently high to be of use in the identification of polygenic
disorders, VNTRs are very important in the finalisation of a genetic map.
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4.4.4 Reliability of Genotyping

Errors in genetic linkage data can occur because of errors in the pedigrees or
during genotyping. A pedigree error usually involves misidentification of
individuals and relationships (Ott, 1 99 1 ), for example nonpatemity, unidentified
adoption, and sample mix-ups. Typing errors include the misinterpretation of
genotypes and data-entry errors (Buetow, 199 1 ). Pedigree errors were minimised in
this study since the parents were included in the analysis, allowing Mendelian
segregation to be checked in all families.
A number of controls were employed in our analysis to identify potential
typing errors (see section 3. 1. 1 ). The error rate was found to be 1.0% for the entire
genome scan and 1.2% for those genotypes analysed as part of this PhD project.
This result is comparable to other studies, such as the Levinson et al. ( 1 998)
schizophrenia genome scan which found results concordant in over 99% of subjects,
and the Lathrop et al. ( 1 983 ) study that estimated a typing error frequency of 1 % in
data obtained from a population study in the south Pacific island, Tokelau. The
estimated reliability of these results should provide confidence in their validity.

4.4.5

ASPEX Programme

Another factor that may have an effect on the reliability of our data is the
statistical programme utilised. The computer package used throughout this genome
scan was the identity-by-descent (IBD) programme of the ASPEX package. This
programme uses only unambiguous IBD sharing to compute a multipoint lod score
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(maximised over As), as well as an exclusion map along each chromosome. Whilst
our analysis of marker DXYS 154 located in the pseudoautosomal regions showed the
programme to be sufficiently sensitive to detect a significant excess in sharing, when
present (see section 3.1.1), there are a few shortcomings with the package that should
be noted. Firstly, the number of parents typed per family affects the detection of
linkage using the ASPEX-IBD programme. A study by Davis and Weeks (1997)
comparing 23 different statistics from a total of 10 popular software packages for
model-free linkage, found that when only one parent was typed in a family structure
including only two affected siblings, the power to detect linkage dropped by over
fifty percent (Figure 33a). When other siblings were included in the analysis, the
parental genotypes could be reconstructed and the loss of power was lower (Figure
33b). In this genome scan, 23 out of the 90 U. S.A. autism families had only one
parent available for typing. Fifteen of these families had no unaffected siblings that
could be used to reconstruct the parental genotypes. In the other 8 families, the
majority (six) had only 1 unaffected sibling, which was not always adequate to
reconstruct the parental genotypes.
Secondly, the false positive rate for the ASPEX programme generally
exceeds the nominal significance level of 0.05 (Figure 34 a and b). In the above
mentioned study, Davis and Weeks (1997) found that the highest false positive rates
in the ASPEX.IBD programme occurred when a family structure that included four
siblings (at least two of which were affected) and one typed parent (at2. lunt) was
used. Therefore, although the power to detect linkage was lower in families with
only 2 affected siblings and one parent typed, the rate of false positive results was
less using this family structure.
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Davis and Weeks (1997) concluded in their study that the most powerful
statistic for affected sibling linkage methods was SIB-PAL sage.asp. This statistic
was reasonably powerful for all situations tested in the study, and they agreed with
others who suggested that the ti test implemented in sage-asp is powerful and
theoretically sound (Blackwelder and Elston, 1985; Knapp et al. , 1994).
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4.5

Implications for Future Studies of the Genetics of Autism

In light of our conclusions that autism is caused by multiple genes, each with
a small effect on the disorder, other study designs and methods of detection may
need to be utilised to detect these genes. In a recent perspective, Risch and
Merikangas ( 1 996) and Camp ( 1997) demonstrated that linkage analysis was likely
to be successful only for loci with As values in the range of 4 or larger, but not for
loci with As values of two or less. Detection of these small genetic effects using sib
pair analysis could require larger samples than are currently available to any
independent research group, perhaps 5 00- 1 OOO pedigrees (Hauser et al. , 1996;
Kruglyak and Lander, 1995). This may be achieved if researchers pool their samples
and data through large multicentre and multidisciplinary projects. A simultaneous
evaluation of all available data with unified methods of analysis (same diagnostic
techniques, markers and statistical analyses) may help to eliminate some genetic
models for this disease, as well as define the most promising chromosomal regions
for follow-up.
Other methods exist that may also assist in the detection of susceptibility
genes in autism. Examples include: using an alternative phenotype than the disease
itself, examining family structures other than affected sib-pairs and their parents,
analysing candidate genes within regions showing susceptibility to autism and/or
scanning the entire genome for association of single nucleotide polymorphisms
(SNPs) to disease loci. The positive linkage results found by genome scans using
sib-pair analysis could be used as candidate regions in these future analyses.
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4.5.1

Refining the Phenotype Definition

By choosing a single trait within the illness as the target of genetic research,
especially one that is principally accounted for by the effect of a major gene, the
deficit should approximate a classical Mendelian pattern of segregation in families
and increase the power to detect linkage. This strategy has not been widely exploited
in psychiatric research (Freedman et al. , 1999). Since autism may result from
different influences, some of them genetic and others environmental, each of the
genetic traits should have its own biological phenotype that contributes to the
pathogenesis of the illness. If this phenotype can be recognised independently from
the full clinical syndrome, then the genes underlying the phenotype could be easier to
detect and give a clearer understanding of the genetic, neurobiological, and
neuropsychological basis of autism and related disorders.
This principle is illustrated by the study of families affected with
haemochromatosis. Certain individuals were noted to have increased serum ferritin
levels, and it was established that these serum levels were related to the presence of
the major gene responsible for the illness (Borecki et al. , 1990). A few gene carriers
had haemochromatosis, whereas many other gene carriers had only elevated serum
ferritin levels. If a similar measurement were available for autism, then its presence
could be used as an alternative phenotype for the illness itself.
There are several potential advantages to such alternative phenotypes.
Firstly, they greatly increase the power of genetic analysis, because they allow
consideration of all members of the study. For autism there are no diagnostic criteria
for parents and no clear cut way of establishing whether parents and siblings affected
by milder subclinical forms of the disorder are unaffected or have a different degree
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of the same condition. In the present statistical models, these family members are
considered unknown, compromising the chance of determining the location of
abnormal alleles by linkage. By using an alternative phenotype all abnormal
members of the pedigree could be identified, increasing the amount of data derived
from the pedigree. It has been estimated that hundreds of sib-pair families are
needed for sufficient power to find genes related to autism, however if a sub
phenotype definition with, for example, an autosomal dominant inheritance is found,
linkage could be detected in as few as 20 families (Freedman et al. , 1999).
Secondly, possible biological differences between autistic probands could be
detected. If different groups of patients had entirely different genetic predispositions
but showed the same clinical phenotype, an alternative phenotype could discriminate
between the two groups and select for a biologically more homogeneous set of
patients, thus increasing the overall probability of detecting linkage.
One such alternative phenotype in autism could be cognitive impairment.
Family studies have shown that the relatives of people with autism are affected by
milder subclinical forms of the disorder, with a particularly high rate of cognitive
deficits (see section 1.5.2.3). There are four cognitive processes known to be
impaired in autism. These include theory of mind, executive function, central
coherence, and structural language skills. By examining the patterns of segregation
of these deficits in families, DNA markers may be found that link to these
impairments. Identifying the genetic basis of these cognitive deficits would greatly
assist in the early detection of children in high-risk families, so that early remediation
programmes could be implemented. Alternative phenotypes could also provide a
clearer understanding of the genetic and neurological basis of autism.
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4.5.2

Alternative Family Structures

4.5.2.1 Cousin Pairs

Affected relative pairs that are more distantly related, for example cousins,
contain more information on linkage than affected sib pairs if the susceptibility allele
is rare (Badner et al. , 1998). This is because more distant relatives share fewer
genes/markers (::s;25%) by chance than sibling pairs (50%), and those they do share
that are identical by descent (IBD) are likely to be linked to the susceptibility locus.
Also, since the power to detect genetic linkage is dependent on both the relationship
of the affected pair and the number of pairs in the sample, the number of families
needed to achieve the same power as the sib-pair approach is significantly smaller
(Teng and Siegmund, 1997).
This approach would be useful in eliminating some of the irrelevant loci
located using the sib-pair approach. Unfortunately, since cousin-pairs are quite
uncommon, it is unlikely that enough cousin-pair families could be collected to
provide sufficient power to detect susceptibility loci in a whole genome scan. What
must be kept in mind is the fact that any gene located through this method is
generally going to be a single gene with a large effect, since cousins have only a
slight chance of sharing all of the genes that may be needed to cause this disorder.

4.5.2.2 Pairs Discordant for Disease

If we assume that the genes contributing to autism have some detectable
behavioural manifestation, such as cognitive function (see section 4. 5.1), siblings
extremely discordant for a specific trait may be used as another appro_ach to eliminate
false positive linkage results detected using the sib-pair method. Discordant sib-pairs
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are used to detect loci by assuming that allele sharing between these siblings will be
significantly less than expected by chance (as opposed to linkage, which assumes the
opposite). A discordant sib-pair is chosen by selecting an unaffected sibling who has
no identifiable autistic-like social or cognitive traits, and an autistic individual from
the same sibship. For such extremely discordant sib-pairs, the chromosomal regions
of reduced allele sharing would likely contain the genes that cause autism.
The number of sib-pairs required for this method is far fewer then those
needed in methods that rely on pairs concordant for the phenotype (ASP method).
Risch and Zhang (1995) have shown that a sample size I 0- to 40-fold smaller would
be sufficient. This approach has also been shown to be the only method that is
uniformly powerful regardless of how the disorder is inherited (with the exception of
rare recessives), whether genes are common or rare in the population, and whether
there are multiple genes or only one (Folstein et al. , 1998).
However, there are some limitations to this approach. Firstly, it was
suggested by Folstein et al. (1998) that only approximately 35% of siblings are
expected to have none of the traits that signal the presence of an autism gene, so
many families will need to be screened to obtain a large enough sample size of
discordant pairs. Secondly, there may not presently be adequate methods to detect
all of the traits and behaviours resulting from genes that contribute to the autism
phenotype. For example, some contributing genes may have no behavioural
manifestations at all. Therefore, distinguishing between individuals who are
concordant or discordant for a trait is not clear-cut in the majority of cases. Unless
quantitative trait loci (QTL) can be identified for autism and the extreme phenotypes
can be accurately identified, this procedure has limited applications for use in
identifying the genes that cause autism.
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4.5.2.3 Extended Families

Another alternative family structure includes families with multiple affected
individuals. The proportion of extended families with several affected individuals is
small for autism. For those that do exist (see Figure 35), autism will generally be
caused by one gene. If traditional genetic linkage methods were to be used to
identify the causative genes, autism research groups from around the world would
have to collaborative to obtain a sufficient number of such families. A new approach
has been developed that requires only a few affected individuals from a single
extended family to identify susceptibility loci. This approach is called "shared
segment analysis" and involves the pooling of DNA from all the affected individuals
followed by a search for segments with reduced diversity, ie. where the same marker
alleles are shared by the pooled samples (Sheffield et al. , 1997). This approach,
however, has only been used successfully in locating genes for rare recessive
disorders, and as yet has not been used with multigenic diseases.

Figure 35: Autistic family with multiple affected individuals
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4.5.3 Association Studies

Linkage analysis carries an advantage over association studies in that it
extends over greater genetic distances and may therefore be detected using fewer
markers. However, association has the advantage that it is considerably more
powerful than linkage for genes with a small genetic influence (As < 2) and therefore
requires smaller study populations (Table 32). This is especially the case if there is a
marker extremely close to or within the disease locus, and if polymorphisms of
functional significance are used (Spielman et al. , 1993). For example, Risch and
Merikangas (1996) showed that in a genome-wide association study using the
transmission-disequilibrium test, 695 parent-child trios provide 80% power to detect
an allele with a population frequency of 0 . 1 , assuming that it confers a two-fold
increase in disease risk in the heterozygous state (compared to homozygosity for the
more common allele). This compares with a requirement of 5382 affected sib pairs
for a model-independent linkage study (Table 32). Since trios are easier to ascertain,
this difference is enormous.

Table 32: Comparison of Number of Sib-Pairs Required fo r Linkage vs. Association
Studies.
Genotype relative
risk (GRR)
4

2
1 .5

Population
Frequency of
m utation (p)
0.01

Linkage
(sib-pairs)

TDT
(trios)

4260

1 098

0.1

1 85

150

0.01

296,7 1 0

5 823

0. 1

5 3 82

695

0.01

4,620,807

1 9,320

0. 1

67, 8 1 6

22 1 8
(Risch and Merikangas, 1 996)
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In autism, genetic studies have been carried out using linkage analysis with
no single major locus being found. The suggestions that the genetic basis of the
disease is controlled by a number of loci of modest effect indicate that genome-wide
scans for linkage will probably be ineffectual. Other approaches, such as the
candidate gene approach and/or genome-wide association studies, may be required to
detect these susceptibility loci.

4.5.3. 1 Candidate Gene Approach
Once a candidate region has been defined and then replicated by another
research group, the candidate gene approach could be used to search for sequence
variants. The choice of gene(s) that are most likely involved in the predisposition to
the disorder among the many genes mapped in that interval (there could be up to
several hundred), is based on their hypothetical function, expression pattern and so
forth. In the case of autism these genes could be selected on the basis of known or
expected role in brain development. More than 30,000 human genes, or Expressed
Sequence Tags (ESTs), have been placed relative to a framework map as part of the
Human Genome Project (HGP). These maps are very important for the successful
identification of susceptibility genes for complex disorders. However, finding the
DNA sequence variation that confers risk for a complex disorder, such as autism,
will be more complicated than identifying the mutation responsible for a single gene
disorder.
Chromosomal rearrangements or null mutations that abolish the function of a
protein are unlikely to be found in complex disorders. More subtle sequence
variations, such as amino acid substitutions producing a different protein isoform,
can be fairly common in the general population and are more likely to represent the
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susceptibility alleles in complex disorders. One such allelic sequence variation has
been identified to cause susceptibility to the psychiatric disorder Alzheimer disease.
This allelic sequence variation is in the apolipoprotein E (APOE) gene, and is
referred to as the APOE-E4 allele. Different dosages of this allele have been shown
to increase risk and decrease the age of onset in both late-onset familial Alzheimer
disease and sporadic Alzheimer disease (Pericak-Vance and Haines, 1995).
In other cases, the susceptibility allele could lie outside the gene-coding
region and influence the levels of expression and the regulation of the gene. This has
been shown in insulin-dependent diabetes (IDDM) where sequence variation at a
minisatellite 5' to the insulin gene influences susceptibility to the disease (Bennett et
al. , 1995).
Singletons could be used to find the sequence variants in the genes identified
as candidates for autism. These families, sometimes referred to as trios when both
parents are used in the analysis, contain only one autistic child and are by far the
most frequent type of autism family (-97%). Cook et al. (1997b) used trios to
determine whether two distinct polymorphisms of the serotonin transporter gene
(HTT) were associated with autism (see section 1.8. 5.8). Genes that regulate
serotonin biochemistry are likely candidates for causing autism, due to the inefficient
serotonin metabolism and defective brain receptors for serotonin found in autistic
individuals (Cook et al. , 1997b). A number of genes that have been identified and
characterised are involved in this system (Table 33). Those that correspond to
regions replicated by multiple groups could be used as candidate genes for further
study.
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Table 33: Chromosomal Positions of Some Serotonin Receptors
Serotonin Receptor

Chromosome

5-HT iA

5

5 -HT IB

6ql 3

5-HT rn

l p35

5-HT IE

6q l 4- 1 5
3p

5-HT2A

1 3 q l 4 . l - 14.2

5-HT28

2q36.3-2q37. l

5-HT2c

Xq2 1

5-HT3

l l q2 3 . l -q23 .2

5-HT4

5q

5-HTsA

7q3 6. l

5-HTsB

2q l l -q l 3

5-HT6

lp35-36

5-HT1

l Oq

5-HTT

17ql l . l -q l 2
(Cook and Leventhal, 1 996)

4.5.3.2 Single Nucleotide Polymorphisms

As previously mentioned, association studies are limited in that the gene(s)
must be tentatively identified before the test can be performed, and the actual
polymorphism within the gene (or one in strong disequilibrium) must be available.
Therefore, at present, genome-wide association studies are not feasible. However,
with advances in the Human Genome Project (HGP) aiming to identify the majority
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of human genes ( 50, 000-100,OOO) and the simple, biallelic polymorphisms (SNPs) in
these genes, Risch and Merikangas ( 1996) propose that association to genes with As
as low as 1.5 could be obtained with a significance level of 5x10·8 . SNPs are single
nucleotide polymorphisms present throughout the genome in great abundance. These
markers can be typed using high-throughput, low-cost automated genotyping
technologies, such as DNA chips. SNPs throughout the entire genome can then be
scanned for association to disease loci in many families in a fast and effective
manner. With new advances in technology, the genes to autism may eventually be
identified.

4.6

Conclusions and Outlook

Given the power of this study to reliably detect genes of moderate effect
(As>3.0, see Table 5), the findings shown here and in the overall genome scan (Risch
et al. , 1999) provide substantial evidence for the absence of such genes. The data

were most consistent with a model of :2: 15 susceptibility loci, each with a small effect
on the disorder. Regions that may contain disease-predisposing loci, however, were
identified. These include: regions on chromosomes 1p and 22q. Results from other
smaller genome scans also indicate these regions as possible candidates for loci
involved in the aetiology of autism. Our results could also not exclude chromosomes
7q, 9q, lOq, l lp and 17, which have previously been suggested to contain
susceptibility loci.
These results are important for future studies. In particular, they have shown
the requirement for a large sample size to detect genes of small effect. By combining
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our data with those from the other linkage studies on autism (IMGSAC, 1998;
Philippe et al. , 1999) there may be sufficient power to produce a significant linkage
result. A simultaneous evaluation of all available data with unified methods of
analysis may help to eliminate some genetic models for this disease, as well as define
the most promising chromosomal regions for follow-up. Replication of promising
loci could be achieved using a number of methods, including samples with different
family structures, such as cousin pairs, extremely discordant sibling pairs and
extended families. If these approaches fail to detect susceptibility loci, other
methods such as the use of alternative phenotypes, linkage disequilibrium studies of
candidate genes, and/or genome-wide association studies using SNPs may be
required.
With advances in the Human Genome Project, the development of rigorous
statistical approaches to the analysis of multifactorial diseases, and the availability of
new technologies for the high-throughput assay of genetic markers, the molecular
characterisation of the genes that control liability to complex disorders, such as
autism, could soon be feasible. With these advances should come insight into the
biology and pathology of brain development and behaviour, and improved diagnosis
and management of the childhood disorder autism.
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APPENDIX 6.2: SOLUTION AND BUFFER PROTOCOLS
(NOTE: all solution protocols are taken from Sambrook et al., 1989)

12% FCS/RPMl 1640

Powdered Medium (RPM l 1640)

32.72g

Sodium Bicarbonate

4g

Fetal Bovine Serum

240ml

Penicillin/Streptomycin

40ml

adjust pH to 7.2, make up to a final volume of 2 litres with dH20, sterilise media by
membrane filtration through a 0.2um filter under positive pressure, aseptically
dispense into sterile bottles and store in the dark at 2-8°C.

RCLB
I M Tris (pH 7.6)

10ml

SM NaCl

2ml

I M MgCh

5ml

make up to a final volume of 1 litre with dH20 and store at room temp.
Final concentration of reagents was lOmM of Tris, lOmM of NaCl and SmM of
MgCh
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WCLB
I M Tris (pH 7.6)

1 0ml

0.5M EDTA, di-Sodium Salt

2 0ml

5M NaCl

1 0ml

0% SDS

2 0ml

make up to a final volume of 1 litre with dH2 0 and store at room temp.
Final concentration of reagents was lOmM of Tris, lOmM of EDTA, 50mM of NaCl
and 0.2%SDS.

50xTAE BUFFER (for lL)
Tris Base

242g

Glacial Acetic Acid

57.4ml

Na2EDTA.2H20

37.2g

make up to a final volume of 1 litre with dH20 and store at room temp.
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l OxTBE BUFFER (for lL)
Tris Base

1 08g

Boric Acid

55g

Na2 EDTA.2H2 0

8.3g

made up to 1 1 with dH20
The working solution ( lxTBE) consists of 89mM Tris-base, 89mM Boric acid, 2mM
EDTA, pH -8.3 at ambient temperatures.

FICOLL LOADING BUFFER (6x)
50mM Tris HCl, pH 8.0
EDTA 1 % (w/v)
Sarcosyl 7.5% (w/v)
Ficoll 4 00 (ave. mol. Wt. = 4 00 OOO)
0.05% bromophenol blue
0.05% xylene cyanol
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6% POLYACRYLAMIDE-UREA GEL SOLUTION FOR USE IN THE ABI
PRISM™ 377 GENETIC ANALYSER (fluorescent detection)
4 0g urea
1 2 ml 4 0% acrylamide stock soln. (per 1 00ml contains acylamide 3 8g and bis
acrylamide 2g)
23 ml dH20
Stir the ingredients together while gently warming in a water bath until the urea
crystals begin to dissolve and the flask is slightly warm when touched. Continue to
stir the soln. with no additional heating until all the urea has dissolved.
Filter the acrylamide soln. through a 0.2um cellulose acetate filter in a cup filter unit
under vacuum, and then degas for five minutes.
Transfer the acrylamide soln. to a 1 00ml graduated cylinder containing 8ml of filtered
1 Ox TBE buffer.
Adjust the volume to 80ml with dH20.

6% POLYACRYLAMIDE DENATURING GEL SOLUTION (19: 1) FOR USE
WITH THE SE1600 POKER FACE II SEQUENCER (radioactive detection)
Acrylamide

57g

Bis-acrylamide

3g

Urea

420.Sg

Dissolve the acrylamide, bis-acrylamide and urea in 850ml of dH20 and adjust the pH
to 7.0.
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or

Liqui-Mix 19

150ml

Urea

420.Sg

Dissolve the urea in 600ml of dH20 and add Liqui-Mix-19.
Add 5g of mixed bead resin (5g/L) to deionise the soln. and stir for 30min.
Filter and make up to 900ml with dH2 0.
Add 100ml of 1OxTBE.
Degas for 30min.
Wrap bottle in foil and store at 4°C.

POLYACRYLAMIDE GEL FIXING SOLUTION
10% methanol / 10% acetic acid

I 00ml of methanol
100ml of acetic acid
make up to a final volume of 11 with dH20 and store at room temp.
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Exclusion of Linkage to the HLA Region in Ninety
Multiplex Sibships with Autism
Tamara Rogers, 1 Luba Kalaydjieva,1 Joachim Hallmayer,2 P. Brent Petersen,3
Peter Nicholas,3 Carmen Pingree,3 William M. McMahon,3 Donna Spiker,4•6
Linda Lotspeich,4, Helena Kraemer,4 Patty McCague,4 Sue Dimiceli,4 Nassim Nouri,5
Tawna Peachy,5 Joan Yang,5 David Hinds,5 Neil Risch5, and Richard M. Myers5

Several studies have suggested a role for the histocompatibility complex of loci (HLA) in the
genetic susceptibility to autism. We have tested this hypothesis by linkage analysis using ge
netic marker loci in the HLA region on chromosome 6p in multiplex families with autism. We
have examined sharing of alleles identical by descent in 97 affected sib pairs from 90 fami
lies. Results demonstrate no deviation from the null expectation of 50% sharing of alleles in
this region; in fact, for most marker loci, the observed sharing was less than 50%. Thus, it is
unlikely that loci in this region contribute to the genetic etiology of autism to any significant
extent in our families.
KEY WORDS: Histocompatibility; HLA region; autism-affected sib pairs.

(Chess, 1 977), encephalitis (Deykin & MacMahon,
1979; Markowitz, 1983), syphilis (Stubbs, 1978; Stubbs,
Crawford, Burger, & Vanderbark, 1977), toxoplasmosis
(Todd, 1986), and herpes simplex (Ghaziuddin, Tsai, Eil
ers, & Ghaziuddin, 1992). Other investigators have also
found evidence for a deficiency in T-cell-mediated im
munity (Warren, Margaretten, Pace, & Foster, 1 986), de
pressed lymphocyte responsiveness (Stubbs, et al.,
1977), and antibodies a against brain antigens (Weiz
man, Weizman, Szekely, Wijsenbeek, & Livini, 1 982;
Plioplys, Greaves, Kazemi, & Silverman, 1 994; Singh,
Warren, Odell, Warren & Cole, 1 993) in autistic patients.
It has been proposed that these autoimmune and/or viral
processes in some way affect the nervous system and
alter central nervous system (CNS) activity, which lead
to the deficits observed in autistic children (Van Gent,
Heijnen, & Trefferes, 1997).
The genetic composition of a person plays a crit
ical role in the immune system's ability to respond to
many antigens. Some of the genes that mediate immune
response are located in the human leukocyte antigen
(HLA) complex on chromosome 6. Investigators have
reported associations between alleles o f the HLA

INTRODUCTION
Autism is a chronic developmental disorder char
acterized by behavioral, communication, and social ab
normalities that manifest in the first years of life. Al
though the etiology of autism is unknown, there is
general agreement that it results fr om early neuro
developmental dysfunction.
Several studies suggest that immune imbalances
might contribute to the abnormal development of the
brain. Two of the possible explanations for this obser
vation are a viral etiology and an autoimmune etiology.
Clinical studies have reported numerous prenatal infec
tions in autistic patients, most of which are viral: rubella
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complex and autism when compared to normal con
trols. These autism-associated alleles include the null
allele of the C4B gene (Warren et al., 1991), the ex
tended haplotype B44-S30-DR4 (Daniels et al., 1 995
Warren et al., 1 992;), the third hypervariable region of
HLA-DRB l (Warren, Odell, et al., 1 996) and two al
leles of the DR beta 1 gene (Warren, Singh, et al.,
1996). The third hypervariable region of HLA-DRB I
showed the strongest association with autism (relative
risk of 1 9.8 for allele I and 4.2 fo r allele 3, respec
tively; Warren, Odell, et al., 1 996).
Family and twin studies strongly suggest a genetic
etiology for autism (Bolton & Rutter, 1990). Family
studies demonstrate that the risk of autism among sib
lings of probands with autism is 3-5%, which is 50 to
I 00 times greater than in the general population (Bolton,
et al., 1 994; Smalley, 1991). Twin studies have demon
strated that the concordance rate for monozygotic twins
is approximately 25-fold higher than for dizygotic twins
(Bailey et al., 1 995; Folstein & Rutter, 1 977; Ritvo,
Freeman, Mason-Brothers, Mo, & Ritvo, 1985; Stef
fenburg et al., 1989). These data strongly suggest the
interaction of multiple genetic loci in the etiology of
autism. Thus, the reports of associations between spe
cific HLA alleles and autism suggest that this region
may harbor one such contribution. Therefore, the HLA
region on chromosome 6p deserves further exploration,
to determine the extent to which such associations might
contribute to the genetic etiology of autism.
To test the hypothesis that a susceptibility gene
in the HLA region contributes to the etiology of
autism, we employed multipoint sib-pair analysis
(Risch, 1 990, 1 993). This method detects how fre
quently two affected sibs share the same chromoso
mal region using the principle of identity by descent
(ibd). Sib-pair analysis is very useful in studying
autism because it is independent of both the affected
status of parents and the mode of inheritance. The
power of the sib-pair method to detect linkage depends
on the risk ratio "-•· The risk ratio "-• is the increase in
the risk of the disorder in sibs of an affected individ
ual, compared with the general population prevalence.
Assumptions about genetic model parameters, such as
number of alleles at a given locus, gene frequencies,
and penetrances are not required in sib-pair analysis
(Risch, 1 990). In the case of autism, the "-• (increase
in risk to siblings) is equal to 75. The value of 75 is
the ratio of recurrence risk (3%) over the prevalence
of autism in the general population (estimated to be
1/2500; Smalley, 1991). Because the "-• value of 75 is
high, affected sib-pair analysis may be a powerful tool

for mapping susceptibility genes in autism, depend
ing on how many individual genes determine the total
value of "-•·
Because our sample is based on multiplex sibships,
we can test for linkage, or the sharing of alleles, in the
HLA region among siblings with autism. In this fash
ion, we have attempted to determine the extent to which
genes in the HLA region contribute to the etiology of
autism. As part of a larger general genome screen,
97 sib pairs from 90 families were analyzed for marker
loci in the HLA region by using the multipoint sib-pair
method to examine this question.

METHOD
Participants and Diagnosis

Families with two or more children with clinical
diagnoses of autism or Pervasive Developmental Dis
order Not Otherwise Specified (PDDNOS) were re
cruited. All presumed affected children were then eval
uated with two standardized diagnostic instruments, the
Autism Diagnostic Interview (ADI; Le Couteur et al.,
1989; Lord, Rutter, & Le Couteur, 1 994) and the Autism
Diagnostic Observation Schedule (ADOS; Lord et al.,
1 989), to determine the research diagnosis of autism.
The ADI is a semistructured interview, based on ICD10 and DSM-IV criteria for autism, that is adminis
tered to the parents of the autistic children. The ADOS
is a semistructured observation instrument used to ob
serve the behavior of the child and corroborate the
ADI information. This instrument was designed to
elicit social, language, and communication behaviors.
To check the reliability of diagnoses, all evaluations
were videotaped and some were randomly selected and
blindly assessed independently by other trained diag
nosticians. To be eligible as a sib pair, affected chil
dren must have scores above the prespecified cutoff
points in all four areas of the ADI (i.e., social im
pairment, language and communication impairment,
unusual and restricted interests and routines, and age
of onset prior to 3 years); also, review of the ADOS
videotape by two or more diagnosticians was required
to confirm the presence of significant deficits in so
cial and communicative reciprocity consistent with a
diagnosis of autism. Families were excluded if there
was no concensus that all affected siblings had such
significant deficits. This resulted in the exclusion of
cases that would have clinical diagnoses of PDDNOS.
For more details on the diagnostic protocol, see Spiker
et al. ( 1 994).

1 97

Exclusion of Linkage to the HLA Region in Autism
A total of 97 affected sib pairs from 90 families
were available for the study, with a male to female ratio
of 3.6 : I for the affected individuals and 0.8 : 1 for the
unaffected individuals. The number of families with
four, three, and two affected children was 2, 3, and 85,
respectively. For families with n affected children,
where n is greater than 2, n- 1 sib pairs were formed by
matching the first listed child (oldest) with each of the
subsequent children; these pairs are fully independent.
Both parents were available for genetic analysis in 67
families, and one parent in the remainder. In those fam
ilies where one parent was absent, unaffected siblings
were included when possible (8 families) to reconstruct
missing parents for ibd tallies.
The affected siblings ranged in age at the time of
the ADI administration from 2.9 to 40.9 years (M = 9.8
years, SD = 7.3, Mdn = 7.3, 25th-75th percentiles =
4.9-1 1 .3 years). Children' s diagnostic evaluation and
school records were gathered to obtain IQ and mental
age data. When available, nonverbal IQ scores were ob
tained from the performance subtests of the Wechsler
Scales or Stanford-Binet Intelligence (4th ed.), or the
full Leiter International Performance Scale or Merrill
Palmer Scale. When these scores were unavailable,
scores from such tests as the Stanford-Binet.Intelligence
Scale (3rd ed.), Slossen Intelligence Scale, or McCarthy
Scales were used, or ratio IQ scores were based on non
verbal scales from various developmental inventories
(e.g., Daily Living Domain of the Vineland Adaptive
Behavior Scale, the full Bayley Scales, or Developmen
tal Profile II). The mean IQ was 66 (SD = 28, Mdn = 66,
range = 15-160). One hundred eight children had scores
below 70 (57% ). The mean mental age was 68 months
(Mdn = 52, SD = 55, range = 13-373 months). There
were no families in which the IQs of all the affected
siblings were below 30. In one family, one affected
child had a mental age below 1 8 months.

solutions were pipetted into a capillary tube (Biotech)
using a programmable pipettor (Corbett Research), and
processed in a thermocycler (MJ Research). After de
naturation for 5 rnin at 94°C, 27 cycles were carried out,
each cycle consisting of 30 sec at 94°C, 75 sec at 55 °C,
and 15 sec at 72°C. A final extension step was performed
for 5 rnin at 72°C. After completion, 1 2 µl of formarnide
and 0.8 µI of GS500 Tamra standard dye were added,
then the samples were denatured for 5 rnin at 94°C and
loaded onto a Perkin Elmer 3 1 0 Capillary Sequencer. In
the other laboratory, the PCR reactions were performed
in a 10 µl volume in 96-well plates and included 30 ng
or DNA, 67 mM Tris-Hcl pH 8.8, 200 µM dNTPs,
16 mM <NH4hS04, 0.01 % Tween-20, 1 .5-3 mM MgC12,
0.2 µM of each primer, 0.2 U Taq polymerase (Perkin
Elmer), using Perkin Elmer 9700 thermal cyders. The
· forward primers for each marker were labeled as above.
The reaction was first denatured at 95 °C for 75 sec, then
35 cycles of 45 sec at 95° C, 45 sec at 57°C, 60 sec at
72 ° C were performed with a final elongation step of
7 min at 72°C. PCR products from 12 markers at a time
were pooled and run on ABI Prizm 377 DNA sequencers.
The products were resolved using the Applied Biosys
tems' GeneScan and Genotyper software packages. In
both laboratories, polymorphic bands were scored and
alleles were assigned to the pedigree members.
The following markers were used in the analysis:
D6S285, D6S 1959, D6S 1029, D6S276, D6S 1 0 14,
D6S497, D6S439, D6S 1 0 1 9, GGAA 15B08, and
D6S426. Location and distance of markers are given in
Figure 1 and are based on a composite of the published
Marshfield, CHLC, and Southampton linkage maps
available on the Internet.
Unaffected sibs were also included in the geno
typing of the families. Individuals performing the geno
typing were blind to the diagnostic status of the sub
jects, although they were aware of the family structures.

Genotyping

Statistical Analysis

DNA was extracted either from whole blood or
immortalized lymphoblastoid cell lines by using stan
dard proteinase K digestion and salting out procedures.
Genotyping was carried out in two laboratories inde
pendently with slightly different procedures. In one lab
oratory, polymerase chain reactions (PCR) were car
ried out in 5 µl and contained 5 ng DNA, 200 µM
dNTPs, 0.1 3-0.4 µM of each primer (the forward
primer had been fluorescently labeled using HEX, TET,
and FAM dyes), 50 mM KCl, 10 µM Tris-HCl, 1 .5 mM
MgC}z, and 1 .25 U Taq-Polymerase (Perkin Elmer). The

Linkage analysis was performed by using multi
point sib-pair analysis. This mapping approach pro
vides optimal use of information by analyzing multi
ple markers, instead of flanking markers which are used
in interval mapping (Hauser, B oehnke, Guo, & Risch,
1996; Olson, 1995). Also, the simultaneous use of mul
tiple markers reduces the effect of recombination and
allows for localization of a disease-susceptibility locus
(Risch, 1990).
The method is based on the sharing of a chromo
somal region by affected sib pairs. A random pair of
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Fig. 1. Results of multipoint exclusion mapping in the HLA region. The vertical axis gives the smallest value of As excluded
(lod score < -2). The horizontal axis is map location on chromosome 6p measured in morgans (M), with O corresponding to
6p-ter. The HLA region is at . 18M, near the marker D6S276.

sibs will share an allele at a genetic locus from a given
parent half the time. Therefore, considering both par
ents simultaneously, the probability they will inherit
the same allele from each of the two parents is 25%.
Similarly, the probability they inherit different alleles
from each parent is 25%. The probability they share an
allele from one parent but not the other is 50%.
If an allele or alleles at a given locus increases the
risk of autism, there will be an excess of sharing of al
leles by affected sib pairs over the prior expectations
for a random pair. The amount of excess depends on
the frequency of the allele (or alleles), and how much
the risk of autism is increased in those who carry it.
One simple way to parameterize this excess is in terms
of A.5, the ratio of risk to a sib of an individual with
autism compared to the population prevalence of autism
due to this locus, Specifically, the probability an af
fected sib pair shares O alleles ibd at this locus, denoted
Zo, is given by .25/A., (Risch, 1 990). Assuming a model
where the parental contributions are independent, we

can obtain the probability z2 that the affected pair shares
) 2 , and for one allele
2 alleles ibd (z2) as ( 1 - 1/2
- 1 )/2 A.,.
ibd the probability z 1 is (2
At a given chromosomal location, the ibd proba
bilities, or equivalently the value of A.,, can be esti
mated and its statistical significance assessed. This
can be done for all genetic markers in a region simul
taneously. The lod score for a sib pair at a given map
location is the log 1 0 of the likelihood ratio of the
marker data, given a value of As > 1 versus a value of
"• == 1 . These lod scores were calculated for each sib
pair at each marker location as well as at points be
tween these markers, under the assumption of a spe
cific A. value. The lod scores at each interval were then
summed over all sib pairs to give the total lod score.
If this score was < -2, linkage was excluded for that
value of A.,; a lod score > 3 was considered suggestive
of linkage.
All calculations were carried out by using ASPEX,
a set of computer programs for performing multipoint
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exclusion mapping of affected sibling pair data for dis
crete traits (D. Hinds and N. Risch, personal commu
nication). Two analyses were performed. In the first
analysis, only ibd data were included from families with
both parents typed, and in families with only one par
ent when an unaffected sib (or sibs) was available for
reconstruction. In the second analysis, data on identity
by state (ibs) were included for those families with
missing parents, using likelihoods based on allele fre
quencies at the marker loci in these families. The results
of these two analyses were similar; only the results for
the ibd (first) analysis are presented.
We also performed analysis of linkage disequilib
rium via the TDT test (Spielman et al., 1993) in fami
lies with genotyped parents. For each of the micro
satellite loci, we tested each allele with a frequency
greater than 1 0% for excess transmission to affected
children from heterozygous parents.

be excluded for most of the region involving the HLA
loci (closest to markers D6S276 and D6S 10I4). Thus,
we can exclude a gene of moderate effect on autism sus
ceptibility from residing in this region.
We also tested each of the markers in the region
for linkage disequilibrium using the TDT test. The re
sults of these tests were also negative. After correction
for the number of loci tested, there were no significant
findings of excess allele transmission for any marker.

RESULTS
This analysis is based on allelic sharing, or ibd, be
tween affected sibs at each of the marker loci, as well as
a multipoint analysis of all the marker data considered
simultaneously. For each marker, the null hypothesis
value for allelic sharing, combining across the two par
ents, is 50%. The observed sharing at each of the mark
ers is given in Table I. The sharing is less than 50% for
all markers except one (D6S285), but does not differ sig
nificantly from 50% for any of the markers. Marker
D6S285 had 56 out of a total 1 09 alleles shared (5 1 %).
Because the ibd in the HLA region was essentially neg
ative (lod scores < 0), we calculated at each location on
the map the smallest value of )., that would be excluded
(lod score < -2) (see Figure 1 ). Values of A; > 1 .6 can
be excluded from the entire region, and values > 1 .5 can
Table I. Results of Identity by Descent Analysis

of Autism Sibling Pairs

Marker
D6S285
D6Sl959
D6S1029
D6S276
D6S l0l4
D6S497
D6S439
D6S l0l9
GGAA15B08
D6S426

Total

% Shared

x2

1 09
67
71
1 23
109
88
82
91
1 30
1 32

5 1 .4
46.3
40.8
47.2
48.6
42.0
45. 1
46.2
45.4
46.2

0.08
0.37
2.38
0.40
0.08
2.23
0.78
0.54
1.11
0.76

DISCUSSION
Specific HLA alleles have been associated with a
variety of disorders. A few of the best documented as
sociations include IDDM, multiple sclerosis, celiac dis
ease, and Graves disease (Farid et al., 1 979; Haile
et al., 1983; Mackintosh & Asquith, 1 978; Svejgaard
& Ryder, 1989). Similar association studies have sug
gested that a susceptibility locus for autism is located
in the HLA region. These association studies compared
autistic subjects to normal controls to calculate relative
risks for autism. In the study presented here, 90 fami
lies with at least two affected individuals were tested.
Identity-by-descent information could be obtained for
most families, thus allowing calculations to be inde
pendent of any gene or allele frequencies, mode of in
heritance, and population stratification.
The linkage results presented here demonstrate that
a moderate gene effect in the HLA region can be ex
cluded. For a moderate gene effect to exist, )., values
greater than 1 .5 would result in positive lod scores. In
this study, positive lod scores could not be found for
any )., values greater than 1 .0, thus excluding a moder
ate gene effect. However, linkage analysis could not for
mally exclude smaller gene effects. Similarly, TDT
analysis did not produce any positive findings. These
results are consistent with those of Spence et al., ( 1 985),
who also found no evidence for linkage with HLA in
27 multiplex autism sibships.
Other results of HLA association studies in autism
were based on singleton cases, whereas our analysis
was based on multiplex sibships. One possible expla
nation for the apparent discrepancy between our results
and previous studies is that the relative risks associated
with alleles in the HLA region must be moderately large
to produce a detectable linkage signal by sib-pair analy
sis. Thus, while our results do not entirely exclude a
possible association between autism and alleles in the
HLA region, they do indicate that if an association ex
ists, it must be weak, and contributes little to the fa
milial recurrence in autism.
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Alternatively, certain alleles in the HLA region may
predispose to autism only for a subset of patients, per
haps those with a suspected autoimmune etiology or
those exposed to recurrent infection or immunologic in
sult. Our families were unselected in this regard, and
may have contained few with this type of etiology. How
ever, based on our results, it is also likely that if HLA
were involved in a significant way in these cases, they
account for a relatively small proportion of all multiplex
families.
Thus, putative immunological abnormalities found
in autistic children (Plioplys et al., 1 994; Singh et al.,
1 993; Stubbs, 1 977; Warren et al., 1986; Weizman
et al., 1 982) are unlikely to be related to susceptibility
genes in the HLA region. The immune system is con
nected to the brain in an integrated regulatory circuit
that is only slowly beginning to be understood. An al
tered immune response during early childhood might
produce changes in brain development. Although it ap
pears that genes in the HLA region have little or no
effect on this process, we have not excluded the possi
bility that genes of immunologic interest other than
HLA might be involved in the pathophysiology of
autism.
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Chromosomal region 15qll-ql3 has been im
plicated to harbor a susceptibility gene or
genes underlying autism. Evidence has been
derived from the existence of cytogenetic
anomalies in this region associated with au
tism, and the report of linkage in a modest
collection of multiplex families. Most re
cently, linkage disequilibrium with the
marker GABRB3-155CA2 in the candidate
locus GABRB3, located in this region, has
been reported. We searched for linkage us
ing eight microsatellite markers located in
this region of chromosome 15 in 147 affected
sib-pairs from 139 multiplex autism fami
lies. We also tested for linkage disequilib
rium in the same set of families with the
same markers. We found no evidence for ex
cess allele sharing (linkage) for the markers
in this region. Also, we found no evidence of
linkage disequilibrium, including for the lo
cus GABRB3-155CA2. Thus, it appears that
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INTRODUCTION
Twin and family studies strongly support the notion
that genetic factors play a significant role in the etiol
ogy of autism. The concordance rate for autism is much
higher in monozygotic twins than in dizygotic twins
[Bailey et al., 1995; Folstein and Rutter, 1977; Ritvo et
al., 1985; Steffenburg et al., 1989] , and family studies
indicate that the sibling recurrence risR is 50-100
times greater than the risk for autism in the general
population [reviewed in Smalley, 1997] . As in other
psychiatric disorders, there is no simple mode of inher
itance. Instead, the observed family pattern is compat
ible with a complex mode of transmission involving
several or many genes. The effect of each separate gene
may be modest, and interactions between genes would
be expected to further complicate the genetic mecha
nisms involved.
Cytogenetic abnormalities have frequently been used
to identify genes associated with inherited syndromes.
Cytogenetic studies in autism have suggested an asso
ciation with chromosomal anomalies in the 15qll-q13
region. Such cytogenetic abnormalities may indicate
that a susceptibility gene (or genes) for autism is lo
cated in this region. Furthermore, symptoms of autism
have been reported in individuals with Prader-Willi
and Angelman syndromes [Arrieta, 1 994] , both of
which result from alterations in the 15qll-q13 region.
When only the paternal region of human chromosome
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15ql l-q13 is inherited, either by deletion of the mater
nal gene or by uniparental disomy, Prader-Willi syn
drome results. Angelman syndrome results when only
maternal copies of 15ql l-q13 are inherited [Christian
et al. , 1995; Sutcliff et al., 1997] . The most common
cytogenetic abnormality reported in autism involves
duplications within the 15ql l-q13 region [Baker et al.,
1994; Bundey et al. , 1994; Cook et al., 1997a; Crolla et
al., 1995; Flejter et al. , 1996; Gillberg et al., 1991; Hotof
and Bolton, 1995; Leana-Cox et al. , 1994; Rineer et al. ,
1998; Robinson e t al. , 1993; Schinzel e t al. , 1994;
Schroer et al. , 1998] . Cook et al. [1997a] described a
family with two affected children in which a maternal
15q duplication segregates with autism. The authors
suggested that, although large genetic abnormalities in
the 15ql l-q13 region are quite uncommon in autistic
patients, there may be a higher rate of small, cytologi
cally undetectable abnormalities in this chromosomal
region in some cases of autism.
Several investigators have recently examined the
15ql l-q13 region for genetic linkage to autism. Cook et
al. [1998] carried out linkage disequilibrium mapping
of markers in this region. Evidence for linkage disequi
librium was found at the GABRB3 locus with the
marker GABRB3 1 55CA-2, but not with the marker
D 15S97. No evidence of imprinting effects were de
tected. Most of the 140 families included in this study
were singleton affected cases. Pericak-Vance et al.
[1997], using sib-pair analysis with 37 autistic multi
plex families, obtained a peak lod score of 2.5 for the
microsatellite marker D15S156, which is located ap
proximately 5 cM distal to the GABRB3 locus, and a lod
score for GABRB3 of 1 .4. A recently reported whole
genome linkage scan found several areas potentially of
interest, most notably one on chromosome 7 with a lod
score of 2.5 [International Autism Consortium, 1998] .
These researchers did not find significant linkage to
autism for markers on chromosome 15. However, this
genome scan included only one marker, D15S 128, in
the 15qll-q13 region.
In the present study, we used multipoint sib-pair
analysis to test for linkage between autism and eight
markers in the proximal region of chromosome 15q. We
analyzed 147 affected sib-pairs from 139 families by
genotyping fluorescently labeled microsatellite mark
ers. To be included in the analyses, autistic individuals
had to satisfy criteria for all three symptom areas of
the Autism Diagnostic Interview (ADI) (social impair
ment, language and communication impairment, un
usual routines, and restricted interests), plus an age
of-onset prior to 3 years. This linkage study of proximal
chromosome 15q is part of a larger investigation of the
genetics of autism that includes an entire genome scan,
which will be reported elsewhere. Our results indicate
that the proximal region of chromosome 15q, in par
ticular markers in the 15ql l-q13 region, does not show
evidence of linkage to autism in these families. Fur
thermore, we find no evidence of linkage disequilib
rium with the two GABRB3 microsatellite markers
GABRB3CA or GABRB3-155CA2.

MATERIALS AND METHODS
Recruitment of Families and
Diagnostic Assessment
Families were recruited for the study if they had at
least two siblings with a clinical diagn osis of autism or
pervasive developmental disorder-not otherwise speci
fied (PDD-NOS). All children were subsequently as
sessed by using the (ADI) [LeCouteur et al., 1989; Lord
et al., 1994, 1997] and the Autism Diagnosis Observa
tion Schedule (ADOS) [Lord et al. , 1989] to determine a
research diagnosis of autism. The ADI is a semistruc
tured interview of parents based on International Clas
sification of Diseases (ICD-10) and Diagnostic and Sta
tistical Manual of Mental Disorders (DSM-IV) criteria
for the diagnosis of autism. The ADOS is a semistruc
tured observational instrument that assesses the child
by observing his/her behavior, and is used to corrobo
rate the ADI interview. The diagnostic assessments
(ADI and ADOS) were videotaped and subjected to in
dependent reliability checks by other trained inter
viewers (typically the senior clinical investigators). To
be considered affected in the sib-pair analysis, an indi
vidual had to satisfy the prespecified cut-off scores in
all three symptom areas of the ADI (social impairment,
language and communication impairment, unusual
and restricted interests) and the age-of-onset had to be
prior to 3 years. Review of the ADOS tape by two or
more diagnosticians was used to exclude children who
did not show significant impairments in social and
communicative reciprocity. Families were excluded if
there was no consensus that at least two affected chil
dren had such deficits consistent with a diagnosis of
autism (e.g. , exclusion of cases that would have a clini
cal diagnosis of PDD-NOS); this entailed exclusion of
33 families. We also excluded families where all af
fected sibs were severely retarded (IQ <30; seven fami
lies), or had significant medical conditions likely to ac
count for the autism (six families). For more details on
the diagn ostic protocol, see Spiker et al. [1994] .
Children's records were reviewed to obtain IQ and
mental age information. When available, nonverbal IQ
scores were obtained from performance subtests from
the Wechsler Scales; Stanford-Binet Intelligence Scale,
fourth edition; the Leiter International Performance
Scale; or the Merrill-Palmer Scale. When unavailable,
scores from such tests as the Stanford-Binet Intelli
gence Scale, third edition; Slossen Intelligence Scale; or
McCarthy Scales were used. For children without these
tests, mental ages and ratio IQ scores were derived
from nonverbal scales of various developmental instru
ments (e.g. , Daily Living Scale of the Vineland Adap
tive Behavior Scale, the Bayley Mental Scale, Develop
mental Inventory II).

Genotyping
Blood was collected on all affected individuals and, if
available, their parents and siblings. Lymphoblast cell
lines were established and genomic DNA was extracted
from peripheral blood lymphocytes or cell lines by us
ing standard proteinase K digestion and salting out
procedures.

Chromosome 15qll-q13 Markers and Autism

Genotyping was carried out in two laboratories inde
pendently with slightly different procedures. In one
lab, polymerase chain reaction (PCR) assays were per
formed in 8 microliter volume reactions containing 10
ng genomic DNA; 2.5 mM of each dNTP; 0.2-0.6 mi
cromolar of each primer pair labeled with Fam, Hex, or
Tet; 0.8 microliters of lOx buffer (Perkin-Elmer, Nor
walk, CT); 1.5-2.5 mM MgC12 ; and 0.2 units AmpliTaq
Gold Polymerase (Perkin Elmer). PCR assays were per
formed in an Applied Biosystems (Foster City, CA)
9600 Thermocycler by denaturing for 10 minutes at
94 ° C, then 15 cycles of 30 sec at 94 ° C, 15 sec at 60 ° C,
and 15 sec at 72 ° C. Another 20 cycles of 30 sec at 94° C,
15 sec at 65 ° C, and 15 sec at 72 °C were performed, and
these were followed by a final extension step of 10 min
at 72 ° C. In the other lab, PCR reactions were per
formed in a 10 µ,L volume in 96 well plates and in
cluded 30 ng of DNA, 67 mM Tris-Hcl pH 8.8, 200 µ,M
dNTPs, 16 mM (NH4)2S04, 0.01 % Tween-20, 1 .5-3 mM
MgC12 , 0.2 µ,M of each primer, 0.2 U Taq polymerase
(Perkin Elmer), using Perkin Elmer 9700 thermal cy
ders. The forward primers for each marker were la
beled as above. The reaction was first denatured at 95 ° C
for 75 sec, then 35 cycles of 45 sec at 95° C, 45 sec at 57°C,
60 sec at 72 ° C were performed with a final elongation
step of 7 min at 72 ° C. Fluorescently labeled markers
were analyzed on Applied Biosystems 373 or 377 Ge
netic Analyzers, and the data were further analyzed by
using Applied Biosystems Genescan and Genotyper
software. In both labs, polymorphic bands were scored
and alleles were assigned to the pedigree members.
The following eight markers were typed: D15Sl28,
GABRB3CA, GABRB3-155CA2, D 15S822, D 15S156,
D 15Sl65, Dl5S1232, and ACTC. These loci span ap
proximately 25 cM of chromosome 15, in the region of
15qll-q13. Figure 1 shows the position of these mark
ers and the distances between them.
Statistical Analyses

Multipoint sib-pair linkage analysis was used to de
tect or exclude linkage. Multipoint sib-pair analysis is
10
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Fig. 1. Multipoint exclusion plot for an autism susceptibility locus on
chromosome 15qll- 13. The top scale is map distance (in centimorgans),
and the Y axis is the lod score. The relative location of the various chro
mosome 15ql l-13 markers is given along the bottom. The solid line is for
A s = 2.0; the dashed line is for As = 1.5.

553

based on allele sharing, or identity by descent (ibd)
between affected siblings over a number ofloci. At each
locus, the null hypothesis is that the likelihood of af
fected sibs sharing an allele is 50%. Lod scores are
calculated per sib-pair at points between markers and
at markers by using a specific value of As , which is the
sibling recurrence risk ratio due to the locus in this
region [Risch, 1990] . Each lod score is the loglO of the
ratio of the likelihood of observing the marker data at
a given value of As (>1) versus the likelihood at a value
of As = 1. For a specific value of As and marker dis
tance, lod scores are calculated for each sib-pair. The
total lod score is an overall sum for all sib-pairs. For a
given value of As , a lod score less than -2 is indicative
of strong exclusion of linkage [Hauser et al. , 1996] and
values larger than 3 suggest linkage. Lod scores are
calculated at multiple points over a genetic distance.
The advantages of this type of analysis compared with
interval mapping with flanking markers are that it al
lows all of the information to be used simultaneously,
and it reduces the effect of recombination in defining a
disease-causing locus [Risch, 1990] . For the six families
with n affected sibs, where n > 2, n - 1 sib pairs were
formed with one sib randomly selected. These pairs are
fully independent for ibd scoring. Thus, in total, there
are 147 independent affeded sib pairs. The transmis
sion disequilibrium test (TDT) [Spielman et al., 1993]
was used to test for linkage disequilibrium for the
tested markers. In this case, w_e employed two tests,
one that calculates a total chi-square statistic on the
full 2xn table, and the second that calculates the maxi
mum chi-square across each tested allele; the level of
significance for both tests was calculated using Monte
Carlo resampling [Lazzeroni and Lange, 1998] . Be
cause we are dealing with multiplex sibships, all resa
mpling was conditional on parental genotypes; the two
alleles of each parent were switched with 50% probabil
ity [Martin et al., 1998] . All statistical analyses were
performed by using the program package ASPEX
(Hinds D, Risch N: ftp site //lahmed.stanford.edu/pub/
aspex).
RESULTS
Family Recruitment

One hundred thirty-nine families encompassing 147
independent sib-pairs were tested. Each family con
tained two or more affected siblings that satisfied the
inclusion criteria for this study. One hundred thirty
five families had two affected sibs, four had three af
fected sibs, and two had four affected sibs. Among af
fected individuals, the male-to-female ratio was 3.4: 1,
and for unaffected individuals, the ratio was 0.8: 1. In
115 of these families, DNA from both parents was
available for testing; in the remaining 24 families, only
one parent had DNA available. In those families where
one parent was absent, unaffected siblings were in
cluded when possible (eight families) to reconstruct
missing parents and ibd tallies.
At the time of the ADI administration, the affected
siblings ranged in age from 2_8 to 40.9 years (mean =
8.7 years, SD = 6.4; 25th-75th centiles = 4.7-10.1

554

Salmon et al.

years). Mental age and IQ estimates were obtained
based on available diagnostic evaluations and school
records. The mean nonverbal IQ was 64 (SD = 27;
range = 15-160). One hundred and seventy children
(59%) had IQ scores below 70. The mean mental age
was 61 months (SD = 48 months; range = 13-373
months). There were no families for which all affected
children had IQ scores below 30. In four families, one
affected child had a mental age below 18 months.
Approximately 90% of our families were Caucasian
of mixed European origin. The remaining 10% were a
mix of African/African-American, Asian, and Hispanic.
Multipoint Sib-Pair Analysis

gene and previously found to be in disequilibrium with
autism [Cook et al., 1998] . We found no evidence of
preferential allele transmission at any locus, either
based on a global test of all alleles, or the allele giving
maximum deviation. The results for GABRB3-155CA2
are given in Table II. Our allele frequency distribution
is very close to that reported by Cook et al. [1998] . In
that study, allele "103" demonstrated excess transmis
sion to affected offspring. The corresponding allele ac
cording to our nomenclature is the "108" allele. In our
families, this allele was transmitted 79 times and not
transmitted 62 times, giving a nonsignificant chi
square of 2.0.

DISCUSSION
The number of shared alleles between affected sib
lings at each locus tested is shown in Table I . None of
By using multipoint sib-pair analysis, we excluded
the loci showed a significant excess of sharing. In fact, the existence of a gene in the region of chromosome
six of the loci showed less than or equal to 50% sharing, 15ql l-q13 conferring a moderately increased risk for
while the other two showed sharing only slightly autism in our set of 139 multiplex families. The entire
greater than 50%. The estimate of sharing at each of region is strongly excluded for A values greater than 2,
s
these loci based on multipoint analysis is also given in while values of A less than 1.5 could
be excluded using
s
Table I. Overall, the estimate of sharing in this region the less stringent criterion of -1. Our uniformly nega
hovers around 50%. The multipoint lod scores for this tive lod scores across this region of chromosome 15 for
region were also negative at all loci for all values of As . all values of A do not support the presence of a sus
We calculated the lod scores for two values of As : As = ceptibility genes of strong or moderate effect.
2.0 and 1.5. These results are given in Figure 1. Values
Our results are in contrast to those from the study of
of As of 2.0 or larger could be strongly excluded over the Pericak-Vance et al. [1997] and Cook et al. [1998] . Peri
entire interval, while a locus with As = 1.5 could be cak-Vance et al. [1997] reported evidence for linkage in
strongly excluded from the region surrounding 38 affected sib-pairs and nine cousin pairs on chromo
GABRB3.
some 15qll-q13. Their maximum lod score was 2.5 at
The chromosomal region 15qll-13 is subject to geno D 15S156, a score below the critical value of 3 . The ob
mic imprinting, and thus allelic expression might de served sharing at this marker in our families was
pend on sex of transmitting parent. Indeed, Cook et al. 53. 7%, and the multipoint sharing at this marker was
[1997b] found a duplication in this region to be ex 50.3%. The International Autism Consortium [1998]
pressed only when maternally inherited, and noted also scanned chromosome 15q (primarily marker
similar observations in other studies. Therefore, we ex D15S128) in 39 multiplex families and found no evi
amined our ibd data separately for alleles inherited dence of a major susceptibility gene for autism, consis
from fathers versus mothers (Table I). Sharing across tent with our results.
the 15ql l-13 region in our families was somewhat
The study of Cook et al. [1998] used the multiallelic
greater for paternally versus maternally derived al transmission-disequilibrium test and revealed linkage
leles (although the difference was not statistically sig disequilibrium between autistic disorder and a micro
nificant), contrary to prediction based on the prior cy satellite marker in the gamma-aminobutyric acid A re
togenetic evidence.
ceptor subunit gene, GABRB3 155CA-2 (MTDT 28.63,
10 df, P= . 00 14). We tested two microsatellite markers
Linkage Disequilibrium
at this locus, GABRB3CA [Mutirangura et al., 1992]
The TDT was used to test for linkage disequilibrium and GABRB3-155CA2. We found no evidence oflinkage
at the eight marker loci, including the markers disequilibrium with either marker.
GABRB3CA, which is adjacent to the gene GABRB3,
The seemingly contradictory nature of the results be
and the marker GABRB3-155CA2, within the GABRB3 tween the respective studies must be interpreted in the
TABLE I. ,Results of ldentity by Descent (Allele Sharing) Analysis of Chromosome 15qll-q13 Markers in 147 Autism Sibling Pairs
Marker

D 15S128
GABRB3CA
GABRB3-155CA2
D15S822
D158156
D15S165
Dl581232
ACTC

Paternal

Maternal

Total

Multipoint
sharing

52/95 (54.7)
47/84 (56.0)
52/94 (55.3)
36/67 (53.7)
30/53 (56.5)
23/46 (50.0)
38/72 (52.8)
30/63 (47.6)

41/96 (42.7)
39/91 (42.9)
44/98 (44.9)
31/69 (44.9)
29/56 (51.8)
27/56 (48.2)
37/70 (52.9)
31/67 (46.3)

93/191 (48.7)
87/177 (49.2)
96/192 (50.0)
68/138 (49.3)
66/123 (53.7)
50/102 (49.0)
77/146 (52.7)
61/130 (46.9)

49.4
49.2
49.2
50. 1
50.3
50.6
49.2
47.9

(%)

(%)

(%)

(%)

Chromosome 1 5 qll-ql3 Markers and Autism
TABLE II. Parental Allele Frequency Distribution and
Transmission Disequilibrium Test Results for Locus
GABRB3-155CA2 for 286
With Autism
Allele
size
92
94
96
98
100
102
104
106
108c
1 10
1 12
114
1 16
118

N (o/o)

179 (35.2)
45 (8.9)
4 (0.8)
0 (0.0)
16 (3.1)
16 (3.1)
80 ( 15.7)
50 (9.8)
75 ( 14.8)
17 (3.3)
10 (2.0)
8 ( 1 .6)
7 ( 1.4)
1 (0.2)

xz

TRa

NTb
111
48
4

0.94
0.17
0.00

13
17
73
44
79
18
17
5
5

19
10
78
41
62
17
4
9
9

1.13
1.81
0.17
0. 1 1
2.05
0.03
8.05
3.56
1.15

97
44
4

TR is transmitted alleles.
bNT is nontransmitted alleles.
<AJlele "108" corresponds to allele "103" from the study ofCook et al. (1998).
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context of the difficulties of detecting genes in a com
plex psychiatric disorder such as autism. Segregation
analysis [Jorde et al. , 1991] and twin studies [Bailey et
al. , 1995; Folstein and Rutter, 1977; Ritvo et al., 1985;
Steffenburg et al., 1989;] provide strong evidence that
autism is not caused by a single major gene. Because
there do not appear to be genes of major effect, differ
ences between autism linkage studies could be ac
counted for by statistical fluctuations suggesting link
age where none is present, or linkage is present but the
gene effect is weak or applies to only a small subset of
patients. If the latter is the case, very large samples
will be necessary to provide compelling linkage evi
dence. Alternatively, if chromosome 15q-associated
cases of autism could be identified by distinct clinical or
other phenotypic characteristics, creating a homoge
neous collection of such families might provide greater
power to detect linkage in this region.
Despite our strong negative results on chromosome
15qll-ql3, this region should still be viewed as an area
of strong interest, given the number ofreports showing
association between autism and cytogenetic abnormali
ties in this region. However, our results clearly indicate
that, for the majority of affected sib-pairs, there is no
major gene in this region causing autism.
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Summary

Introduction

Autism (MIM 209850) is a pervasive neurodevelop
mental disorder with symptoms usually apparent during
the first 3 years of life. It is characterized by a triad of
features, including limited or absent verbal communi
cation, a lack of social reciprocity or responsiveness, and
limited, stereotypical, and ritualized interests and be
haviors. Autism is the most severe of the disorders now
characterized as "pervasive developmental disorders"
(PDD) (MIM 209850), which also include Asperger syn
drome (MIM 209850) and PPD that is not otherwise
specified (PDD-NOS).
Autism was first typified as a distinct clinical entity
by Kanner (1943). The etiology of this syndrome has
been debated ever since, with various proponents fa
voring behavioral, environmental, dietary, viral/immu
nologic, autoimmune, or genetic theories. On the basis
of the prevalence studies that have been performed, the
indication is that autism is generally rare, with a mean
prevalence of 1/2,500 children (Smalley et al. 1988).
The infrequency of familial cases of autism probably
led some early theorists to doubt an inherited component
in this disorder (Hanson and Gottesman 1976). For ex
ample, for a typical rare recessive disease, multiple-in
cidence sibships are not unusual, since the recurrence
risk in sibships is 25% . The recurrence risk of autism
in sibships is far below that 25% figure. However, with
the completion of several systematic family studies, it is
now possible to provide a consistent sibling recurrence
figure of 2 %-6%, which is substantially higher than the
population prevalence of 1/2,500, or 0.04% (Smalley et
al. 1988; Bolton et al. 1994). The most recent summary
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We have conducted a genome screen of autism, by link
age analysis in an initial set of 90 multiplex sibships,
with parents, containing 97 independent affected sib
pairs (ASPs), with follow-up in 49 additional multiplex
sibships, containing 50 ASPs. In total, 519 markers were
genotyped, including 362 for the initial screen, and an
additional 157 were genotyped in the follow-up. As a
control, we also included in the analysis unaffected sibs,
which provided 51 discordant sib pairs (DSPs) for the
initial screen and 29 for the follow-up. In the initial
phase of the work, we observed increased identity by
descent (IBD) in the ASPs (sharing of 51.6%) compared
with the DSPs (sharing of 50.8%). The excess sharing
in the ASPs could not be attributed to the effect of a
small number of loci but, rather, was due to the modest
increase in the entire distribution of IBD. These results
are most compatible with a model specifying a large
number of loci (perhaps ;,,: 15) and are less compatible
with models specifying ::;;;10 loci. The largest LOD score
obtained in the initial scan was for a marker on chro
mosome lp; this region also showed positive sharing in
the replication family set, giving a maximum multipoint
LOD score of 2.15 for both sets combined. Thus, there
may exist a gene of moderate effect in this region. We
had only modestly positive or negative linkage evidence
in candidate regions identified in other studies. Our re
sults suggest that positional cloning of susceptibility loci
by linkage analysis may be a formidable task and that
other approaches may be necessary.
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Further supporting a genetic etiology in autism are the
results of twin studies, which have documented a dra
matically higher concordance rate in MZ twins than in
DZ twins (Folstein and Rutter 1 977). S ummarizing the
largest and most systematic of these studies (Steffenburg
et al. 1 989; Bailey et al. 1 995), we can derive MZ-twin
and DZ-twin probandwise concordances of 81 % (47/
58) and 0 % , respectively, for autism. The latter figure
is likely to be an underestimate as a result of small sam
ple sizes, and the true DZ-twin concordance is likely to
be similar to the nontwin-sib rate of 2 %-6%. Using a
3 % rate gives an MZ-twin concordance:DZ-twin con
cordance ratio (MZ:DZ concordance ratio) of -25-fold.
We note that, whereas the sib recurrence is based on
numerous. studies and a sizable total sibling population
(n = 597), the MZ-twin concordance rate is based on a
much smaller sample and thus is more susceptible to
statistical fluctuation. Nonetheless, it is likely that the
MZ:DZ concordance ratio in autism is quite large.
Autistic features have also been described in individ
uals with well-characterized genetic disorders, most no
tably fragile X syndrome (FMRl [MIM 309550)) ( Fein
stein and Reiss 1998) and tuberous sclerosis (TSCl
[MIM 1 9 1 1 00]) (Smalley 1998). In addition, case studies
have been reported that show associations between au
tism and a variety of isolated chromosomal transloca
tions, inversions, and deletions (Gillberg 1 998). These
findings provide evidence that genetic abnormalities can,
in some cases, produce behaviors typical of autism, but
they account for only a small percentage of cases and
do not explain the familial aggregation of autism.
Autism does not follow a simple mode of inheritance.
Genealogical studies suggested an increased risk pri
marily in close relatives (sibs) Oorde et al. 1 990), and a
reported segregation analysis was most consistent with
a polygenic model of inheritance Uorde et al. 1991).
These results suggest that family recurrence is unlikely
to be explained by a simple, monogenic mechanism.
The first linkage study in autism was performed by
Spence et al. ( 1985), using 20 classic blood-group and
serum-protein markers on 34 multiplex sibships and as
suming a recessive model. No significant linkage findings
were obtained.
Recent advances in molecular biology have allowed
genome surveys for disease-susceptibility loci to be per
formed on a much larger scale. For example, Hallmayer
et al. ( 1 996) examined 35 microsatellite markers on the
X chromosome in 3 8 multiplex autism families. Al
though they excluded most of the chromosome from
carrying a gene of large effect, including the fragile X
region, they found modest evidence (maximum LOD
score 1 .24) for linkage in one region on proximal Xq.
A genome screen of the full genome, using 3 1 6 mi
crosatellite markers on 39 multiplex families, has also
been reported recently (International Molecular Genetic
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Study of Autism Consortium 1998). Initial positive find
ings were followed up in an additional 60 families. No
statistically significant findings were obtained. The most
positive finding was a LOD score of 2.53, on chromo
some 7q, with the next most positive finding being a
LOD score of 1.97, near the telomere of chromosome
16p.
In this report we describe the results of what, to date,
is the largest genome screen in autism. We have surveyed
90 multiplex sibships with 97 independent affected sib
pairs (ASPs) in an initial analysis of 362 rnicrosatellite
markers. Regions with positive results, as well as other
candidate regions, were then followed up with addi
tional markers, as well as by analysis of a second set of
49 multiplex sibships containing 50 independent ASPs.
A total of 519 markers was analyzed in the first set of
families, and 149 of these markers were also analyzed
in the second set of families.

Families And Methods
Family Recruitment and Diagnostic Assessments

Families were recruited nationwide for this study, by
advertisement with local and national parent support
groups and by referrals from clinicians. Initial intake
criteria required that at least two siblings have a clinical
diagnosis of a PDD. If both the initial telephone intake
interview of parents and collected medical records were
consistent with a presumptive diagnosis of autism in at
least two children, then a follow-up visit by a diagnos
tician was arranged with the family. During these visits,
the children were assessed-both by interview, of o ne
or both parents, using the Autism Diagnostic Interview
(ADI) (LeCouteur et al. 1989; Lord et al. 1994, 1 997),
and by observation of the children, using the Autism
Diagnosis Observation Schedule (ADOS) (Lord et al.
1989)-to determine a research diagnosis of autism. The
ADI is a scored, semistructured interview of parents that
is based on ICD-10 and DSM-IV criteria for the diag
nosis of autism. The ADOS is a semistructured instru
ment, which allows assessment of the child through o b
servation of his or her behavior and which is used to
corroborate the results of the ADI interview. Diagnostic
assessments (by ADI and ADOS) were videotaped and
subjected to independent reliability checks by other
trained interviewers (typically, the senior clinical inves
tigators). To be considered affected in the linkage anal
ysis, an individual had to satisfy the prespecified cutoff
scores in all three symptom areas of the ADI ( social
impairment, language and communication impairment,
and unusual and restricted interests) as well as have an
age at onset of <3 years. In addition, review of the ADOS
tape by two or more diagnosticians was used to exclude
children who did not show significant impairments in
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Table 1
Distribution of Family Structures
No. OF
GROUP AND No.
OF AFFECTED SIBS
FS1:
2
2
2
2
2
2
3
3
4
4
FS2:
2
2
2
2
3

Unaffected
Sibs

Available
Parents

Families

0
0
1
1
2
3
0
1
0
1

2
1
2
1
2
1
2
2
2
1

48
15
13
5
2
2
2
1
1
1

0
0
1
2
1

2
1
2
2
2

34
1
12
1
1

social and communicative reciprocity, irrespective of the
results of the ADI interview (e.g., this would lead to the
exclusion of some individuals who would have had a
clinical diagnosis of PDD-NOS). Families were excluded
from subsequent analysis if, on the basis of all available
information, there was no consensus that at least two
affected children had deficits consistent with a diagnosis
of autism. For more details on the diagnostic protocol
and ret'iability of videotapes of the ADI assessments, see
the work of Spiker et al. ( 1994).
Children's records were reviewed to obtain IQ and
mental-age ( MA) information. When available, nonver
bal IQ scores were obtained from performance subtests
of either the Wechsler Scales or the Stanford-Binet In
telligence Scale-4th Edition, from the Leiter Interna
tional Performance Scale, or from the Merrill-Palmer
Scale. When unavailable, scores from such tests as the
Stanford-Binet Intelligence Scale-3rd Edition, Slossen In
telligence Scale, or McCarthy Scales were used. For chil
dren for whom results of these tests were not available,
MAs and ratio IQ scores were derived from nonverbal
scales of various developmental instruments (e.g., Daily
Living Scale of the Vineland Adaptive Behavior Scale,
the Bayley Mental Scale, and Developmental Inventory
II).
For inclusion in the linkage analysis, we also required
that at least one affected child have both an MA of ;:;. 1 8
m o and a nonverbal I Q ;:;.JO. This led to the exclusion
of some additional families (N = 6) in which all children
were severely impaired ( MA <18 mo and IQ <30).

Two-Stage Analysis
Families were analyzed in two stages. The initial stage
involved genotyping of family set 1 (FSl), which in-

eluded 90 multiplex families. These families comprise a
total of 1 87 affected and 30 unaffected sibs; 67 families
have two parents available, and the remaining 23 have
one parent. The precise breakdown of family structures
is given in table 1. Among the affected sibs, the male:
female ratio is 3.6:1, whereas in the unaffected sibs it is
0.8: 1.
Subsequent to the initial genome screen performed on
FSl , a follow-up study was conducted on a second fam
ily set (FS2), which comprises a total of 49 multiplex
families, ascertained in a manner similar to that used
with FSl . These families contain a total of 99 affected
and 1 5 unaffected sibs; 48 of the 49 families have both
parents available, whereas the single remaining family
has one parent. The precise breakdown, by family struc
ture, is given in table 1 . The male:female ratio in the
affected sibs is 3.0:1, versus 0.7:1 in the unaffected sibs.

Laboratory Procedures

Blood was collected from all affected individuals and,
if available, from their parents and unaffected siblings.
Blood samples were drawn into Vacutainer sodium hep
arin (green cap) tubes. The lymphoblasts were isolated
and immortalized with fresh or frozen virus stocks, by
standard Epstein-Barr-virus transformation protocols
(Anderson and Gusella 1984). The DNA was extracted
from both whole blood and immortalized lymphoblast
cell lines, by standard proteinase K-digestion and salt
ing-out procedures.
Genotyping was performed in two laboratories in-

Table 2
Markers with Highest Sharing in ASPs and DSPs
in Initial Genome Screen
Marker
ASPs:
D 1 S1631
D 13S779
D9S282
D1S1609
D3S2418
D17S1298
D1 5S652
D10S1412
D 15534
DSPs:
GATA145DO
D16S403
D 18S844
D16S3253
D7Sl 8 1 9
D4S2361
D 1 1 S2371
D4S2366
D20S482
D 16S769

No. (%) Sharing

Z Score

80/122 (65.6)
64/101 (63.4)
60/95 (63.2)
79/130 (60.8)
60/96 (62.5)
51/81 (63.0)
79/132 (59.8)
53/86 (61 .6)
8 1/137 (59.1 )

3.44
2.69
2.66
2.46
2.45
2.33
2.26
2.16
2.14

34/49 (69.4)
42/63 (66.7)
39/60 (65.0)
29/43 (67.4)
35/54 (65.3)
32/49 (65.3)
26/39 (66.7)
34/53 (64.2)
31/48 (64.6)
32/50 (64.0)

2.71
2.65
2.32
2.29
2.18
2.08
2.08
2.06
2.02
1.98
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dependently, according to somewhat different proce
dures. In one lab, PCR was performed, by Perkin-Elmer
9700 thermal cyders, in a 10-µl volume in 96-well plates
and included 30 ng of genomic DNA, 67 mM Tris-HCl
pH 8 .8, 200 µM of ·each dNTP, 16 mM (NH4 )2S04,
0.01 % Tween-20, 1 .5-3 mM MgC12, 0.2 µM of each
primer, and 0.2 units of AmpliTaq polymerase (Perkin
Elmer). The forward primers for each marker were flu
orescently labeled with FAM, HEX, or TET dyes. The
reaction was first denatured for 75 s at 9 5 °C; then, 35
cycles of 45 s at 95°C, 45 s at 57° C, and 60 s at 72°
C were performed, .followed by a final elongation step
of 7-12 min at 72° C. PCR products were pooled from
-7-15 markers that were separable on the basis of size
and dye color and were run on ABI Prizm 377 DNA
sequencers. Tamara-labeled DNA internal-size standards
were run in each lane, and the products were resolved
by the GeneScan and Genotyper software packages from
Applied Biosystems. Three CEPH control DNAs from
individuals 133 1-01 , 1331-02, and 1347-02 were used
to verify the sizes of PCR products for each marker.
In the second lab, PCR assays were performed in 8µl reactions containing 10 ng of genomic DNA; 2.5 mM
of each dNTP; 0.2-0.6 mM of each primer pair labeled
with the fluorescent dyes FAM, HEX, or TET; 0.8 µl of
10 x buffer (Perkin-Elmer); 1.5-2.5 mM MgCl2, and 0.2
units of AmpliTaq Gold Polymerase (Perkin-Elmer).
PCR assays were performed in an Applied Biosystems
9600 Thermocycler by denaturation for 10 min at 94° C,
15 s at 60° C, and 15 s at 72°C. Another 20 cycles of
30 s at 94° C, 15 s at 65 °C, and 15 s at 72°C were
performed, and these were followed by a final extension
step of 10 min at 72°C. Fluorescently labeled markers
were analyzed on an Applied Biosystems 373 Genetic
Analyzer, by Genescan and Genotyper software. In both
labs, polymorphic bands were scored, and alleles were
assigned to the pedigree members, by researchers who
were blind to affection status.
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the intermarker intervals, 28 have an interval length >15
cM, although only 7 are >20 cM; the largest gap is 23
cM.
Marker set 2 (M52). - Additional microsatellite mark
ers were obtained from Research Genetics and were an
alyzed subsequent to the initial genome screen. The
choice of markers was based on ( 1 ) saturation of regions
giving positive linkage evidence in the analysis of FS1
with MSl; (2) follow-up of specific regions, on the basis
of either candidate loci (chromosome regions 6p and
15q) or the genome screen of the International Molec
ular Genetic Study of Autism Consortium ( 1 998) (chro
mosome region 7q); and (3) addition of markers in
regions that had large gaps in the initial screen with MS1
and that did not have significantly negative linkage ev
idence in the preliminary analysis. In total, 1 57 addi
tional markers were typed, which constituted MS2. All
of these markers were typed in FS1; 89 of these were
also typed in FS2. In addition, 60 of the original MS 1
markers were genotyped in FS2 in the follow-up, for
reasons ( 1 ) and (2) above. Thus, in total, 5 19 markers
were typed in FSl, and 149 were typed in FS2.

Statistical Analysis

Linkage analysis. - Because all siblings had at least one
parent available and most had both parents available,
the statistical analyses were based entirely on identity by
descent (IBD), obviating the need to use allele frequen
cies of the parents. When one parent is missing, a sib
pair can be scored for IBD with the included parent,
without bias, provided that the typed parent is hetero
zygous and that each of the two sibs inherits from the
untyped parent an allele that is distinct from the alleles
of the typed parent. Also, sharing from the untyped par
ent was scored, when possible, by reconstruction of the
genotype of the missing parent, by use of one affected
sib and all unaffected sibs (in the ASP analysis). If the
genotype of the parent can be so reconstructed, then
unbiased scoring can be performed by comparison of
Genetic Markers
the affected sib with each remaining affected sib, who
Marker set 1 (MS 7). -The genetic analysis was per was not used for reconstruction.
formed in two stages. The first stage consisted of a ge
Sib-pair analyses were based on fully independent
nome screen on the 90 multiplex FS1 families and used pairs. When a family contained three or more affected
a total of 3 62 microsatellite markers. These were derived sibs, independent pairs were formed between the first
from version 8 .0 of the Marshfield fluorescently labeled sib and each remaining sib (giving n - l pairs for a fam
genome screening set ( Center for Medical Genetics, ily with n affected sibs). In the 90 multiplex FS1 families,
Marshfield Medical Research Foundation) and were ob there are thus a total of 97 independent ASPs; in the 49
tained from Research Genetics. Of these markers, 346 multiplex FS2 families, there are 50 independent ASPs
are autosomal, 14 are X linked, and 2 are pseudoau (see table 1 ) .
tosomal. If a sex-averaged total autosomal map length
Initially, the number of alleles shared versus the num
of 3,500 cM is assumed, the average spacing between ber of alleles unshared, at each marker across sib pairs,
markers for the autosomal component is 10 cM; if a was evaluated and compared to a x2 distribution. Under
length of 1 80 cM for the X chromosome is assumed, the null hypothesis of no linkage, the expectation is that
the average spacing on that chromosome is 12 cM. Of sharing will be 50%. Subsequently, multipoint sib-pair
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analysis was performed to extract the maximum infor
mation from the genetic-marker data. This analysis is
parameterized in terms of the value As, the sibling re
currence ratio, which translates into specific values for
ASP IBD. For a genetic model with no dominance var
iance, the probability Zo of an ASP sharing no alleles IBD
is .25f"s, the probability z 1 of an ASP sharing one allele
IBD is .50, and the probability z2 of an ASP sharing two
alleles IBD is .25 (2 - -t, ); the overall sharing is y =
.25(3 - -t,). For a multiplicative model which allows
dominance variance, again Zo = ·�; , Z1 = ( � - i )!As,
and z 2 = ( 1 - ! �)2; the overall sharing is y = 1 We use the latter model in all the multipoint anal
yses that we present, although, for modest gene effects,
results are nearly identical in either model.
Multipoint LOD scores can be calculated for a fixed
model (i.e., fixed value of Ash this approach allows for
exclusion mapping. For a fixed value of As, negative
LOD scores can be obtained if the model gives a poorer
representation of the marker data than does no gene
effect. We use the LOD-score criterion of -2 for exclu
sion of a locus with a given As value; this provides a
conservative exclusion level (Hauser et al. 1996). Alter
natively, the likelihood of the marker data can be max
imized at each point, as a function of the genetic model
(As value), to derive a maximum LOD score (MLS) curve.
This curve never drops to <0, the value obtained when
As = l.
Unkage-disequilibrium analysis (LO). -We also ex
amined LD, with all 5 1 9 autosomal and X-linked loci,
using a transmission/disequilibrium test (IDT) (Spiel
man et al. 1 993). For families with both parents, we
scored directly transmissions to all affected children
from heterozygous parents. As in the linkage analysis,
we can still score children from single parents, provided
that the parent is heterozygous and that the child is
heterozygous for alleles different than those in the typed
parent. We can also score transmissions from the missing
parent when the genotype of that parent can be recon
structed on the basis of the unaffected sibs.
We examined two statistical tests-a "global x2"
(GCS) test, which sums X = (observed-expected)2/ex
pected across each allele tested, and a "maximum x2"
(MCS) test, which takes the maximum value of the sta
tistic 'X across all tested alleles. In this case, neither sta
tistic has a formal x2 distribution when multiple sibs
from the same family are tested, if linkage is present
(Spielman et al. 1993). To make our test of LD inde
pendent of any linkage present, we calculated the level
of significance empirically, using Monte Carlo simula
tion; we simply randomly inverted or not, with proba
bility 50%, the allele label for the two alleles of hetero
zygous parents and recalculated the two statistics for
each permutation step. The proportion of simulated sta
tistics that exceed the observed value is the derived em-
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pirical significance level. This procedure allows us to
assess LD, conditional on the degree of sharing of alleles,
at a given locus, by sibs from multiplex families (Martin
et al. 1 997; Lazzeroni and Lange 1998).
Computer program. -All statistical analysis, including
the pointwise and multipoint sib-pair analyses and the
IDT analyses, were performed with the ASPEX program
package. We also used this package to confirm relation
ships among study subjects and to search for and elim
inate unlikely double crossovers in the multipoint anal
yses, in regions that had dense markers.
Controls

In the course of this study, a number of controls were
employed, to determine the degree to which potential
biases might be confounding our results. After -60
markers were run in FSl, we examined the distribution
of IBD for all sib pairs, to confirm the presumed rela
tionships, identify any mixup of samples, and identify
any potential half-sibs. All families segregated appro
priately according to presumed relationships ( no half
sibs were identified), with the exception of two sib pairs,
in which IBD was nearly 100% . These pairs were re
ported to us to be DZ twins, whereas our genotyping
determined them to be MZ. We left these twin· pairs in
the·analysis, both as a positive control and to determine
the genotyping-error rate. The lab remained blind to the
identity of these pairs.
As another control for our genetic analyses, we also
included unaffected sibs in our molecular and statistical
analyses. FS 1 contains 30 unaffected sibs, which allowed
us to construct 51 independent affected-unaffected sib
pairs, or DSPs. These were derived by pairing, in each
family, one unaffected sib with each affected sib. Re
maining unaffected sibs were used for reconstruction of
the genotypes of untyped parents. This selection scheme
allowed us to tally IBD for these pairs as fully indepen
dent. Because of the typically modest recurrence risk of
autism in sibships (Smalley et al. 1988), we assume that
the DSPs should deviate little from the null expectation
of 50% sharing-and that they thus can serve as a useful
negative control.
Results
Family Recruitment

The first stage of analysis included the 90 multiplex
FSl families comprising 187 affected offspring, 30 un
affected sibs, and 157 parents. Two additional families
with affected MZ twins (originally thought to be DZ)
were also included. At the time of ADI administration,
the age range of the affected siblings was 2.9-40.9 years
(mean 9.8 years, SD 7.3 years, 25th-75th percentile
4.9-1 1 .3 years). MA and IQ estimates were determined
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on the basis of available diagnostic evaluations and 10 loci in the DSP group that exceed this threshold,
school records. The mean nonverbal IQ was 66 (SD 28, which are listed in table 2. These numbers are not dif
range 1 6-160). One hundred eight subjects (57%) had ferent from the number expected (.025 x 360 = 9.0)
IQ scores <70. The mean MA was 68 mo (SD 55 mo, under the null hypothesis of no linkage. The most sig
range 13-373 mo). There were no families in which all nificant locus, in either group, was D1S163 1, for the
affected children had IQ scores <30. In one family, one ASPs, with a sharing of 65.6% and a Z score of 3 .44.
The remaining loci in the ASP group were found on
affected child had an MA of <18 mo.
The second set of study subjects, obtained with similar chromosomes 1 (two additional loci), 3, 9, 10, 13, 15,
recruitment and inclusion/exclusion criteria, comprised and 17. The locus on chromosome 15, D15S652, is telo
a total of 99 affected children, 15 unaffected sibs, and meric of and not linked to the candidate region, on prox
97 parents, from 49 families. For this group, at the time imal 15q, associated with the inverted duplication found
of ADI administration, the age range of affected subjects in some autistic subjects (Gillberg et al. 1991; Cook et
was 2.8-25 .3 years (mean 6.6 years, SD 3.5 years, al. 1997). Aside from locus D1S1631, there appears to
25th-75th percentile 4.3-7.6 years). The mean nonver be no substantial difference between the tail Z scores
bal IQ was 61 (SD 23, range 15-124). Sixty-two subjects for the ASP group and those for the DSP group.
We also examined the full distribution of Z scores,
(63% ) had IQ scores <70. Mean MA was 47 mo (SD
23 mo, range 1 3-150 mo) . Again, there were no families for both the ASPs and the DSPs. These distributions are
in which all children had IQ scores <30, and there were given in figure 1 . For convenience, we have p lotted each
Z score as a function of cp- 1 [(R - ! )/S], where R is the
three children with MA <18 mo.
The unaffected children were presumed to be devel ordered rank of that Z score, S = 346 is the total number
oping normally, on the basis of parental report; all of of autosomal markers, and <Ii is the cumulative normal
these children were in regular educational programs and distribution function. Under the null hypothesis (no link
schools. None had any clinical diagnoses, according to age), this curve should fit the line y = x . In figure 1, the
parental report, nor, during telephone intake interviews, line y = x is depicted as the thin unbroken line; the thick
did parents report any developmental concerns. Children dotted line represents DSPs, and the thick dashed line
with a possible PDD diagnosis based on the ADI inter represents ASPs. As can be seen in the figure, both the
view but who did not meet the ADI criteria.for autism ASP and DSP lines run parallel but above the line y =
were categorized as being of uncertain status and were x, but more so in the case of the ASP line. This indicates
not included in this analysis. Eighty-eight percent of our that the entire distribution of Z scores for the ASPs is
sample was white ( of varied European and Middle East shifted upward, compared with that for the DSPs, and
ern origin), 5% was black, 3 % was Hispanic, and 4% this shift is most noticeable at the left end of the distriwas Asian. The vast majority of affected subjects were
living with parents, and a small number were in resi
Z Scores for Concordant and Discordant Sib Pairs
dential living facilities.
4.0 �-------�----,-------,

FS 7 : Pointwise /BO Scores
A total of 346 autosomal, 14 X-linked, and 2 pseu
doautosomal microsatellite loci were studied in FSl,
which contained 97 independent ASPs and 51 indepen
dent DSPs. Tallying the total number of alleles shared
across all 346 autosomal markers gives 19,902138,572,
or 51.6%, for the ASPs and 9,344/1 8,386, or 50.8%,
for the DSPs. The slight increase in IBD, to >50%, in
the DSPs suggests the possibility of some modest scoring
bias toward allele sharing in sibships.
Of greatest interest is the right-hand tail of the ob
served IBD distribution in the ASPs and DSPs. For each
marker, we calculated a Z score, Z = (s - u)/.Js + u ,
where s is the number of shared alleles and u is the
number of unshared alleles. Under the null hypothesis
of no linkage, Z should have a normal distribution with
mean O and variance 1 . When a threshold of 1 .96
(P = .025 for a one-sided Z test) is assumed, there are
9 loci in the ASP group that exceed this threshold and
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Figure 1
Observed distribution o f Z scores for sharing a t 346
autosomal marker loci in ASPs and DSPs, compared with the expected
distribution under no linkage. The thin unbroken line represents no
linkage; the thick dashed line represents sharing for ASPs; the thick
dotted line represents sharing for DSPs.
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bution (i.e., deficiency of negative sharing). The final
" blip" at the right end of the ASP line is due to marker
D1S163 1 .
Observed versus Expected Distribution Of 180 Scores

As discussed above, family and twin studies suggest
that autism is a highly heritable disorder. However, these
data alone cannot reveal the precise mode of inheritance.
The very high MZ:DZ concordance ratio, taken at face
value, is strongly suggestive of multiple interacting loci
( epistasis), with no single locus having a substantial ef
fect. The results of our initial genome screen would seem
to support this conclusion. However, given the high re
currence-risk ratio for sibs (As = 75-100) and the high
( 1 5-25) MZ:DZ concordance ratio, one may reasonably
ask what the distribution of IBD scores would look like
for various genetic models consistent with those values.
For the purpose of computational simplification, we as
sume a multiplicative epistatic model (Risch 1990) with
K loci of equal effect. Given the 1 5-25 MZ:DZ con
cordance ratio, models with as few as two loci can be
excluded. For a model with K loci, the ith locus will
have an individual value of As; = (>-. 5 );: for i = 1 , . . . ,K
(Risch 1 990). The ASP sharing Y; at each of these loci
will be Y; = 1 - .5(As;ri = 1 - .5(>-.5 rf. according to a
multiplicative model. For example, for K = 3, Y; =
75.7%; for K = 5, Y; = 67.5% ; for K = 1 0, Y; =
59.7o/o'; and, for K = 20, Y; = 55.1%. If As = 1 50, then
the corresponding Y; values for K = 3, 5, 10, and 20 are
only slightly higher-namely, 78.3 %, 69.7%, 61.1 %,
and 55.9%, respectively. Similar numbers can be ob
tained by parameterization in terms of the MZ:DZ con
cordance ratio, which we here denote as "}..MD·" Ac
cording to a multiplicative model, for K contributing
loci of equal effect, the total >-.MD is (>-.MDf, where >-.MDi
is the ratio contributed by the ith locus. Furthermore,
the expected ASP IBD sha ing for a locus with value AMD;
�
is given simply by Y; = f >-.Mo;· Since, in a model with
K loci of equal effect, >-.Mo; = (>-.M0)i: for i = 1, . . . ,K, we
can calculate the expected sharing, under the assumption
that >-.Mo = 25, for K = 3, 5, 10, and 20 as being 85.5%,
69.0%, 58.7%, and 54.2%, respectively. It can be seen
that these numbers are larger than those based on the
sib risk ratio for smaller K values (i.e., <.5) but that they
begin to converge at K > 5.
Certainly our data are not consistent with a three
locus model, since we do not have three regions with
sharing approaching 70% . Recombination will tend to
decrease sharing away from these high values, but, given
our map density, if is unlikely that the sharing would be
significantly diminished. In fact, we can calculate sys
tematically, making some simplifying assumptions, what
the distribution of sharing (and associated Z scores)
should be under these alternative genetic models.
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Consider the distribution of Z scores derived from a
genome screen. Fo�iven marker, Z is defined, as
above, as (s - u)I-Js + u. Under the null hypothesis of
no linkage, Z is approximately normally distributed,
with mean O and variance 1. Now consider a genetic
model of K disease loci, each of which has sharing Y;·
We assume that the loci are unlinked. Assume a genetic
map with a marker every w cM. On average, the distance
of a disease locus to the closest marker will be -'.f; the
distances to remaining markers, in order of distance, are
7
3.;" 5
, .;" , .;" , etc. For a marker at recombination distance
r from a disease locus, the sharing will be y(r) = [r 2 +
( 1 - r} 2 ]y + 2r(1 - r)( l - y). Thus, assuming a map
function relating recombination fraction r to map dis
tance w-for example, r = f(w)-we can calculate the
expected values of sharing y for markers surrounding a·
disease locus.
In the present analysis, we assume the Kosambi map
ping function r = f(w) = (1 - e-4w}/2( 1 + e-4w). As in
our screen, we assume a map density of 10 cM, with a
total map length of 3,500 cM. For each of K putative
disease loci, we estimate sharing y(r) at neighboring loci
at distances 2.5 cM, 7.5 cM, 12.5 cM, . . . , up to 47.5
cM, using the Kosambi map function and the y(r) for
mula given above.
For the model with K loci of equal effect, there are K
loci each with value y(r), where y(r) ranges over the 10
values based on the 10 different marker distances. In our
genome screen of ASPs, the average total number of
transmissions scored at a locus was 1 10 (i.e., s + u, in
the notation above). Therefore, for the K markers with
expected sharing y(r), we used sampling from a normal
distribution with mean y(r) and variance v(r) =
y(r)[l - y(r)]/110 to obtain the expected distribution
of their observed sharing. We selected the K points from
this distribution to be equally spaced to preserve the
mean y(r) and variance v(r). For exampl , for K = 5 we
chose the five points y 1 (r) = y(r) - �2v(rb_y2 (r) =
y(r) -./v(r)/2, .Yl.{d_ = y(r), y4 (r) = y(r) + ,/v(r)/2, and
y5 (r) = y(r) + ,/2v(r). These five points have sample
mean y(r) and variance v(r). For the jth such point, the
e ected Z score was then derived by taking Z;(r) =
2j1 10[y;(r) - f] = 10.49[2y;(r) - 1]. As an example,
consider the genetic model with As = 75, K = 5, and the
third-closest marker ( 12.5 cM). For this case, y =
.675, r = .122, y(r) = .600, y1 (r) = .534, y2 (r) = .567,
y3(r) = .600, y4 (r) = .633, and y5 (r) = .666; Z 1 (r) =
.71, Z 2 (r) = 1.41, Z 3 (r) = 2.10, Z 4 (r) = 2.79, and
Z 5 (r) = 3.48.
In this fashion, Z scores for 1 0K markers were de
rived. For the remaining 346 - 1 0K markers, we dis
tributed their Z scores as above but according to a nor
mal distribution with mean O and variance 1 . We have
calculated these expected distributions, assuming that
As = 75 and K = 3-20. The results for K = 3, 5, 1 0,
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and 20 are given in figure 2. As in figure 1 , we have
Observed versus Expected Z Scores for 346 Markers
plotted the Z scores as a function of <1>- 1 [(R - ! )IS],
where R is the rank of the observed Z score and S is
the total number of markers (346). A normal distribu
'
I
I
/'
3.0
tion appears as a straight line (y = x) on this plot and,
J
' ...
.i '" , .. .._,,
in figure 2, is depicted by the thick unbroken line. The
,
t
/
,..
expected curve corresponding to K = 3 is given by the
thin dashed lined, for K = 5 by the thin dotted line, for
1 .0
K = 1 0 by the thin short-dashed line, and for K = 20
jN
by the thin unbroken line. The curve for the actual data
is given by the thick dashed line. In calculating the Z
scores for the actual data, we used 50.8% for expected
- 1 .0
sharing under the null hypothesis, instead of 50%, to
allow for some potential genotyping bias, as observed
in the DSPs. As can be seen in figure 2, the actual data
most closely approximate the expectations for the model
-3·':s. ...
.o_______,
0______
_�
3.o
1 .0------1..,_
with K = 20. The fact that the thick dashed line lies
Probit ol Rank
above the y = x line at the left end of the plot indicates
that the excess sharing in ASPs compared with DSPs is
Observed distribution of Z scores for sharing at 346
due to the entire distribution being shifted to the right, Figure 2
autosomal marker loci in ASPs, compared with the expected distri
rather than to a small subset of marker loci showing bution, when a model of K = 3, 5, 10, or 20 loci of equal effect is
increased sharing. The right end of the plot, although assumed. The thick unbroken line represents no linkage; the thick
reasonably consistent with K = 20, is quite deviant from dashed line represents the observed data for ASPs; the thin long-dashed
the distribution expected for K = 5 or 1 0 , with the ex line represents K = 3; the thin dotted line represents K = 5; the thin
ception of the final marker (D1S163 1 ). For other values short-dashed line represents K = 1 O; the thin unbroken line represents
K = 10.
of K, the distributions lie between the curves in figure
2. For example, for K = 15 the distribution lies ap
Most significant among these assumptions, however, is
proximately midway between the line for K = 10 and
that
the disease-susceptibility loci are unlinked, which
that for J( = 20; for K = 13 the distribution is somewhat
will be unlikely for models with K � 20. The effect of
closer to the line for K = 10.
having linked disease loci is to increase sharing locally
To assess goodness of fit of each predicted distribution
in the region of the linked loci-and to decrease it, on
to the observed distribution, we calculated the statistic
average, elsewhere. Thus, the impact will be to create a
W = E;.:f(Z;1 - Z;o)2, where Z,1 is the ith (rank-ordered)
distribution more similar to the case of fewer disease loci
Z score for the expected distribution and Z;o is the cor
with larger effect. Therefore, our modeling is actually
responding Z score for the observed distribution. A small
conservative in concluding that the observed distribution
value of W indicates a good fit of the observed distri
is most compatible with a large number of disease loci.
bution to the predicted distribution. The corresponding
value of W for values of K = 3, 5, 1 0, 13, 15, 1 7, and
Sharing by Gender of Parent
20 is 53.1, 1 6.7, 5.1, 3 .6, 3.1, 2.8, and 2.7, respectively.
Thus, models with �10 loci appear unlikely, whereas
The observation of genomewide excess sharing and a
those with �15 seem more plausible. The best fit is given putative model of many genes of small effect accounting
by the model with K = 20 loci, although the value of for the total familial effect in autism allow us to posit
W does not increase much up to K = 1 5 . Models spec a further prediction. If, in fact, there are many genes
ifying a small number of loci (i.e., one or two) with scattered around the genome, then the excess of sharing
moderate effect (As = 2) also give a reasonable fit (al that we have observed should differ when tallied sepa
though not as good as is given by the model of 20 loci rately for paternal versus maternal meioses. The reason
with equal effect), provided that the number of residual is that the female linkage map, at 4,200 cM, is -1.5
loci remains large (e.g., �15). Thus, our results, al times the genetic length of the male map, at 2,800 cM.
though consistent with a genetic basis of autism, suggest Because there is globally less recombination in males,
that the most likely model is one with many (�15) con the expected genetic distance (recombination fraction
tributing loci, with a possible gene of larger effect on [8]) to a disease-susceptibility locus in males is expected
chromosome 1.
to be less than that in females, and thus the expected
In calculating the expected distributions, we have allele sharing at a marker linked to the disease locus is
made a number of simplifying assumptions, such as expected to be greater when one examines fathers than
equal spacing and equal polymorphism of the markers. when one examines mothers.
I
/

/
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Table 3
Global Allele Sharing in ASPs and DSPs, by Sex of Parent and Genetic
Map-Interval Male:Female Ratio

SEX RATIO
(Male:Female)
ASPs:
>1 (85 markers)
<1 (261 markers)
Total
Total (maternal + paternal)
DSPs:
> 1 ( 85 markers)
<1 (261 markers)
Total
Total (maternal + paternal)

No. (%) SHARING
Maternal
Paternal

2,336/4,560 (51.2)
2,413/4,712 (51.2)
7,459/14,275 (52.3)
7,694/15,025 (51.2)
9,795/18,835 (52.0) l0,107/19,737 (51.2)
1 9,902/38,572 (51.6)

l,167/2,304 (50.7)
l,1 10/2,160 (51.4)
3,66617,200 (50.9)
3,401/6,722 (50.6)
4,83319,504 (50.9)
4,51118,882 (50.8)
9,344/18,386 (50.8)

To quantitate this prediction, define d(O) = y - !,
where y is the sharing at a disease locus. Then, at
0 distance, the value of y is y(O) = [0 2 + (1 - 0)2 ]y +
20(1 - 0)(1 - y), so that d(O) = y(O) - i = ( 1 20)2d(O). If we assume a uniform distribution for the
map distance, w, from a random marker locus to the
nearest disease locus, then, over some total map length
L, the expected value of d is
L

E(d) =

"f, J d(O)[l - 20(w)]2dw ,
0

where w is some mapping function relating map distance
to 0. For the Haldane mapping function O(w) = ( 1 e-2w)l2, E(d) = d(O)( l - e-4L)/L d(O)IL, for L > so
cM. Similarly, for the Kosambi mapping function
O(w) = (e 4w - 1 )!2(e 4w + 1), E(d) = d(O)[( l + e 2Lr ! log( l + e-2L) + log2 - t]/L .193d( O)/L for L > 50
cM. In either case, E(d) ex: Therefore, if female map
distances are 1.5 times male map distances and if we let
dm represent the d value for male (paternal) meioses and
let d1 represent that for female meioses, then we have
E(dm )/E(d1) ex: 1 .5. Therefore, when the observed sharing
rate of .508 (from the discordant pairs) is used as the
null value, the observed sharing for concordant pairs,
.516, gives a sex-averaged value of E(d) = .008. There
fore, the prediction discussed above would give sex- spe
cific E(d) values of E(dm ) = .010 and E(d1) = .006, or
sex-specific sharing values of Ym = 5 1 .8% and y1 =
5 1 .4%. If we use 50% for the null-hypothesis sharing
value, then the sex-specific sharing becomes Ym =
51.9% and y1 = 5 1 .3%.
The observed total sharing for ASPs, stratified by sex
of parent, is Ym = 9,795/18,835 = 52.0% and Yf =
10,107119,737 = 5 1 .2% (table 3), close to the predic
tion. For comparison, we also examined the parent-spe
cific allele sharing for the DSPs. There was no difference

=

=

t.

in overall allele sharing, by sex of parent, for this group
(50.8 % paternal, 50.9% maternal).
We can make this prediction more precise b y noting
that the male:female ratio of map distances is not uni
form throughout the genome but, rather, is region spe
cific. Some regions (e.g., telomeres) tend to show an ex
cess of recombination in males. Thus, we would expect
the observed excess of paternal allele sharing to be re
stricted to those regions where the female map distances
exceed those of the male. To test this hypothesis, we
identified the location of each of the 346 marker loci on
the Marshfield genetic maps (Center for Medical Ge
netics, Marshfield Medical Research Foundation). By ex
amining, for each locus, flanking markers up to 10 cM
away (sex averaged), we determined whether the genetic
length of the flanking interval was greater in males (male:
female ratio >1 ) or in females (male:female <1 ) . As ex
pected, the number of markers with a male:female ratio
>1 (n = 85) was approximately one-third the number
with a male:female ratio <1 (n = 261 ). As predicted, the
paternal excess of sharing in ASPs was restricted to
markers lying in regions with a male:female ratio <1
(52.3 % paternal sharing vs. 51.2% maternal sharing)
(table 3). Again, the DSPs showed no such trend, since
the paternal and maternal sharing were nearly equal in
both groups (table 3).

Multipoint Sib-Pair Analysis in FS T
We performed multipoint sib-pair analysis on the data
from FSl , for the 360 autosomal and X-linked markers
of MSl . The results are shown in figure 3. In the figure,
the MLS curve is represented by the dashed line. There
were nine locations that gave an MLS � 1 .0 : chromo
somes lp (MLS 1.87), .l q (MLS 1.19), 7p (MLS 1 .00),
llp (MLS 1 .25), 13q (MLS 1 .49), 15q (MLS 1 .75), 1 7p
(MLS 1 .30), 18q (MLS 1 .00), and 20p (MLS 1 .09). The
MLS on chromosome lp was diminished compared with
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the significance obtained with marker DlS1631 (table
2), because of less sharing at neighboring markers.
These results are consistent with those shown in fig
ures 1 and 2, in that no regions revealed linkage evidence
that was near significance, even when a liberal criterion
of MLS 3 .0 was used. Thus, it is unlikely that any genes
of moderate to large effect underlie this disorder.

Follow-up in FS2

The 49 families of FS2, comprising 50 ASPs, were
analyzed for a total of 149 markers, 60 of which were
original (i.e., MS1 ) markers typed in FS1 . A total of 157
additional markers (MS2) were typed in FS1; 89 of these
were also typed in FS2. Many new markers were typed
only in FS1 , either to fill in larger gaps in the original
screen or to increase marker density in certain candidate
regions, in particular on chromosomes 6p and 15q. On
the basis of preliminary positive results in the first stage
of analysis, markers were added on chromosomes 1 ( two
regions), 3, 9, 10, 1 3 , 15, and 17.
Results of multipoint analysis of the combined data
from both FS1 and FS2, for all 517 autosomal and X
linked loci, are given in figure 3 (the MLS curve for the
total data is represented by the unbroken line; the ex
clusion curve fixing As; = 3.0 is represented by the dotted
line). The linkage evidence, in FS2, for markers on prox
imal chromosome 1 p was positive, with allele sharing
of 50%..-66 % (average 56%}; in FS1, maximal sharing
in multipoint analysis was observed near marker
D 1 S 1 63 l . With the inclusion of FS2 and additional
markers in this region, the MLS of 2.15 now occurs at
a slightly more proximal location (near marker
D 1S1675}. This location gives, by far, the strongest link
age evidence in our study. The next most significant re
sult is on chromosome 17p, where the MLS peaked at
1 .21, near marker D l 7S1876. Only two other regions
had an MLS ;;;,,t.O, one each on chromosome 7p (MLS
1 .01, near marker D7S2564} and 18q (MLS 1.00, near
marker D 1 8S878}. All other regions with MLS ;;,,LO in
the initial scan were less positive in FS2, leading to a
reduction in the total MLS for FS1 and FS2 combined.
Notably, only chromosome lp had substantially positive
allele sharing in FS2, leading to a modest increase in the
MLS for FS1 and FS2 combined.
Proximal chromosome 15q is a candidate region for
an autism-susceptibility locus, because of reported in
verted duplications in a number of patients (Gillberg et
al. 1991; Cook et al. 1997). Furthermore, some positive
linkage results were reported in this region in a small
collection of multiplex families (Pericak-Vance et al.
1997). We previously have reported that, in this region
of chromosome 15, there is a lack of linkage evidence
in the 97 FS1 ASPs ( Salmon et al., in press). The addition
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of 50 ASPs from FS2 has not altered this conclusion,
since our linkage evidence is still uniformly negative
across the entire region (fig. 3 ). The positive linkage
results that we obtained on this chromosome were near
marker D15S1050, which is 62 cM away.
We have also previously reported a lack of linkage
evidence with markers in the HLA region on chromo
some 6p in FS1 (Rogers et al., in press}. The data in this
region remain negative with the addition of FS2.
In a previous analysis of 38 of the ASPs included in
the present study, we examined markers on the X chro
mosome. Although we excluded most of the chromo
some, including the fragile X region, from harboring a
gene of large effect, a region of Xq did show modest
evidence of linkage, with a LOD score of 1.24. In the
present study, based on a much larger number of fam
ilies, there is no evidence of linkage anywhere on the X
chromosome.
A genome screen of 39 multiplex families with autism,
with follow-up in an additional 60 families, found sug
gestive evidence of linkage on chromosomes 7q and 1 6p
(International Molecular Genetic Study of Autism Con
sortium 1998). The MLS in the same region of 7q is
0.62 (for marker D7S684}, on the basis of a total of 139
families and 147 ASPs. We had a slightly more positive
result at marker D7S1804 ( MLS 0.93), located 10.3 cM
more proximal. The original study had an MLS of 2.53.
Thus, if a susceptibility locus resides in this region, its
effect is likely to be small, given the modest LOD scores
observed.
In our initial scan (i.e., with FS1), a region of chro
mosome 13q had an MLS of 1 .65, near marker
D 13S779. In our follow-up, the linkage evidence at this
location was negative (46.3 % sharing); however, a re
gion of modestly increased sharing appeared somewhat
distal in the same area, with an MLS of 0.68, near
marker D13S800 (fig. 3 ) . This region has also been re
ported in another recent genome screen (Vieland et al.
1998). Again, the modest level of linkage evidence in
our collection of 147 ASPs suggests that a gene of large
effect in this region is unlikely.
Using a strict exclusion criterion of -2 (Hauser et al.
1996), we were able to exclude -95% of the genome,
for a value of A s; = 3.0 (fig. 3). When the less strict
exclusion criterion of - 1 was used, 99% of the genome
could be excluded.

Positive Controls
In our study, we had initially included two twin pairs
originally thought to be D Z but subsequently, through
our genotyping, shown to be MZ. These subjects were
left in the study as a positive control and to estimate the
rate of genotyping error. The individuals performing ge-

Risch et al.: A Genomic Screen in Autism

503
,,

, ·....,..,ei
o+.................-.+'I'<�.,..............,...-,.....,...
.3

.. ..
-44-,.....,...._..,..,',,:.....'>'::,...:�........��-·�·........'�
":l..-l
2.0
l.O
.0

l.O

.0

2.0

0 ..J..p,#...;......,;,....,..,...-.4=�::;::,...-.4-...-,.l
_, -:

1.0

.0

.

1.0

.o

2.0

l.O

.o

2.0

2.0

;:::;'.,:-:,::-...,..::,,.,..,.-..-.-..;
o +;=�

. ·.

•3

.0

1.0

.0

l.O

.:

.:'\

l.l

l.O

.l

.0

�··.::

.0

12

II

',, '

r

.0

.l

l.O

�·. .!\!
.l

.0

l.l

�···.
1.5

1.0

:,

.5

.0

1.0

.l

,; ...·.
1.0
l.l

1.5

13

:, :

.o

l.O

.l

II

16

:_..f f{\

.)

.0

.l

.0

l.O

�,........,
.. ..............
-�
..-= ........

19

.0

.l

l.O

1.0

.l

.0

l.O

.0

.l

l.O

21

' "'

.0

.l

.0

.l

l.O

X

..... - _ ,,. ... .. - -

.l

1.0

.o

6

.2 •• •

:'... :

.0 .2 .•

.6

.0

.l

1.0

l.l

Figure 3
Multipoint sib-pair analysis of ASPs. The dashed line represents the MLS for FS1 with MS1 ; the unbroken line represents the
MLS for FS1 + FS2, with all markers; the dotted line represents the exclusion plot for As = 3.0, with all families and markers.
notyping were blinded to the status of these subjects.
Considering a total of 946 loci scored for these two pairs,
we found them to be genotypically discordant at 10 loci,
or a rate of 1.0%. It should be noted that, in our study,
families were analyzed intact, so that some genotyping

errors (Mendelian inconsistencies) could be identified.
These Mendelian inconsistencies were identified and cor
rected (by additional genotyping, if necessary) and were
not included in the error rate given above.
As a second positive control, we included the pseu-
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doautosomal marker DXYS1 54. This marker is com
pletely linked to sex, since it does not recombine between
the X and Y chromosomes. In our study, we had a large
predominance of affected males (male:female ratio 3.6:
1 in FS1 and 2.8: 1 in FS2). Thus, a majority of our ASPs
are brother pairs, whereas a minority are sister pairs or
of mixed sex. Overall, 73 % of our ASPs are concordant
for sex (63 % males and 1 0 % females). Therefore, we
expect, at locus DXYS1 54, excess sharing of alleles in
herited from the fathers, but not of those inherited from
the mothers. In FS1 and FS2 combined, there were 5 8
paternal alleles shared and 2 2 paternal alleles not shared,
giving a x2 of 1 6 .2 (the LOD score equivalent of which
is 3.52). By contrast, there was no difference in the shar
ing of maternal alleles: 42 alleles were shared and 45
alleles were not shared. The significantly increased shar
ing of paternal alleles at this marker demonstrates that
our methodology was sufficiently sensitive to detect a
real excess of sharing of this magnitude (i.e., 73 % ) when
such an excess was present.

LO

We performed TDTs for all 5 17 autosomal and X
linked loci analyzed in this study. Here we report the
results of the GCS test (see the Linkage-Disequilibrium
analysis [LD] subsection, above). In figure 4 we have
plotted the distribution of observed ( empirically derived)
P values, as a function of their rank. Under the null
hypothesis of no LD, the distribution of P values should
be uniform, and thus this plot should approximate the
line y = x, which, in figure 4, is represented by the
straight unbroken solid line; the values for affected off
spring are represented by the dashed line, and those for
unaffected offspring are represented as the jagged un
broken line. As can be seen in the figure, for P < .OS the
observed and expected distributions are the same for the
two types of offspring and fit the line y = x well. These
results are not unexpected, in that it is a priori unlikely
that a disease locus would lie very close to and in LD

Discussion
We have performed a genomic screen by linkage anal
ysis of 90 multiplex sibships with autism, including 97
independent ASPs, with 3 60 autosomal and X-linked
markers. Regions that, in this screen, initially either (a)
had positive results, (b) had gaps, or (c) were identified
as specific candidate regions were subjected to follow
up with additional markers. We also genotyped a second
set of 49 multiplex sibships (50 ASPs), with markers in
specific target regions. In total, 5 1 9 markers were run
on FS1, and 149 were run on FS2. More than 1 60,000
genotypes were generated.
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Figure 4
Observed distribution of P values from IDT tests for
5 1 9 markers for affected and unaffected offspring. The straight un
broken line represents expectation under no LD; the dashed line rep
resents unaffected offspring; the jagged unbroken line represents af
fected offspring.
Analysis of allelic sharing for the initial 360 markers
in FS 1 was most consistent with a multigenic inheritance
pattern, in that a global excess of allele sharing was
observed in the ASPs versus the DSPs, but not specifically
for a small number of loci. The overall distribution of
allele sharing was most consistent with a model of ;,, J S
susceptibility loci.
These results are not inconsistent with the observed
recurrence risks in nuclear families and twins. The very
high (25-fold) MZ:DZ concordance ratio is indicative
of at least several interacting loci and, potentially, of
many such loci. Multilocus inheritance does not preclude
the possibility of one or a few loci with larger effects;
there is a limit, however, on how large these effects can
be, given our modest linkage findings. A previous study
of family recurrence risks in autism found a model with
3 interactive loci as providing the best fit to the data,
with a range of 2-10 loci (Pickles et al. 1995). Our
results clearly exclude a model with as few as 3 loci and
are also inconsistent with a model with as few as 1 0
loci.
Our results also do not preclude the possibility of
etiologic heterogeneity, with a subset of cases having a
simpler (e.g., Mendelian) etiology. However, as ex
plained above, such a group would need to be relatively
minor, given both our results and the large MZ:DZ con
cordance ratio.
Our most significant findings were for proximal chro
mosome 1 p. The most sign ificant increase in sharing in
our initial screen was for marker D 1 S 1 63 1 , with 6 6 %
sharing and a Z score o f 3.44 (table 2 ) . The multipoint
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analysis of FS 1 brought this score down to an MLS of
1 .88; however, this region was also the most positive in
our follow-up and, in 147 ASPs, gave a total MLS of
2.15 and sharing of 60%. We note, however, that this
result falls short of formal statistical significance for a
genome screen (Lander and Kruglyak 1 995). The MLS
location after follow-up was somewhat more proximal
than that in the initial screen, near marker D151675.
No other region had an MLS >1.3 in our follow-up.
Our next most significant finding was for chromosome
17p, where the MLS was 1 .2 1 . We had modestly positive
LOD scores in regions identified in other genome
screens-chromosomes 7q and 13q. Our results for
chromosome 15q, in the Prader-Willi region, which, on
the basis of cytogenetic evidence, is a candidate region
for an autism-susceptibility locus, were uniformly neg
ative, consistent with our earlier results (Salmon et al.,
in press). However, in our initial screen, we did identify
another region, more distal on chromosome 15q, that
had an MLS of 1 .75; but, in the follow-up, the MLS in
this region decreased to 0.81.
We employed several controls in this study, to identify
potential biases. First, we analyzed unaffected siblings
in our multiplex sibships, to create a comparison group
for our linkage and LD results. Second, we kept two
pairs of MZ twins, originally thought to be DZ, in the
genotyping set, as a positive control for our genotyping,
as well as to estimate the error rate in genotyping. Fi
nally, we included a pseudoautosomal marker com
plete1y linked to sex, as a positive control, reflecting the
excess of sex-concordant (primarily brother) pairs in our
study. As predicted, this marker showed a clear, statis
tically significant paternal excess of sharing (MLS 3 .52).
These controls provide confidence in the validity of our
conclusions.
We also took a conservative approach to phenotyping.
All study subjects were evaluated by both ADI assess
ment and ADOS assessment, and all questionable cases
were excluded from analysis. Furthermore, to reduce po
tential heterogeneity, we excluded families in which all
affected children had extremely low IQ, since this group
may have distinct etiologies related to their severe-to
profound mental retardation. In total, we excluded 45
families from further analysis. The primary reason for
the family exclusions was that not all affected sibs had
a strict diagnosis of autism, as defined by agreement of
all diagnosticians. As a result, the families in our study
included few broadly defined, questionable, or mild
cases (e.g., clinical diagnoses of either PDD-NOS or As
perger syndrome), even though most of the children in
these excluded families did exhibit symptoms and be
haviors indicative of the autism spectrum, some at the
very high end of the spectrum and some at the very low
end.

We employed these conservative diagnostic rules for
inclusion within the study, which were applied equally
to all affected subjects in a family, for two reasons. First,
we wanted to enhance our chances of detecting any link
age, by creating a more homogeneous set of families.
Second, we wanted to gain confidence that any negative
results that we might obtain would not be due to the
use of a too-broad diagnostic spectrum whose genetic
basis is still uncertain (even though a number of recent
family studies of autism probands suggest the presence
of a broad range of mild behavioral symptoms and pos
sibly related disorders in these families [Bailey et al.
1998]). Although our exclusion of " mild" or autism
" spectrum" cases might be questioned by some who ar
gue strongly for their inclusion within genetic studies,
the only negative effect that this exclusion would have
on our analysis would be to reduce the sample size. A
homogeneous group of strictly defined affected subjects
should maximize the chances of detection of linkage, for
any plausible genetic model.
Although our genomic-screen results are largely neg
ative, in that we did not identify a chromosomal region
with significant linkage evidence, we have not formally
excluded the possibility of one or a few disease-predis
posing loci of moderate effect. On the basis of our re
sults, the most likely location for such a locus or loci is
on chromosome 1 p-and, possibly, on chromosome
17p. We are currently examining these regions more
closely. However, given the lack of strong linkage evi
dence in this large collection of families, positional clon
ing of any susceptibility genes in this disorder may be a
difficult undertaking, and other approaches, such as LD
studies of candidate genes and/or genomewide associa
tion studies may be required.
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